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Abstract
The majority of solid tumours develop hypoxia because oxygen demand exceeds 
oxygen supply. In association with this is the poor prognosis and response to therapy. 
In oncology, it is well appreciated that merging anatomical and functional information 
has a significant impact on the extent of disease and target volume delineation. 
Commercial image-fusion software packages are becoming available but require 
comprehensive evaluation to ensure reliability of image-fusion and the underpinning 
registration algorithms, particularly for radiotherapy. The present work seeks to assess 
such accuracy for a number of available registration methods provided by the 
commercial package ProSoma™.
The molecular imaging modality of Positron Emission Tomography (PET), in 
conjunction with radio-labelled molecules that undergo chemical changes inside 
tumours as a result of the presence or absence of oxygen, has became a promising 
technique for the non-invasive quantification of tumour hypoxia. Herein the 
relationship between tumour hypoxia and vasculature geometry is considered using a 
novel mathematical approach, likewise the spatiotemporal distribution of a hypoxia 
PET sensitive tracer is determined. Representation of the oxygen distribution in 2-D 
vascular architecture using a reaction diffusion model enables quantitative 
relationships to be obtained, specifically between tissue diffusivity, tissue metabolism, 
anatomical structure of blood vessels and oxygen gradients. Similarly, tissue activity 
curves (TAG) are a potential key in providing information on cellular perfusion and 
limited-diffusion. In this thesis a development to the work of Kelly and Brady (2006) 
is described and verified, with a particular interest in simulating TACs of the most 
promising hypoxia PET sensitive tracer, ^"^Cu-ATSM.
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Introduction
/ Head and neck squamous cell carcinoma accounts for approximately 5% of all 
malignant tumours worldwide (Rothschild et al, 2007) and it represents 93% of all 
oral cavity tumours (Goshen et al, 2006). Early stage disease can be cured with either 
radiation or surgery; conversely tumour control for locally advanced head and neck 
squamous cell carcinoma has been less than satisfactory with an estimation of the 
recurrence rate of 30% (Goshen et al, 2006). This in part is due to tumour hypoxia 
(Chao £7 a/., 2001).
Hypoxia in malignant tissue is influenced by the merging of complicated 
physiological phenomenon; increasing tumour aggressiveness, failure of local control 
and metastatic potential of solid tumour. All these pathophysiological complications 
play a significant role in tumour resistance to radiotherapy and chemotherapy 
treatment (Semenza, 2003) and also in surgery (Isa et al, 2006). The resistance of 
hypoxic tumour to chemotherapy is in part related to the inefficient diffusion of drugs, 
as a result of the significant increase of the interstitial fluid pressure (Dayan et a l, 
2008). In radiotherapy it is well appreciated that the presence of oxygen acts as a 
sensitiser agent as it plays a major role in increasing the damage produced by 
radiation (Isa et a l, 2006). The presence of an adequate oxygen tension, of 
approximately 25 -  30 mmHg, significantly increases the lifetime of these toxic free
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radicals, leading to a more effective radiotherapy outcome (Isa et al, 2006, Padhani, 
2005). This in turn explains the poor local control and quality of life in survivors, of 
squamous cell carcinoma patients of head and neck and cervical cancer, where oxygen 
partial pressure ip02), known also as oxygen tension is less than 10 mmHg (Padhani 
et al, 2007).
The goal of radiotherapy is to deliver the necessary radiation dose to cancer cells 
while minimizing dose to surrounding normal tissues. Increasing dose to the whole 
tumour target can cause tissue scarring or necrosis of the structure in which the 
tumour resides, leading to increase in the complication rate (Chao et al, 2001, 
Monogioj et al, 2006). Recently, with the advent of radiotherapy techniques such as 
intensity modulated radiotherapy (IMRT) and image guided radiation therapy (IGRT), 
it has become possible to deliver a higher dose to the tumour while maintaining low 
dose (tissue tolerance) to the surrounding tissue, allowing sparing of critical organs 
and better local tumour control (Daisne et al, 2003, MacManus et al, 2009). Today, 
almost 50% of all cancer patients benefit from radiotherapy during their treatment 
course. Typically, radiotherapy can be required for certain reasons for instance to 
deliver a cure to the patient as a stand alone treatment, to shrink the size of a tumour 
before surgery, to reduce the risk of a cancer recurrence, especially after surgery, to 
complement chemotherapy and to control symptoms and improve quality of life if 
tumours that are too advanced to deliver a cure. As a consequence, determining the 
spatial extent of hypoxia is important in monitoring the response to therapy (Vavere 
and Lewis, 2007), staging of disease that contributes directly to treatment manegment 
(Fukui et a l, 2003) and delineation of tumour sub-volumes, which represents the 
detected hypoxic cells within the gross target volume (/iGTV) for treatment planning 
(Lehtio et al, 2001). Head and neck cancers are an ideal site for this application, as 
such type of gross tumour often including functional structure, with increase of dose 
to the whole target tumour carrying a possibility of significant complications (Chao et 
a l, 2001).
In the light of the above, success of radiotherapy relies in great part on accuracy of 
target volume delineation and dose delivery, both strongly depending on imaging 
technology. In other words, the whole process is influenced by the sensitivity and 
specificity of a particular imaging modality. To date there is no existing imaging
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modality that provides 100% sensitivity (no false-negative examination) or 100% 
specificity (no false-positive examination).
In principle, the use of multimodality imaging is intended to fill the gaps in individual 
imaging modalities, tending to provide more reliable tumour volume delineation that 
eventually leads to a better definitive local control. Ideally, accurate delineation of 
tumour volume has a direct impact on the treatment regime as well as treatment 
complications (McQuade et al, 2005). Clinically, it is well appreciated that merging 
of anatomical and functional information has a significant impact on sensitivity and 
specificity for certain types of cancer, in particular those of the head and neck. 
Grégoire et a l  (2007) have shown through a recent literature survey the various multi­
modality imaging techniques that are now involved in oncology applications. The 
focus of such techniques is on the extent of disease and target volume delineation. As 
already mentioned, typically it is expected that the use of multimodality imaging in 
treatment planning will provide for more reliable tumour volume delineation, 
eventually leading to improved local control, which in turn improves the quality of 
patient cure. Recently studies have shown that PET/CT technology has provided 4% 
to 15% improvement in overall accuracy of staging and restaging and 30% to 50% 
improvement in the confidence of lesion localization (Griffeth, 2005).
The unique feature of the PET modality is that it allows measurements of regional 
tracer concentration in tissue; quantitatively and non-invasively (Huang et a l, 1998). 
In general, the objective of such a procedure is to find and work on a set of features 
which suffer both inter- and intra-variance in patients. In principle, data taken over 
multiple time points, in the form of tissue activity curves (TACs) provide improved 
indication of the presence of hypoxia. The shape of the curve provides information on 
the degree of perfusion and vascularization, as well as the hypoxia fraction (Kelly and 
Brady, 2006). With regard to the ease of use of the various hypoxia PET agents {eg. 
FETNIM and FMISO), researchers have come to consider ^"^Cu-ATSM as an 
exceptional hypoxia agent in terms of the inter and intra-variance in tumour lesions, 
rapid delineation of tumour hypoxia (<1 h) and high tumour to background tissue 
ratio (tumour to blood ratio »  2.0) (Vavere and Lewis, 2007).
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To the best knowledge of the author, ^^Cu-ATSM has not yet been widely involved in 
clinical oncology. There exists little in the published literature that actually establishes 
an indication of clinical trials using ^°Cu-ATSM. More detailed information on ^®Cu- 
ATSM-guided IMRT plans for head and neck patients can be found in Chao et al. 
(2001). To-date, studies have focused on the molecular mechanisms of copper metal 
transporters mediating both entry and exit of copper; there are still at an early stage of 
investigation. Here it is understood that the tumour microenvironment plays a major 
role in patient cure; tumour physiology is clearly of considerable importance in 
establishing confidence in target volume delineation.
1.1 Motivation and Content
This thesis is constructed on the basis of five papers published or submitted to peer 
reviewed journals (Dalah et al, 2008, Dalah et at, 2010a, Dalah et al., 2010b, Dalah 
et al., 2010c, Dalah et ah, 2010d), the nature of which sit between the fields of 
medical imaging and mathematical modeling of systems biology and physiology. 
Understanding of these fields is required in order to allow a discussion of the factors 
contributing to tumour sub-volume delineation. Thus said, a detailed introduction to 
image processing and reconstmction techniques, likewise mathematical modeling, are 
beyond the scope of this thesis; use simply being made of these.
In order to motivate the work that follows. Chapter 2 introduces the phenomenon of 
tumour hypoxia and discusses plasma and oxygen movement. The influence of 
vascular architecture on oxygen tension and heterogeneity will also be discussed. 
Leading to an introduction to different existing methods to quantify hypoxia. Some of 
these are invasive such as the oxygen microelectrodes method, detecting radiation 
induced damaged to DNA and the use of immunohistochemical analysis. Others, 
however, are completely non-invasive such as imaging modalities. As an instance, use 
of the blood oxygen level dependent technique (BOLD) based on magnetic resonance 
imaging (MRI) and the use of nuclear medicine radioactive tracer marker imaging 
techniques, based on the imaging modalities, SPECT and PET, provide for a 
distinctive opportunity to investigate the features of tumour hypoxia (Padhani et al., 
2007). Ultimately, such efforts have lead to the introduction of possibly the most 
sensitive hypoxia PET agent to-date, ^^Çu-ATSM.
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In Chapter 3, discussion is provided of a phantom based study that was designed to 
evaluate the commercial image registration and fusion package ProSoma™. In 
particular, the work seeks to assess the associated accuracy for a number of available 
registration methods: manual based, marker based, volume based and automatic 
based. Registration and fusion were evaluated using CT, MR and PET images. In 
addition, discussion is provided concerning the choice and geometry of fiducial 
markers in phantom studies, the partial volume effect (PVE) and the effect of window 
and level adjustment on target size, especially in regard to the application of 
multimodality imaging in treatment planning.
Based on the above, medical imaging is affected qualitatively and quantitatively. PVE 
is particularly significant with PET imaging, as a major impact of its poor spatial 
resolution. This in turn highlights the need for a subjective analysis study. In Chapter 
4, the focus is towards pointing out the different target delineation methods that are 
used with PET at the present time, with support of visual and semi-automatic based 
studies. The visual based assessment involves experts from the department of nuclear 
medicine and radiotherapy at the Royal Surrey County Hospital (RSCH), while semi­
automatic based study has involved profile analysis at full width half maximum using 
the commercial image manipulation software, hnageJ.
Increased tumour radio-sensitivity with increased oxygen concentration across 
tumour-bearing regions is an important aspect of radiotherapy. Representation of the 
oxygen distribution in a 2-D vascular architecture using a reaction diffusion model 
enables quantitative relationships to be obtained, specifically between tissue 
diffusivity, tissue metabolism, anatomical structure of blood vessels and oxygen 
gradients. In Chapter 5 a development of the reaction diffusion model of Kelly and 
Brady (2006) will be demonstrated, with a significant refinement to the mathematical 
representation of vasculature geometry. The case for this chapter is built upon arguing 
for the difference between oxygen supply, through an existing tumour vasculature and 
neovasculature, on oxygen heterogeneity at the cellular level.
Further work is being developed to simulate the uptake of various positron emission 
tomography (PET) reagents, such as ^^F-FMISO and ^"^Cu-ATSM, to demonstrate 
their potential use in radiation therapy treatment planning as an indicator of tumour
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hypoxic regions. In Chapter 6, the developed representation of tumour vasculature is 
used as the basis of a model to simulate tissue activity curves of ^"^Cu-ATSM. The 
model developed in the present study is a refinement to the novel computerized 
reaction diffusion equation method developed by Kelly and Brady (2006), with a 
particular interest in simulating TACs of the most promising hypoxia selective tracer, 
"^"^Cu-ATSM, demonstrating its potential role in tumour sub-volume delineation for 
radiotherapy treatment planning.
A summary of the main findings of this thesis and recommendations for future work 
will be outlined in Chapter 7.
Tumour Hypoxia
In Chapter 1, the concept of tumour radio-resistance • was introduced. The reason 
behind the poor local control of squamous cell carcinoma patients of head and neck 
and cervical cancer was also explained, addressing a need to detect and quantify 
tumour hypoxia. The present Chapter is intended to give a more detailed preface to 
the causes, vasculature structure and architecture of tumour hypoxia. Further, a brief 
introduction will be given to the different types of tumour hypoxia, highlighting the 
different available techniques that are used clinically to quantify tumour hypoxia, 
pointing out the advantage and disadvantage of each technique. This ultimately leads 
to a prologue of possibly the most promising hypoxia selective positron emission 
tomography agent, ^"^Cu-ATSM.
2.1 Microcirculation in Normal Vasculature
In the human body, the three major types of blood vessel are arteries, these 
demonstrating a more circular shape, and capillaries and veins, demonstrating a semi­
elliptical shape (Figure 2.1). As the heart contracts, it forces oxygenated blood to 
move into the large artery, leaving the ventricles. Blood then passes into smaller 
arteries, till they reach their smallest branches, the arterioles, the latter feeding into the 
capillary beds of body organs and tissue. Blood drains from capillaries into venules.
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the smallest veins and then on into the larger veins that ultimately empty into the 
heart. Such description is fully illustrated in Figure 2.2.
Of all blood vessels, only capillaries have intimate contact with tissue cells, directly 
providing for cellular needs. This in turn is due to the microscopic structure of 
capillaries. Because of the exclusive role that capillaries play among all blood vessels 
in the microcirculation process at the microcellular level, a brief introduction to the 
geometry and functional performance of capillaries will follow.
Figure 2.1 : Doppler-ultrasonography demonstrating an artery (A) that takes a more 
circular shape and a vein (V) which takes on a more elliptical shape. Adapted from 
Lauer et al. (2001).
Capillaries
In general, capillaries have a length that ranges from 0.25 -  1 mm, with an average 
diameter ranging from 8 - 1 0  pm, just large enough for red blood cells (~ 8 pm in 
diameter) to slip through. Most tissues have a rich capillary supply with the exception 
of cartilage and epithelia that suffer from a lack of capillaries, but they still receive 
nutrients from blood vessels in nearby connective tissues. Capillaries, however, do not 
function independently, instead they tend to form an interweaving network called 
capillary beds. The flow of blood from an arteriole to a venule is through a capillary 
bed and is refened to as the microcirculation.
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In most body regions a capillary bed consists of two types of vessels: (1) a vascular 
shunt, the short vessel that directly connects the arteriole and venule at opposite ends 
of the capillary beds and (2) true capillaries, the actual exchange vessels. The true 
capillary acts as a valve to regulate blood flow into the capillary. Thus, blood flowing 
through a terminal arteriole may go either through the true capillaries or through the 
shunt. When the pre-capillary sphincters are relaxed, and therefore open, blood flows 
through the true capillaries and the microcirculation supplies the tissue cells. 
Conversely, when the sphincters are contracted (closed), blood flows through the 
shunts and bypasses the tissue cells, see Figure 2.2. This in turn leads to the concept 
of fluid movement in those capillaries.
V ascu lar shunt
Precapiilary sp h incters
M etartenole
T horoughfare  
channel
T erm inal
(a) Sphincters op en
P o stca p illa ry
ven u le
(b) Sphincters closed
C a p illary  b e d s
Postcapillary
ven u le
Figure 2.2: Illustration of oxygenated blood (depicted in red) and deoxygenated blood 
(depicted in blue) together with a depiction of the microscopic structure of capillary 
beds. In detail. Figure 2.2a shows the process of microcirculation, the true capillaries 
taking part in this process, whereas Figure 2.2b shows bypassing of the 
microcireulation (adapted from Marieb, 2004).
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Movement of Fluid along the Capillary
Movement of fluid along each capillary is in part dominated by the blood pressure 
gradient along the capillary. By the time blood reaches the capillaries, the blood 
pressure drops to approximately 40 mmHg and by the end of the capillaries it is only 
20 mmHg or less (Figure 2.3). Such low capillary pressures are desirable because (1) 
capillaries are fragile and high pressures would rupture them and (2) most capillaries 
are extremely permeable and thus even the low capillary pressure forces solute 
containing fluids to filters out of the bloodstream into the interstitial space causing 
high interstitial fluid pressure, a phenomenon that is highly associated with solid 
tumours.
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Figure 2.3: High blood pressure is observed for the arterial system, starting from 120 
mmHg and reducing to 40 mmHg at the arterioles (the opening side to capillaries), 
followed by a blood pressure decrease at the venules (the exit side of capillaries). The 
gradient between capillary ends is usually in the range of 20 mmHg or less (adapted 
from Marieb, 2004).
Typically, all the nutrient and gas exchange occurs across the capillary walls by 
diffusion. Fluid is forced out of the capillaries at the arterial end of the capillary beds 
while most of it returns to the bloodstream at the venules end. The direction and 
amount of fluid that flows across the capillary wall reflects the balance between the 
two dynamic and opposing pressures that control the mechanisms of gain and loss.
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known as the hydrostatic and colloid osmotic pressures. Figure 2.4 demonstrates, in 
terms of typical values, the pressure level of these two dynamic forces. The pressure 
values represent the pressure level in normal vasculature.
The hydrostatic pressure (HPc) is responsible for the fluid pressing against the 
capillary wall (the hydrostatic pressure is the same as the blood pressure) while the 
colloid osmotic pressure (OPc) is the opposing hydrostatic pressure which tends to 
force fluid into the capillary wall back to the bloodstream. In theory, blood pressure 
which forces fluid out of the capillaries is opposed by the interstitial fluid hydrostatic 
pressure (HPif) acting outside the capillary and pushing fluid in. Therefore, the net 
effective hydrostatic pressure (netHP) acting on the capillaries at any point is the 
difference between HPc and HPif.
The netHP ranges from 35 -  40 mmHg at the arterial end and 1 7 - 2 0  mmHg at the 
venous end. Similarly, the net effective osmotic pressure (netOP), which pulls fluid 
back into capillary bloodstreams is -  25 mmHg. Thus one can determine whether 
there is a net gain or loss of fluid from the blood by calculating the net filtration 
pressure NFP. This has been described in greater detail in Junquerira et al. (1989) and 
Marieb (2004). In tumour vasculature, clinical examination of e.g., cervical cancer 
patients have shown significantly elevated interstitial fluid pressure (EFP), ranging 
from -  3 to 48 mmHg with a median of 19 mmHg, compared to normal tissue IFP, 
which ranges from -  5 to 5 mmHg (Milosevic et al., 1998; Milosevic et al., 2001).
Now that we have discussed the two dynamic and opposing pressures that control the 
mechanisms of gain and loss at each point along the capillary wall, we will proceed to 
give a brief introduction to the different types of diffusion that molecules undergo 
(e.g., oxygen molecules) in order to reach their final destination, cell cytoplasm.
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Figure 2.4: The balance between the two dynamic and opposing pressures that control 
the mechanisms of gain (delivery) at the left end of the capillary and loss (collection) 
at the right end of the capillary, being known as the hydrostatic and colloid osmotic 
pressures. The figure has been taken from Marieb (2004).
Plasma Membrane Transport
The cells of the body are submerged in interstitial fluid (extra-cellular fluid), as 
illustrated in Figure 2.5. The interstitial fluid consists of a huge number of substances 
including, amino acids, sugar, fatty acids, vitamins, regulatory substance such as 
hormones, salts and waste products. Thus, in order for cells to remain healthy, each 
cell must extract certain amounts of the substance from this mixture at a specific time. 
The selective permeability of the cell plasma membrane is a characteristic of healthy 
intact cells. When this plasma membrane is severely damaged the membrane becomes 
permeable and allows substances to flow into and out of the cell freely, a phenomenon 
that been evident with development of cancer.
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Figure 2.5: Tissue cells are submerged in the interstitial fluid. A red blood cell 
approaches the tissue cell in need of oxygen and deposits oxygen in it through the 
arterioles. The carbon dioxide is taken from the cell through the venules (adapted 
from Marieb, 2004).
Typically, substances move through the plasma membrane in two ways, passively or 
actively. In the passive process, substances cross the membrane without any energy 
input from the cell. Conversely, in the active process, the cell provides the metabolic 
energy needed to move substances across the membrane. An explanation of the full 
passive and active process is beyond the scope of this thesis; the reader is therefore 
referred to the excellent text of Junquerira et al. (1989).
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In brief, the two main types of passive transport in cells are diffusion and filtration. 
Diffusion is an important means of passive membrane transport for every cell of the 
body; it is upon this that a molecules’ kinetic energy depends. The speed of diffusion 
is influenced by (1) molecular size (i.e. smaller molecules appear to move faster) and 
(2) temperature (i.e. the warmer the molecule the faster its movement). By contrast, 
filtration generally occurs only across capillary walls.
In regard to the foregoing, a molecule will diffuse through the membrane by simple 
diffusion, facilitated diffusion and carrier assisted diffusion (Figure 2.6). Simple 
diffusion take place when lipid-soluble substances diffuse directly through the lipid 
bilayer. Such substances include oxygen, carbon dioxide, fat-soluble vitamins and 
alcohol. In distinction, facilitated diffusion is when substances are unable to pass 
through the lipid bilayer; such substance can transport either by binding to protein 
carrier in the membrane or by movement through water-filled protein channels. Those 
substances include certain molecules such as glucose, amino acids and ions. 
Conversely, large molecules (e.g. proteins) passes across the lipid bilayer through an 
integral protein called carrier. At this stage our focus is toward understanding the 
mechanism of oxygen movements.
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gradient
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Figure 2.6: Simple diffusion includes substance such as oxygen, carbon dioxide, fat- 
soluble vitamins and alcohol. Facilitated diffusion includes substances such as 
glucose, amino acids and ions that either need to bind to protein carrier in the 
membrane or that move through water-filled protein channels. Finally, larger 
molecules, for instance sugar, can pass only by combining to an integral protein called 
carrier. The figure has been taken from Marieb (2004).
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Oxygen Movements
The pattern of oxygen movement is even more complex to that described above; as 
blood passes through the lungs, oxygen diffuses down its partial pressure gradient 
from the alveoli into the bloodstream where it combines with haemoglobin (Hb) in the 
red blood cells and is carried through the heart down into large and small arteries, 
finally branching into a capillary network to be drained into the collecting venules 
(Hoofd, 1993). In this pathway, and particularly in the capillaries, oxygen is released 
from its carrier, the haemoglobin, at the arteriole end and transported by diffusion 
through the plasma into the capillary membrane to the tissue in a radial direction.
In addition to the radial direction, oxygen also moves along the capillary as shown in 
Figure 2.5, down its partial pressure gradient, in an axial direction. In general, typical 
values for arteriole blood range from 80 -  100 mmHg (Vaupel et a l, 1989) and by the 
time the venule ends are reached it drops below 40 -  45 mmHg (Hockel and Vaupel,
2001). With such oxygen tension gradients, the axial movement through capillaries is 
maintained. This wide range of oxygen tension (p02) spectrum has been found in 
blood, normal tissues and malignant tissues (Vaupel et al., 1989), see Figure 2.7. The 
latter finding was also confirmed by Filho et al. (1994), with no statistical differences 
between blood p02 in normal and tumour blood vessels being found. The reversible 
combination of oxygen with myoglobin (Mb) will, at the cellular level in tissue, allow 
oxygen to transport by diffusion in two ways: the diffusion of free oxygen, referred to 
as the oxygen partial pressure pÛ2 and measured in mmHg, and by diffusion of the 
complex myoglobin molecule that is usually measured in terms of oxygen 
concentration (Salathè and Kolkka, 1986).
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Figure 2.7: Range of pÛ2 values usually found in blood, normal tissues and malignant 
tissues, adapted from Vaupel et al. (1989).
2.2 Vascular Architectures and Oxygen Tension
The major types of solid tumour, for example squamous cell carcinomas, gliomas, 
adeno-carcinoma (breast and pancreas) and sarcomas develop hypoxia because 
oxygen demand exceeds oxygen supply (Lanzen et al., 2006). This oxygen deficiency 
can be related to a number of factors, such as low oxygen partial pressure in arterial 
blood as a result of pulmonary diseases: it reduces the ability of red blood cells to 
carry oxygen as a result of anemia, methemoglobin formation, or carbon monoxide 
poisoning; there is reduced tissue perfusion and inability of cells to use and 
metabolize oxygen because of intoxication (Hockel and Vaupel, 2001). In addition, 
the fact that oxygen has low solubility in tissue (Secomb et al., 2004) results in its 
limited diffusion distance into the tissue, ranging from 150 -  200 p,m outside the 
vasculature (Hill 1928; Isa et ah, 2006; Oh et al., 2009). Therefore, cells that continue 
to grow out of the tumour vasculature, generally beyond 1 - 2  mm^ (Padhani et al., 
2007) receive less oxygen and thus become hypoxic, see Figure 2.8.
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Figure 2.8; Pattern of viable, hypoxic and necrotic cells in a solid tumour. Anoxia, 
i.e., a complete lack of oxygen, occurs in tumours with a radius in the region of 150 
pm or larger (adapted from Pharm et al. 2004).
One way for the vasculature to overcome the issue of oxygen and nutrient deficiency 
is to develop new blood vessels whose origin can be from two different but yet 
existing populations: a vessel could be generated from (1) pre-existing host vessels, 
which provide the stmcture from which neovascularization arises and (2) it might also 
be generated from tumour micro-vessels that arise from neovascularisation as a result 
of tumour angiogenesis factors. With the existences of the two types of vessel 
generation in tumour vasculature, tumour regions can be classified into three major 
categories (1) well oxygenated regions maintained through pre-existing host vessels;
(2) hypoxic regions, a subsequent development to neovascularization and (3) necrotic 
regions (dead region).
Simply, when a new vessel is generated from pre-existing vascularity a series of 
morphological and functional changes occur. First, the venules become tortuous, 
elongated, and often dilated to the extent that there is no increase in the micro-vessels 
density; this causes a reduction in the exchange area for oxygen and waste products. 
Arterial vessels on the other hand seem to remain functionally intact and probably 
maintain and respond to physiological and pharmacological stimuli. Conversely, when 
the vessel is generated from neovasculature the vessel usually originates from the 
venule side of the tumour mass so that the newly formed vascular network is both
17
Chapter!. Tumour Hypoxia
supplied and drained by venules. As a consequence, the oxygenation level in tumour 
tissue cells will be significantly reduced. This is simply due to the low initial oxygen 
partial pressure that reaches the supply end of the capillary. In this circumstance for a 
supply venule with a typical pressure of 40 mmHg or less (and by the time oxygen 
reaches the drainage end of the capillary, which is also a venule), the oxygen tension 
typically decreases to 20 mmHg or less, as discussed in section 2.1. This is described 
in greater detail by Vaupel et al. (1989).
The deficiency in supply induces abnormal vascular architecture, being typically 
associated with a variable micro-vessel density (MVD) based on different tumour 
types. However, MVD heterogeneity has also been seen in the same tumour cell-line 
(Schor et al., 1998). For instance, the histological section of neoplastic lymph nodes 
have shown micro-vessel densities (MVDs) in the range of 241 ±72 micro vessels mm" 
 ^ (Wolfesberger et al., 2008), while histological sections of colon adenocarcinoma 
tumour cell-lines have shown MVDs in the range of 183.7 ± 33 microvessels mm"  ^
(Fukumura et al, 1997). An average of 92 vessels mm"  ^was seen in seven histological 
sections of fibroscarcoma tumour by Pogue et al. (2001). Fenton et al. (1999) have 
seen an average of 189 vessels mm'^ in a sarcoma tumour cell-line. These are 
somewhat different to the values employed by Kelly and Brady (2006), who use a 
value of 58.1 ± 9.5 microvessels mm'^. Further to the observation of Schor et al. 
(1998), MVD heterogeneity is also influenced by the tumour region. In two lung 
tumour masses, a higher MVD was observed at the tumour periphery, with an average 
of 203 vessels mm'^, while lower MVD was seen midway to and near the tumour 
centre (core), with an average of 172 and 92 vessels mm'^, respectively. Such tumour 
blood vessels are usually disorganized, permeable, leaky, twisted, unevenly 
distributed with irregular diameter and expressing unusual branching patterns (Yuan 
et al., 1995; Schor et al., 1998; Vaupel et al., 1989; Padhani et al., 2007). See Figure
2.9 for an illustration of this.
In associated with this, is the aggressiveness and ability for spreading of metastatic 
seeds through body lymph circulation, thus inducing secondary tumours in different 
sites of the body (O'Donoghue et ah, 2004).
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Figure 2.9: 3-D reconstructed scanning electron microscope image used for 
quantitative measurements of normal vasculature (left) and tumour vasculature (right), 
adapted from Konerding et al. 1999.
Hypoxia Environment and Angiogenesis
It is appreciated that causes of cancer can be initiated at the microscopic (intracellular) 
scale, the mesoscopic (cellular) and macroscopic (tissue) scales. The cellular scale 
controls process such as migration of metastatic cells, angiogenesis and hypoxia (Hu 
and Verkman, 2006). On the process of hypoxia however, a large amount of clinical 
evidence suggests that hypoxia aggressive behavior is associated with the hypoxia 
inducible factor - 1 alpha (HIF-la) (Serganova et al., 2006). The HIF-la, usually 
adapts to changes in the cologenic cells that are centrally located on the tumour when 
oxygen tension pÛ2 is in the range of - 0 . 2 - 1  mmHg. These cologenic cells have the 
power to overcome nutrient deprivation and escape the hostile environment either 
through metastasis (Padhani et ah, 2007) or by promoting cell mutation (McQuade et 
ah, 2005). As they remain viable after treatment, this raises the possibility of 
secondary metastasis and disease recurrence.
In principle, as tumour cells grow beyond the oxygen limited diffusion distance, the 
tumour vasculature promotes the host vasculature system to supply more nutrients and 
oxygen to its cells; in order to compensate for oxygen and nutrient deficiency, such 
mechanism is known as tumour induces angiogenesis (Chaplain et a l, 2006).
Angiogenesis is a process of inducing new vascular network is the growing tissue that 
usually transfers tumour from a harmless state to a malignant state, known as the 
'switch’. Normally, there are a number of angiogenesis mediators arising from cancer
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cells, extracellular matrix, stormal cells (i.e. connective tissue cells), blood and 
endothelial cells. From this, the most important is the vascular endothelial growth 
factor (VEGR) family (Vaupel and Harrison, 2004). This group stimulates plasma 
protein leakage that further stimulates blood vessels permeability, resulting in increase 
of intra-tumoral pressure. This facilitates more tumour cells entry into bloodstream, 
thus increasing the possibility of permitting metastasis seeding (Ballinger, 2001). 
Simultaneously, VEGF diffuses out of the tumoural vascular toward the host vascular 
system to initiate the growth of new blood vessel sprouting which migrate towards 
and penetrate the tumour (Chaplain et ah, 2006). The whole process is illustrated in 
Figure 2.10, leading to an increase in the tumour size and the micro-vessel densities. 
Such a process is developed over relatively large temporal scale, in the range of weeks 
and even longer.
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Figure 2.10: The various stages of angiogenesis, (1) endothelial cells degrade basal 
lamina and begin to migrate; (2) endothelial cells form sprouts which start branching;
(3) sprouts grows toward tumour and branching increases; (4) sprouts finally connect 
with tumour, completing angiogenesis (Schor et al., 1981).
The angiogenesis sprouts that eventually produce the vascular network are currently 
the focus of numerous studies since the factors effecting the generation of these 
sprouts may raise some light on where the deregulation is occurring in tumour 
angiogenesis (switch). However, hypoxia or low pÛ2 tension is not the only reason 
behind the stimulation of angiogenesis factors; others include low pH and 
hypoglycemia (Johns and Cunningham, 1981).
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2.3 Types of Tumour Hypoxia and Detection Methods
Tumour hypoxia can occur in three major ways through means of: (1) perfusion 
related acute hypoxia that appears from inadequate blood flow in tumour cells, such a 
tumour is often caused by temporary occlusion and temporary increases in interstitial 
pressure; (2) diffusion related chronic hypoxia, caused due to the increase of oxygen 
diffusion distances, as a result of tumour expansion; (3) Anemic hypoxia that is 
related to reduced 0% carrier capacity in blood, which might be through tumour 
association or treatment related (Lewis et al., 2001;Padhani et al., 2007).
Assessing tumour hypoxia in humans has been shown to be difficult due to the lack 
of: reliability, reproducibility and practicality (Chao et al., 2001). Table 2.1 lists a 
number of clinically validated techniques; these are classified based on their 
invasiveness, contract, in the case of imaging technique (i.e., image contrast), spatial 
coverage (e.g., 2D or 3D) and their application. Then we will consider each technique 
individually, highlighting its advantages and disadvantages.
Table 2.1: Techniques used to quantify tumour hypoxia.
Techniques Invasive Spatial
coverage
Contrast Measures
Polarographic
electrode
Yes 2D Relatively
high
Oxygen tension
DNA analysis Yes 2D High Hypoxic cells
Fluorescence and 
immunohistochemical 
analysis
Yes 2D High Hypoxic extent
Autoradio graphy Yes 2D High Hypoxic extent
BOLD-MRI No 3D Relatively
high
Blood flow + 
deoxyhaemoglobin
SPECT&PET No 3D Poor Blood flow + 
hypoxic extent
Polarographic Electrode
Here, the oxygen microelectrode is based on the polarographic method and is one of 
the most widely used devices for measuring tumour oxygenation quantitatively. In 
general, the polarographic oxygen analyzer incorporates an electrochemical sensor 
that responds to changes in the partial pressure of the oxygen in a sample. The sensor 
cell consists of: (1) a cathode, or sensing electrode; (2) an anode, or reference
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electrode and; (3) an electrolyte, usually aqueous potassium chloride. The cathode is 
separated from the blood sample by a permeable membrane that permits the diffusion 
of oxygen from the blood sample into the measurement cell. A predetermined 
voltage, selected to make the sensor specific for oxygen, is applied between the two 
electrodes. When the sensor is exposed to the sample, the oxygen in the sample 
diffuses through the membrane to the sensing surface of the cathode where it is 
electrochemically reduced and produces a linear output current that is proportional to 
the partial-pressure changes of the oxygen in the sample (Toma-Dasu, 2004).
Although the microelectrode probe provides a quantitative measurement it does not 
provide spatial information, the key factor in target delineation in radiotherapy. 
Moreover, its invasive nature and technical limitations in distinguishing between 
viable hypoxic tumour tissue and necrotic tissue has limited its use. In addition, the 
method has a poor access to deep located tumour sites such as primaries in the 
esophagus, larynx and lung (Lehtio et al., 2001). Furthermore, the turbulence effect 
caused by injecting the electrode needle reduces its reliability (McDougall et al.,
2002). On the other hand, the method is applicable to certain tumour types, such as 
those of the head and neck, prostate, breast and soft tissue (Ballinger, 2001).
In addition to the microelectrode technique, a number of invasive methods have been 
developed to measure the spatial extent of hypoxic cells within a tumour. Detecting 
radiation induced damaged to DNA is one of such interest, use being made of a needle 
biopsy immediately after a single dose of 3.5 -  10 Gy. Because small fragments of 
damaged DNA migrate faster than the intact DNA, use of gel electrophoresis allows 
analysis of DNA shape, consequently leading to determination of hypoxic cells. The 
technique is attractive as it allows direct measurement to the damaged DNA but it 
suffers the drawback of invasiveness and limited accessibility to a number of tumours. 
In addition, the technique is applicable only to tumours treated with relatively large 
radiotherapy doses (Ballinger, 2001 ; Isa et al., 2006).
Another technique, but completely invasive, is the use of nitromidazoles compounds 
together with fluorescence microscopy or immunohistochemical analysis. 
Nitromidazoles are a group of compounds that are selectively trapped in viable 
hypoxic cells, among this group of compounds, pimonidazole BF5 that is widely used
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in practice. The later is introduced to a body intravenously, and after allowing 
sufficient time for distribution and binding, a biopsy specimen usually in the form of 
very thin tissue slices is taken from the tumour. This of course requires extraction of 
the tumour from the body. To determine the bounded EF5 in tumour, an appropriate 
antibody tagged with a fluorescent or immunohistochemical signal is used. Therefore, 
hypoxic cells extent can be determined with extremely high resolution either by using 
fluorescence microscopy or immunohistochemistry (Ballinger, 2001). Similarly, one 
can also list the use of a positron emitter radionuclide with an autoradiography (AR) 
imaging technique system; while the technique is completely invasive, it nevertheless 
allows high image contrast analysis of hypoxic cell extent (Dence gr al, 2008).
Because the common feature of the above techniques are their invasive character, we 
now turn to non-invasive techniques. Here recent review has highlighted two 
modalities that show potential for application in this area; the blood oxygen level 
dependent technique (BOLD) using magnetic resonance imaging (MRI) and the use of 
a radioactive tracer marker imaging technique, in which nuclear medicine imaging 
modalities, SPECT and PET, provide a distinctive opportunity to investigate the 
features of tumour hypoxia (Padhani et ah, 2007). While SPECT has much to offer as 
a nuclear medicine imaging technique, the sensitivity and spatial resolution of PET is 
by comparison much better.
BOLD-MRI
In brief, conventional magnetic resonance imaging (MRI) measures the behavioral 
properties of hydrogen nuclei (protons) in tissue. Typically, protons spin about their 
axes in a random alignment but when they are placed in a strong magnetic field a 
proportion of those protons align with the direction of the magnetic field. Such 
aligned position is physically slightly favourable, as the nucleus is at a lower energy 
in this position. This results in a net or macroscopic magnetization pointing in the 
direction of the main magnetic field. Exposure of individual nuclei to radiofrequency 
(RF) radiation causes nuclei excitation, leading to promotion of the nuclei to a higher 
energy state. Over time, nuclei relax back to the low energy state, energy exchange 
taking place with surrounding nuclei, a process measured in terms of the spin-lattice 
relaxation time T l. However, when energy exchange take place elsewhere not with
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the surrounding nuclei, this results macroscopically in loss of the transverse 
magnetization leading to spin-spin relaxation time T2. MR images are formed from 
the signal generated from both T l and T2. All of T l and T2 relaxation time are 
approximately the same in pure water, 2 - 3  seconds. However, in biological 
materials, T2 relaxation time is considerably shorter than T l relaxation time. For 
instance in cerebrospinal fluid (CSF), T l = 1.9 seconds and T2 = 0.25 seconds, 
whereas for brain white matter, T l =0 .5  seconds and T2 = 0.07 seconds. Tissue 
contrast in BOLD, using magnetic resonance imaging (MRI), BOLD-MRI, is in part 
affected by blood flow and paramagnetic deoxyhaemoglobin within the red blood 
cells (i.e., where oxyhaemoglobin is not paramagnetic). Deoxyhaemoglobin increases 
the magnetic resonance (MR) transverse relaxation rate of water in blood and 
surrounding tissues. This explains the sensitivity of BOLD-MRI to the oxygen tension 
level within the tumour and to tissue adjacent to perfused vessels. As such, BOLD- 
MRI images are more likely to reflect on acute (perfusion-related) tissue hypoxia that 
occurs because of transient occlusions of vessels, and on tissue oxygenation. The 
latter is based on the assumption that the oxygenation of haemoglobin is proportional 
to blood arterial p 0 2  which is in equilibrium with oxygenation of surrounding tissues. 
The primary advantages of BOLD-MRI are that there is no need to administer a 
radioactive contrast agent and images at high temporal resolution and with high 
spatial resolution, can be obtained and repeated as needed. The major limitations of 
BOLD-MRI include the fact that they do not measure tissue p02  directly either in 
blood or in tissues, resulting from the non-linear relationship of the transverse 
relaxation rate of water and tissue p02. This non-linearity issue, which leads to 
inaccurate quantitative measurement of oxygen tension in blood and tissue, are 
explained clearly by Ballinger (1998) and Padhani et al. (2007).
Hypoxia SPECT and PET Reagents
In recent decades investigations into alternative, non-invasive imaging methods for 
measuring the level of oxygen tension within tumour regions have been pursued by 
numerous researchers. The use of single photon emission computerised tomography 
(SPECT) and positron emission tomography (PET) in conjunction with radio-labelled 
molecules that undergo chemical changes inside tumours as a result of the presence or 
absence of oxygen, has led to a number of promising SPECT and PET reagents. As an 
example, from the labeling of active ^^ °I (half-life of 13 hours) with lAZGP
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(galactopyranoside) and using the image technology of SPECT, it has been shown that 
there is rapid clearance of lAZGP from bloodstream. However, its accumulation in 
tissue does not match microelectrode measurements (Ballinger, 2001; Chapman et al., 
2001). On the other hand, ^^02 is considered to be the gold standard PET agent for 
tumour hypoxia (Serganova et al., 2006), its only drawback is the short half-life of 2 
minutes.
The current lead PET agent is with a half-life of 109.8 minutes, this agent being 
examined by number of research groups (Darling et ah, 1998; Rasey et ah, 2000; 
Serganove et ah, 2006; Padhani et ah, 2007) and labeled to different tracers, such as 
FMISO (fluromisonidazole), FDG (fluoro-2-deoxy-D-gloucose) and FETNIM 
(fluoroerythrontro-imidaole).
^^F-FETNIM is a potential possible substance candidate for exploring the sensitive to 
hypoxia. Lehtio and co-workers (2001) reported a variable uptake of FETNIM in the 
blood flow of head and neck patients, with clear tumour to muscle uptake (i.e., good 
image contrast) 3 hours after injection.
Another clinical experience was reported using FMISO; the tracer was extensively 
evaluated in certain types of tumour, such as head and neck, kidney, lung, and 
prostate (Dearling et ah, 1998; Ballinger, 2001; Padhani et ah, 2007). Additionally, its 
biochemical and synthesis structures have been discussed in detail by Chang et ah 
(2007). FMISO has the advantage of being well tolerated by patients, the imaging 
session requiring from 20 -  30 minutes, conducted anywhere between 75 -  150 
minutes after injection (similar to that for a bone scan). Useful and well validated 
images can be achieved with a modest dose of radiation, commensurate with typically 
250 -  400 MBq of activity.
FMISO has shown to produce a homogeneous uptake in most normal tissue, and its 
tumour delivery is not limited by perfusion. Because of its partition coefficient (< 1), 
it diffuses freely into all cells. FMISO is blood flow dependent, accumulating in tissue 
by binding to intracellular macromolecules of p02 < 10 mmHg. Although FMISO has 
shown a direct effect with respect to tumour oxygenation, it nevertheless suffers the 
limitation of low contrast ratio between hypoxic tumours and normal tissues, with
25
Chapter!. Tumour Hypoxia
tumour to blood ratio >1.2 (Rasey et al., 2000; Vavere and Lewis, 2007). In addition, 
the complexity of its metabolic pattern slows the cellular washout of the tracer, which 
requires a delay of approximately 2 hours after injection to permit clearance from 
normal background tissues.
In an effort to better characterize the relationships between FETNIM and FMISO, a 
number of studies (Chapman et al., 2001; Lehtio et al., 2001; Tolvanen et al., 2002) 
have investigated the uptake correlation of both FETNIM and FMISO in head and 
neck cancer patients. While in all of these studies no difference was observed in intra 
tumor uptake using both tracers, higher uptake in normal tissue was observed with 
FMISO. Nevertheless, FETNIM tends to be more hydrophilic than FMISO, leading to 
a slightly higher effective dose (0.017 versus 0.013 mSv/MBq).
Similarly, Rajendran et al. (2004) and Thorwarth et al. (2006) have studied the 
correlation between FDG and FMISO in 12 head and neck cancer patients. Both 
studies agreed that the uptake correlation between FDG and tumour hypoxia is still of 
concern, also revealing no general correlation between FDG and FMISO uptake. 
However, some of the studies did produce poor correlation between both FDG and 
FMISO to early chemotherapy or radiotherapy response.
Further to the discussion above, FMISO uptake has shown direct relation to tumour 
oxygenation level, however, its low contrast image and slow blood clearance raises 
the need for an alternative PET agent. We therefore, give a more detailed introduction 
to the possibly most promising hypoxia PET selective agent, ^"^Cu-ATSM. The 
discussion begins by presenting copper radioisotopes in context.
Copper Radionuclide Family
Copper metal is an essential element for many important cellular reactions, in 
particular, those which rely on the redox property (i.e. oxygenation status of tissue 
cells). Because a high concentration of Cu is toxic, intracellular copper is tightly 
regulated, so only sufficient amount will be absorbed while the excess copper is 
efficiently excreted. The mechanism of copper entry into cells may be mediated by 
divalent metal transporter 1 (DMTl) or copper transporter 1 (Ctrl); the first is thought 
to be controlling copper (II) uptake in the small intestine, whereas Ctrl is thought to
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mediate Cu (I) uptake in many tissue. For more information the reader is referred to 
Fisses and Kaplan (2005). However, studies that focus on the molecular mechanism 
of copper transporters, mediating both entry and exit of copper are still at an early 
stage of investigation.
More recently, the copper radionuclide family has attracted a considerable attention in 
nuclear medicine. In particular, they have the potential for both diagnosis, such as 
^°Cu, ^^Cu, ^^Cu and "^^ Cu, and therapy, for instance "^^ Cu and ^^Cu (Dearling et al., 
1998). McCarthy and co-workers (1999) have produced a comparison between copper 
radionuclides, the focus of which is the half-life and production. Table 2.2 shows the 
physical characteristic of the whole copper radionuclide family, together with the 
application of copper radionuclides.
Although ^^Cu is a generator produced radionuclide, the short half-life (~ 9 hours) of 
the parent ^^Zn has limited its usefulness. Conversely, the longer lived ^^Cu (half-life,
61.9 hours) is being produced at high yield using a high energy proton beam at 
Brookhaven National Laboratories (BLIP), the high energy physics facilities allowing 
only limited availability of this radionuclide. "^^ Cu with its intermediate half-life of 
12.7 hours has applications for both imaging and therapy. ^°Cu has a half-life of 23.7 
minutes while ^^Cu has a longer half-life of 3.32 hours; both are produced using 
biomedical cyclotrons. Similar to ^^ F, the ^"^Cu-bis(thiosemic^bazone) complex, 
shown in Figure 2.11, have also been labeled with different tracers as shown in Table 
2.3. Investigating the hypoxia selectivity in tumour and other tissues using "^^ Cu- 
bis(thiosemicarbazone) complexes and other different tracers has been the main 
interest of a number of research groups (Darling et al, 1998; Fujibayashi et al., 1999; 
Obata et al., 2005).
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Table 2.2: Physical characteristics of the Cu radionuclide family (McCarthy et al., 
1999; Obata 2005).
Nuclide M ajor gamma Decay mode  ^maximum Application
^"Cu 1333 keV 
&1760 keV 
&850keV
93% ( +) 
&7% (EC)
3.92M eV(6% )&
3.00 MeV(18%)
2.00 MeV(69%)
Hypoxia 
imaging tracer "
^'Cu 284 keV
& 656 keV
60% ( +) 
&40% (EC)
1.22 MeV Hypoxia 
imaging tracer
“ Cu 875 keV 98% ( +) 
& 2% (EC)
2.91 MeV Hypoxia + 
blood flow 
imaging tracer
"^Cu 1345 keV 19% ( +) 
&43%(EC) 
&3 8%(  )
0.656 MeV Hypoxia 
imaging tracer 
+ therapeutic 
agent
Figure 2.11: The chemical structures of "^^ Cu- bis(thiosemicarbazone) complexes that 
allows binding to the different chemical analogues shown in Table 2.3, through 
combing with the four free chains R ,^ R  ^ and R"^  (Fig. adapted from Vavere and 
Lewis, 2007).
Possibly the most promising hypoxic reagent is copper(II)-diacetyl-bis(N4- 
methylthiosemicarbazone), or ^"^Cu-ATSM, which was developed as an alternative to
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^^F-FMISO. ^"^Cu-ATSM is a neutral lipophilic molecule of low molecular weight, 
high membrane permeability, and low redox potential (- 297 mV) (Fujibayashi et al., 
1997; Atf et al., 2003). As a result, ^"^Cu-ATSM shows a rapid delineation of tumour 
hypoxia, less than 1 hour from injection and a reasonably high tumour to blood ratio 
» 2  (Dence et al., 2008). Therefore, ^^Cu-ATSM holds exceptional promise as an 
agent for delineating sub-volumes of tumour regions (AGTV) using PET (McCarthy et 
al., 1999; Obata et al., 2005; Padhanie et al., 2007).
Table 2.3: Results from an
bis(thiosemicarbazone) complexes, 
(Vavere and Lewis, 2007).
in vitro study comparing thirteen ^^Cu- 
where only five of them were hypoxia selective
Complex R" R^ R^ R^ Selectivity in Chinese Hamster Ovary 
cell-line type (CHO320)
Cu-GTS H H H H Normoxia (significant)
Cu-GTSM H H CHs H Normoxia (significant)
Cu-PTS C H s H H H Not significant
Cu-PTSM CHs H C H s H Hypoxia (significant)
Cu-PTSMz CHs H C H s C H s Not significant
Cu-PTSE CHs H C 2 H 5 H Normoxia (significant)
Cu-PTSP C H s H C 2 H 5 H Not significant
Cu-ATS C H s CHs H H Not significant
Cu-ATSM CHs C H s C H s H Hypoxia (highly significant, P<0.0001)
Cu-CTS C 2 H 5 C H s H H Hypoxia (highly significant, P<0.00095)
Cu-CTSM C 2 H 5 CHs C H s H Not significant
Cu-DTS C 2 H 5 C 2 H 5 H H Hypoxia (highly significant, P<0.0001)
Cu-DTSM C 2 H 5 C 2 H 5 C H s H Hypoxia (highly significant, P<0.0026)
Retention Mechanism of ^ ^Cu-ATSM in Tumour Hypoxia
Based on literature reports on cellular Cu metabolism, the initial cellular accumulation 
of Cu-ATSM is driven by filtration across the membrane followed by the reduction of 
Cu(II)-ATSM to Cu(I)-ATSM and trapping of the latter complex in the cellular space. 
A schematic diagram demonstrating this process is illustrated in Fig 2.12. When the
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unstable complex Cu(II)-ATSM reaches the extracellular space, it dissociates into 
Cu(II)-ATSM and Cu(I)-ATSM, followed by retention or washout based on the 
oxygen tension level of cellular space. In regions displaying oxygen deficiency the 
resultant Cu(I)-ATSM will become bound to intracellular macromolecules, in other 
words it will be trapped. Conversely, in regions with a sufficient level of oxygen, 
Cu(I)-ATSM will be oxidized back to Cu(II)-ATSM and will be washed out through 
the blood stream. This explains the hypoxia selectivity of ATSM (Aft et al., 2003; 
Vavere and Lewis, 2007; Wood et al., 2008).
extracellular intracellular
unstable 1 1
C u2+-ATSM ^
1 1
- M — dissociate •ATSM
\
1
1 1
1
1 in present of in oxygen absence
—  — C u ' W S M  + O j redox interaction
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1
trapped in tissue cells
Figure 2.12: Retention and washout mechanisms for ATSM from the cellular space in 
tumour vasculature. When the unstable complex Cu(II)-ATSM reaches the 
extracellular space, it dissociates into Cu(II)-ATSM and Cu(I)-ATSM, followed by 
retention or washout based on the oxygen tension level of the cellular space.
In the literature numerous research groups have made an attempt to study the 
correlation between the different '^^ Cu tracers as well as the correlation between the 
different chemical analogues of ^^ F, in particular ATSM, FMISO and FDG. Herein we 
highlight the conclusion of some of these studies.
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Both chemical isomers, PTSM and ATSM have been extensively examined by 
Dearling et al. (1998), the study revealing significant selectivity of tumour hypoxia 
using ATSM in both in vivo and in vitro studies, while almost no selectivity was 
observed with Cu-PTSM. However, the latter have shown to be a blood flow agent 
not a hypoxic agent.
Similarly, McCarthy et al. (1999) has also reported that, ^^Cu-ATSM is well tolerated 
by patients; good image quality was provided in relatively short times of less than 60 
minutes from injection, which opens up the opportunity for the longer half-life copper 
radionuclide, ^"^Cu-ATSM.
In addition, Takahashi and colleagues (2000) explored the use of ^^Cu-ATSM in six 
lung patients, where they reported high quality PET imaging after only 20 minutes 
from injection, with a relatively high tumour to background ratio of 3.0 ± 1.5.
McQuade and co-workers (2005) have studied the correlation between ^"^Cu-ATSM, 
"^^ Cu- ATSE and ^"^Cu-ASSM in a mammary carcinoma cell culture (in vitro). Their 
findings indicate ATSE uptake depends on oxygen concentration that ranges between 
1000 to 50,000 ppm. Conversely, ASSM uptakes are substantially lower at all oxygen 
concentrations. However, ATSE have elevated uptake of hypoxic cells, similar to 
ATSM but over a wider oxygen concentration range. Additionally, ATSE indicates a 
trend of regular change in uptake with oxygen concentration, from -  10 % mmHg 
down to ~ 0.1 % mmHg, see (Figure 2.13). As a consequence, ATSE can be used to 
image hypoxic levels which are less extreme than those detected by ATSM.
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Figure 2.13: The correlation between ATSM, ATSE and ASSM Cu tracers, with 
ATSE, indicating a trend of regular change in uptake with oxygen concentration, from 
~ 10 % down to -  0.1 % (McQude et ah, 2005), where 1 % = 10,000 ppm (Ebbesen et 
a l, 2004).
An effort to better characterize the relationship between the different analogues 
and ^^Cu-ATSM was conducted by number of studies, use being made to different 
tumour cell-lines and the high resolution hypoxia spatial detection technique of 
autoradiography. The fact that ^^ F and .^ ^Cu have different half lives with (^^F <110 
minutes) and (^ "^ Cu = 12.7 hours) raises the potential of undertaking a dual-tracer 
autoradiography study. This in turn allows study of the same section of tumour using 
different ^^ F and "^^ Cu analogues; the shorter lived radioisotope (^^F) imaging is 
acquired first, and after waiting 40 hours for ^^ F to decay, then "^^ Cu imaging is 
acquired. In addition, a second examination is carried out using immunohistochemical 
analysis, to correlate regions of accumulation to micro-blood vessels and proliferation 
cells that represent the source of the supply and consumption of oxygen. The 
following are examples of a few study cases that exist in the literature, demonstrating 
the intra-tumour uptake correlation of the different chemical analogous of ^^ F and
64,Cu.
Tanaka and Co-workers (2006)
This group have carried out ex vivo autoradiography in order to determine regional in 
vivo uptake, where use has been made of different tumour cell-lines such as
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melanoma B16, sarcoma Meth-A, adenocarcinoma Colon26 and Lewis lung 
carcinoma LLCl. The aim of the study was to address the intra-tumoural 
accumulation correlation between ^^F-FDG and ^"^Cu-ATSM in those different tumour 
cell-lines, and to check if such accumulation is a common phenomenon that is shared 
by ATSM and FDG. They reported no evidence of correlation between FDG (tumour 
metabolic agent) and ATSM (tumour hypoxia agent); see Figure 2.14. However, each 
agent provided useful and important information due to the different accumulations 
within tumour region, being an indication of different intra-tumoural characteristics. 
The study classified tumour cells with high ^^ F- FDG uptake as the radio-sensitive 
cells, whereas the regions with elevated “^^Cu- ATSM uptake were classified as the 
radio-resistant cells.
B. Melh-AA. LLCl
i m  Backgroud 
0 - 25 %
I
25 - 50 % 
50 - 75 % 
75 - 100 %
Figure 2.14: An ex vivo autoradiography images for regional in vivo distribution for 
^^F-FDG and ^"^Cu-ATSM in the following tumour cell-lines: A) Lewis lung 
carcinoma LLCl, B) sarcoma Meth-A, C) melanoma B16 and D) adenocarcinoma 
Colon 26, adapted from (Tanaka et al., 2006).
Dence and Co-workers (2008)
This group have undertaken an ex vivo autoradiography study of regional in vivo 
uptake, in an effort to understand the regional distribution of ^^Cu-ATSM (hypoxia) 
with ^^F-FMISO (hypoxia), ^^F-FDG (metabolism) and ^^F-FLT(fluorothymidine) 
(proliferation) in a gliosarcoma 9L tumour cell-line. The study revealed excellent 
correlation between ’^ F-FMISO and ^'^Cu-ATSM regional distribution, especially with
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images taken at 10 minutes and 24 hours post injection of ATSM versus 2 hours post 
injection of FMISO. In addition, they observed a strong correlation between "^^ Cu- 
ATSM and ^^F-FLT; however, the regional correlation between ^"^Cu-ATSM and ^^ F- 
FDG was very poor, agreeing with the finding of Tanaka et al. (2006). Figure 2.15 
represents the ex vivo autoradiography obtained for regional in vivo uptake for the 
different PET molecular pathways tracers.
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Figure 2.15: An ex vivo autoradio^aphy of the regional in vivo uptake of (A and B) 
“ Cu-ATSM and '®F-FMISO, (C) ®Cu-ATSM and '*F-FDG and (D) ^Cu-ATSM and 
'*F-FLT in a gliosarcoma 9L, adapted from Dence et al. (2008).
Oh and Co-workers (2009)
This group have undertaken an ex vivo autoradiography study of regional in vivo 
uptake, to understand the regional distribution of ^"^Cu-ATSM (hypoxia) with ^^ F- 
FDG (metabolism), using Lewis lung carcinoma (LLCl) tumour cell-line. Similar to 
previous studies, there was no correlation between the regional accumulation of 
ATSM and FDG, see Figure 2.16. With Cu-ATSM mainly accumulated at the tumour 
edge, the main accumulation of FDG was seen close to tumour core.
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Figure 2.16; Ex vivo autoradiography images of the regional in vivo distribution of 
^^F-FDG and ^^Cu-ATSM in Lewis lung carcinoma LLCL The autoradiography 
images of both positron sources are displayed in the same tumour section, with ATSM 
mainly accumulating at tumour edges, FDG main accumulation near tumour core 
(adapted from Oh et al., 2009).
2.4 Summary
Tumour hypoxia usually occurs as a result or as a consequence of the vasculature 
deficiency, which is characterized by its permeable blood vessels and variable blood 
perfusion. Such vasculature structure leads to a highly heterogeneous distribution of 
blood vessels, with a greater micro-vessel density than in normal vasculature. Such 
vascular structure, increases the challenge to quantify and evaluate the oxygenation 
level. Although, the micro-polarographic electrode allows for quantitative 
measurements, its lack of reliability, spatial coverage, invasiveness and accessibility 
to different tumour types limits its clinical use. On the other hand, imaging benefits 
from the ability to be reproduced, with 2-D to 3-D spatial coverage and non- 
invasiveness. MRI for instance provides a high 3-D spatial coverage without use of a 
radioactive agent; however, it does not provide accurate quantitative measurements of 
oxygenation level in blood and tissue. Finally, we are led to conclude that PET has the 
greatest potential at the present time. With the high correlation of intra-tumour 
accumulation of ATSM and FMISO to immunohistochemical analysis, PET provides 
the mean oxygen measurement in tissue. Nevertheless, PET suffers the drawback of 
poor spatial resolution, which is related to the physical characteristic the imaging 
technique. Those parameters will be quantified and discussed in further detail in 
Chapter 3.
35
Multimodality Imaging in Radiotherapy
In Chapter 1, the concept of radiotherapy was introduced; its role in the treatment 
course for cancer patients was also pinpointed. It is well appreciated that the goal of 
radiotherapy heavily relies on the accuracy of target volume delineation in 3-D, a 
process that strongly depends on imaging technology. Therefore, the aim in this 
chapter is to give a more detailed introduction to the role of imaging in radiotherapy, 
particularly to the concept of target volume delineation in radiotherapy treatment at 
the present time, pointing out the limitations of each imaging modality. Moreover, a 
brief introduction to the concept of multimodality imaging will also be covered, with 
special attention to its role in improving target volume delineation for the purpose of 
radiotherapy treatment planning. Explanation of the physics of CT, MRI, SPECT and 
PET are beyond the scope of this thesis, the focus instead being more towards 
understanding the parameters that potentially effect the accuracy of delineating a 
precise target volume using imaging technology, in particular PET. These parameters 
are in particular the window width and window level and also the partial volume 
effect (PVE).
3.1 Radiotherapy Imaging Modalities
In oncology, imaging modalities can be classified into: anatomical (structural) and 
functional imaging (physiological). From this, CT (Computer tomography) and MRI
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(magnetic resonance imaging) are mainly used to obtain patient internal structural 
information. Conversely, SPECT (single photon emission computed tomography) and 
PET (positron emission tomography) are used to obtain patient functional information 
(physiological). Most of these imaging devices use scintillator based detector material 
(i.e. CT, SPECT and PET). The following is a brief introduction to the main 
characteristics and physical properties of scintillator detectors.
In principle, a scintillation detector utilizes a crystal that fluoresces when hit by an x- 
ray or gamma ray photon, producing light energy. The strength of the detector signal 
is proportional to the number of attenuated photons successfully converted into light 
energy. Thus a property of an ideal scintillator crystal is one with high density, high 
effective atomic number, high luminous efficiency, short decay time, good spectral 
match to the detector photomultiplier electronic signal and low cost (Moses, 1999; 
Podgorsak, 2005). Examples are shown in Table 3.1, the details representing the 
principal properties of commercial PET scintillators.
The success of radiotherapy relies strongly on the accuracy of target volume 
delineation, a process that directly depends on imaging technology. In other words, 
the whole process is influenced by the sensitivity and specificity of a particular 
imaging modality. To date, there exists no single imaging modality that provides 
100% sensitivity (a complete absence of false-negatives) or 100% specificity (a 
complete absence of false-positives). Table 3.2 provides the level of sensitivity and 
specificity of CT and FDG-PET for certain types of tumour. If, for instance, the 
objective was to avoid missing a tumour, a high sensitivity approach needs to be 
selected, which will result in lower specificity and in the inclusion of non-neoplastic 
tissue (i.e. normal tissue) in the gross target volume (GTV). On the other hand, if the 
aim is to avoid including non-neoplastic tissue in the GTV to protect normal tissue, a 
high specificity approach needs to be selected; however, such an approach reduces 
sensitivity and increases the risk of missing tumour cells (Grégoire et al., 2001).
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Table 3.1: Physical properties of commercial PET scintillators, taken from Zanzonico 
(2004).
Properties
Bismuth
Germanate
BGO
Gadolinium
Oxyorthosilicate
GSO
Lutetium
Oxyorthosilicate
LSO
Sodium Iodide 
Nal(TI)
Composition & 
hygroscopic
Bi4Ge30i2 GdzSiOs-.Ce Lu2Si0 5 :Ce NaI:TI
(Y/N) N N N Y
Density
(gm/cm^)
7.1 6.7 7.4 3.7
Effective atomic 75 59 66 51
number (Zeff)
% probability of 
photoelectric
40 25 .32 17
interactions
Scintillation 300 60 40 230
decay (ns).
Scintillation 
light wavelength
480 440 420 410
(nm)
Reflective index 2.15 1.85 1.82 1.85
(n)
FWHMat 12 9 10 8
511 keV
Recently, with the advent of stereotactic radiotherapy, intensity modulated 
radiotherapy techniques (IMRT) and 3-D planning of brachytherapy, it has become 
possible to deliver a higher dose to the tumour while maintaining low dose (tissue 
tolerance) to the surrounding tissue, allowing sparing of critical organs and better 
local tumour control (Schinagl et al., 2006). In association with this, there is a demand 
for better definition of disease extent and volume estimation.
In regard to the above, an adequate determination of treatment volume is an important 
task in radiotherapy. The first tumour lesion that can be detected clearly in the image 
is identified as the gross target volume (GTV). As discussed earlier in Chapter 2,
38
Chapter 3. Multimodality Imaging in Radiotherapy
tumour cells can certainly extend beyond the visible GTV, giving rise to mesoscopic 
(cellular) scale imaging needs. Based on the physiological information and clinical 
experience a clinical margin is added to the GTV to produce what is known as the 
clinical target volume (GTV). Finally, a planning margin is added to account for any 
additional uncertainty in the process of radiotherapy delivery (i.e. setup uncertainty) 
to produce the planning target volume (PTV); see Figure 3.1.
Table 3.2: Comparison of the sensitivity and specificity of two image technologies to 
certain cancer types (taken from Gergorie et al., 2007).
Cancer types % Sensitivity 
CT ^^F-PET
% Specificity 
CT ^^F-PET
Head and neck 36-86 50-96 56-100 88-100
Non-small cell lung cancer 45 80-90 85 85-100
Cervical carcinoma 57-73 75-91 83-100 92-100
Esophageal carcinoma 11-87 30-78 28-99 86-98
Gross Target 
Volume (GTV)
Clinical Target 
Volume (CTV)
Planning Target 
Volume (PTV)
Figure 3.1: Definition of target volume in radiotherapy treatment planning, adapted 
from Kim and Sue (2006).
Computer Tomography
In oncology, for over 20 years CT images have been the cornerstone (Doi, 2006); for 
treatment planning it is still considered to be the standard imaging modality (Grégoire 
et al., 2007). CT images are thought to be superior to all other imaging modalities, 
providing the most accurate and reliable geometrical and spatial information. In
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addition, it presents true intrinsic data of the electronic density of all internal structure 
of body tissues, which is particularly important in treatment dose calculation. 
However, CT images suffer from poor contrast in terms of the ability to distinguish 
between muscular and tumour structures (e.g. soft tissues). In addition, CT images 
show a significant degradation when a metallic structure is present in the field of view 
(FOV) of the scanner, such as dental fillings. In association with this, larger inter and 
intra- observer variation on the delineated GTV is observed, causing an additional 
limitation on assessing oropharyngeal and oral cavity tumours.
Magnetic Resonance Imaging
MRI with the various sequences, for instance the un-enhanced weighted and contrast 
enhanced weighted sequence, is another distinctive anatomical imaging modality that 
can complement and sometimes replace CT. MR images have been shown to be 
superior to CT in distinguishing between soft tissues, bone marrow, extent of 
nasopharyngeal carcinoma (NFC), orophayngeal cancers (OPC), prostate and brain 
tumours (Nishioka et ah, 2002). Such an advantage contributes to smaller inter­
observation variation in delineation of GTV if compared to computerised tomography. 
However, MRI may present geometric distortion at the edges of the object; also its 
lack of electronic density information limits its use in treatment planning (Kim and 
Sue, 2006). Figure 3.2 represents a de-indentified image of a brain cancer patient, 
where the lesion is clearly seen on MR images (bottom panel) but is hardly seen on 
the CT image (top panel).
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Figure 3.2: Typical CT images in the top panel sequence, and typical MRI in the 
bottom panel of image sequences; both represent brain images for the same cancer 
patient. The lesion is hardly seen in the CT images, while it is very clearly seen in the 
MR images, as taken from the ProSoma™ workstation in the radiotherapy department 
at the Royal Surrey County Hospital.
Positron Emission Tomography
The imaging technology of positron emission tomography (PET) offers substantial 
advantages over anatomic imaging modalities in all oncology applications; generally 
it has the ability to distinguish benign from malignant lesions, whereas CT and MRI 
cannot (Grosu et al., 2005). Additionally, it enables visualization of the various 
molecular pathways of tumours including: metabolism; oxygen delivery and 
consumption; proliferation and receptors of gene expression (Weber and Figlin, 
2007). That in turn, provides distinctive clinical information such as early detection of 
recurrence of the disease, disease response to therapy, better definition of disease 
extent leading to more reliable GTV delineation in treatment planning and evaluation 
of organ functionality (Vogel et al., 2004).
In medical imaging, resolution is often expressed through the point-spread function 
(PSF). In PET the PSF is usually defined as the full width half maximum (FWHM) of
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the Gaussian shaped function or the tenth width half maximum (TWHM) in the case 
of lower PSF values (Alessio and Kinahan, 2006). A PET system, however, has the 
major drawback of substantially low resolution, typically ranging from 6 - 8  mm if 
compared to CT and MRI, where both are less than 2 mm.
Generally, the physical basis of PET technology imposes certain limitations on the 
spatial resolution (Muehllehner and Karp, 2006). One of those limitations is positron 
range, while the second limitation is photon colinearity (Townsend, 2004). Table 3.3 
shows examples of the positron range for different radioisotopes. Typically, and as the 
positron travels through a medium, losing energy (kinetic) through coulomb 
interactions with the electrons of the medium, this process of energy loss continues 
until the positron becomes energetically thermalised, then self-annihilation through 
emission of positronium (2-gammas or 3-gammas) will take place. To date groups of 
researchers are putting considerable effort into studying the feasibility of enhancing 
information through the process of detecting the 3-gamma decay signal; for detailed 
information on this subject, see the text of Kacperski and Spyrou (2004).
In principle, the positron energy will not be fully scattered during its journey. Thus 
the annihilation electron-positron system could have residual momentum; in order to 
conserve momentum, annihilation photons will be emitted less than 180° apart, 
causing further contribution to loss of spatial resolution (Townsend, 2004). The two 
photons, assumed to be collinear, form a straight line including the point of emission 
of the positron. These effects place lower limits on spatial resolution, the contribution 
from detector size and design degrading spatial resolution more significantly.
Table 3.3: Different PET radioisotopes showing different positron ranges in water, 
(taken from Phelps et a l, 1975).
Isotope Maximum 
energy (MeV)
Maximum range 
in water (mm)
Average range in 
water (mm)
"Cu 0.656 2.4 0.64
"C 0.960 3.9 1.1
" o 1.720 7.9 2.5
18p 0.635 2.4 ' 0.6
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Considering the drawbacks of conventional PET, there is a substantial need to 
improve the spatial information acquired using the PET image. This has leads to the 
introduction of the new technology of the integrated PET/CT system, which partly 
overcomes the limitation of conventional imaging of both CT and PET.
The Integrated PET/CT
Clinically, it appears that the fusion of PET/CT imaging modality provides additional 
information beyond that afforded by conventional functional images or anatomical 
images alone (PET or CT). CT scan based radiation treatment planning may 
overestimate or underestimate the target volume because of its limitation mentioned 
earlier, whereas FDG-PET has shown a superior accuracy in determining malignant 
lesions because of its superior sensitivity and specificity if compared to CT, as 
illustrated in Table 3.2. Thus the integrated PET/CT imaging technology has been 
shown to improve the anatomical localization of abnormalities, imaging of biological 
tumour sub-volumes, superior evaluation of tumour response during or after therapy 
and the development of “ response adapted therapy”, in which changes to target 
volumes could potentially be made during a treatment course. However, quantitative 
analysis and treatment monitoring are still under investigation for certain cancer types 
(MacManus et al., 2009).
The considerable step towards overcoming the limitations of all of the conventional 
CT and PET imaging systems was initially introduced by the group of Townsend 
(2000) at the University of Pittsburgh. Simply, they integrated the two units of CT and 
PET in one gantry unit (Figure 3.3). Such a setup allows for immediate collection of 
both PET and CT data with minimum potential for mis-registration, in considerably 
shorter scanning times (~ 45 minutes). This allows better localization of activity in 
normal versus abnormal structures, better identification of inflammatory lesions and 
improved localization for biopsy or radiotherapy (Alessio and Kinahan, 2006). In one 
study separately performed PET to diagnostic CT improved staging by 21 %, while 
integrated PET/CT was 34 % more accurate than diagnostic CT alone, which reduces 
the number of false positive (Veit et al, 2006) . However, data interpretation of 
PET/CT might incorporate challenges partly due to CT based attenuation and use of 
contrast agents.
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Figure 3.3: Illustration of the major PET/CT scanner components (adapted from 
Alessio and Kinahan, 2006).
The major concern of CT based attenuation correction is in part due to the differences 
in photon energies of both PET and CT. Photon attenuation is dependent on the 
photon energy (E) and electron density (Z) of an object. It is well known that high- 
energy photons are attenuated less than low energy photons. Further, it is well 
appreciated that a high density object more efficiently attenuates than a low density 
object. Clinically, CT images are generally produced with nominal energy of 70 keV, 
thus photons will primarily interact through the photoelectric effect, which is 
approximately proportional to In comparison, 511 keV annihilation photons of 
PET undergo a predominance of Compton scattering events, consequently showing 
little dependence on Z. This means high Z material would induce more significant CT 
photon attenuation than the 511 keV photons. Obviously, differences in attenuation of 
low Z material are much smaller. To overcome this problem the reconstructed CT 
scan needs to be segmented into different tissue types using different Z material (for 
example, air, tissue and bone), to confidently generate accurate and reliable 
attenuation correction factor (ACEs) charts. Saying that, there is a need to undergo
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low energy CT study with no use of a contrast agent to obtain ACFs. For further 
information see the excellent text of Weber and Figlin (2007).
3.2 Image Registration and Target Delineation
Considering the challenges of all conventional anatomical and functional imaging 
modalities, selection and delineation of GTV and organs at risk (OAR) should be 
made on the basis of all of the available diagnostic information and on the knowledge 
of the physiology of the disease. This includes the probability of local and nodal 
inflammation. Such a goal is achieved in part through the use of integrated imaging 
modalities (Vogel et ah, 2004). -
An initial attempt at registering anatomical information and functional information 
was almost entirely carried out visually, through an expert reviewer, typically using a 
light box; see for instance Hill (2001). For accurate image fusion, images of different 
modalities have to be accurately aligned with each other. This can be achieved by 
either imaging the patient in exactly the same position or by re-orienting the images to 
make them fit together. The latter is called mathematical or software image co­
registration and shall be covered in further detail in this chapter.
Simply, all methods of software image co-registration rely on spatially transforming 
one of the images to match the other. This can be qualified by two kinds of 
transformation (1) rigid body transformation, where for instance the object is shifted, 
rotated and stretched and (2 ) elastic (non-rigid body) transformations which are called 
warping as it includes plastic deformations of the object. Image registration, through 
the use of software packages, can be completely manual, based only upon the 
subjective visual evaluation, leading the operator to translate or rotate the images by 
discrete correctional amounts. In addition, it can be semi-automatic, requiring some 
guidance from the use of fixed sets of markers. Image registration through sets of 
fixed landmarks should be reliably identified on both modalities. Clinically, 
landmarks are usually through the use of external (fiducial) markers, however, 
anatomical landmarks are occasionally used. Image registration can also be by 
completely automated methods, based on several different techniques such as 
transformation using information provided in the anatomy of the entire image. This is 
either (1) a surface matching technique that can be found in both modalities (e.g. the
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brain contour) and (2 ) information in every pixel of the entire image, usually achieved 
by an iterative process, which involves very complicated statistical measurements in 
order to determine the quality of the respective iteration. The latter type of 
measurement is used to differentiate between various voxel-based co-registration 
methods such as mutual information (MI), normalized mutual information (NMI), 
count difference, or shape difference (CSD). A certain number of iterations are 
acquired before such a process is terminated to provide the registration matrix with 
which the image will be transformed (Baneqee and Toga, 1994).
Mongioj et a/. (2006) have pointed out that in order to achieve highly accurate image 
registration there is a need to accurately define values for nine parameters, namely the 
transformation values defined by the three rotation angles (0 , (p and \|/) and the three 
Cartesian translation values (x, y, z), complemented by the voxel size of the imaging 
device.
In regard to ease of use of the various available image registration software packages, 
clinicians have reported a considerable degree of difficulty in registering images for 
anatomical sites other than the brain, the problems being associated with: (a) 
differences in patient position using different imaging facilities, even in combining 
one CT image with that of another CT image taken on a different facility, and also in 
the use of an integrated PET/CT facility where the positioning problem would have 
been minimized (Vogel et ah, 2004); (b) misregistration related to the particular 
scanning protocol (e.g. breath hold with remaining internal organ movement) (Crum 
et al., 2003; Griffeth, 2005); (c) deformation of soft tissue (Crum et al., 2003); and (d) 
differences in voxel intensity (gray values) resulting from the different image 
formation processes involved in multimodality imaging.
Considering these factors, comprehensive examination of commercial fusion packages 
has been suggested to be of importance in establishing confidence in the reliability of 
these in their routine applications in oncology, particularly in treatment planning 
(Daisne et al., 2003; Mutic et a l, 2001). Although a number of studies have explored 
various approaches in assessing the accuracy of registering different sets of data, 
especially integrated PET/CT data, to the best of this authors knowledge there exists 
little in the published literature which actually establishes confidence and the
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reliability of various available packages, including Analyze (Mayo Clinic, Minnesota, 
USA), AcQSim (Onco-diagnostic Simulation/Localisation System, Marconi, 
Cleveland, OH), and ProSoma™ (Oncology Systems Limited, Shropshire, UK), as 
well as registration software supported by individual treatment planning systems, 
including PLATO (Nucletron B.V., Veenendaal, the Netherlands).
In regard to the methodology for assessing the accuracy of registering different sets of 
data, Kagawa et al. (1997) have used the total conjugate deviation method, evaluating 
the accuracy of registering CT/MR images using fiducial marker registration, while in 
regard to PET/CT volume registration this has been examined by Chao et al. (2001), 
after drawing regions of interest (ROI) on the common target volume presented in 
both data sets. Mutic et al. (2001) explored two registration methods to register 
multimodality images: (i) a point matching system where at least three common 
points need to be selected on both data sets and; (ii) interactive images, where a 
colour wash of one set is displayed over the grayscale of the other. Similarly, the 
registration accuracy of CT, MR and PET images have been evaluated by the group of 
Daisne et al. (2003) using the difference in translation (in mm) and rotation (in 
degrees). Likewise, Ciernik et al. (2003) assessed target registration of PET/CT data 
based on translation along the x and y axes.
Present Study Methodology
In the present study, phantom based investigations have been made seeking to 
establish the accuracy and reliability of the ProSoma™ registration and fusion 
package. Figure 3.4 is a screen shot taken for the 3-D image registration and fusion of 
the commercial software package of ProSoma™. The software package allows 
representation and analysis through coronal, sagittal and transverse sectional image 
display. The software package includes manual, semi-automatic and automatic 
facilities as described above. Phantom registration and fusion have been assessed 
using the following devices, all of which are available at the Royal Surrey County 
Hospital (RSCH): computer tomography (CT); an integrated PET/CT; and a magnetic 
resonance imaging system (MRI). The following provides a description of all the 
imaging devices involved in this study, followed by full description of the phantom 
design, supported with figures.
47
Chapter 3. Multimodality Imaging in Radiotherapy
j" :J vv.-i,«n"
«3 ...
E l i f J C C r C T
% Ë*  .
'■3 1 ?  4 )
1 * ‘f’-r-
" a
A  a
•................. “
Figure 3.4; Screen shots taken for the desktop layout of ProSoma™ workstation in the 
radiotherapy department in the Royal Surrey County Hospital (RSCH). Shown on the 
left, in the boxes 1, 2 and 3, are: 1 the coronal plan; 2 the saggital view of the plan and; 
3 the transverse view of the plan.
Imaging Acquisition
The integrated GE Discovery Loadstone PET/CT system involved in this study makes 
use of a conventional bismuth germanate (BGO) detector block system (see Figure 3.5 
for typical detector block system specification), offering a variable intrinsic full-width
j  *
half maximum (FWHM) resolution of 4.8 and 5.6 mm for 2-D and 3-D images, 
respectively. The system completely relies on the corrected CT data to correct for the 
attenuated 511 keV photons. In our case, a 2-D image mode was acquired for 10 
min/ 2  frames (2  bed positions) using a matrix of 128 128 pixels, the image being 
reconstructed to an average thickness of 4.25 mm.
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Figure 3.5: Conventional bismuth germanate (BGO) detector block system, with 
typical crystal size taken for an ECAT-BXACT 31 scanner located in the Physics 
Department of the University of Birmingham (a scanner now only used in non clinical 
studies).
CT scans were performed with an abdominal protocol using the GE Lightspeed RT/16 
CT scanner for a reconstructed slice thickness of 5 mm and a pitch of 0.75. Images 
were acquired using a matrix of 512 512 pixels, and reconstructed with a final 
resolution at FWHM of 0.8 0.8 mm^.
MRI scans were performed with a pelvic protocol acquisition system using the GE 
SIGNA MRI for reconstructed slice thicknesses of 5 mm. Images were acquired using 
a matrix of 256 256 pixels.
Phantom Details and Preparation
All the quality assurance (QA) tests were carried out using the commercially available 
National Electrical Manufacturers Association (NEMA) standard body phantom
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recommended by the International Electro-technical Commission (lEC). The main 
features of the NEMA lEC body phantom is that it contains a lung insert and an insert 
with six finable spheres of various sizes and diameter. Table 3.4 lists the sphere 
specifications in term of diameter and size. This arrangement allows use of the 
phantom in evaluation of CT, MR and PET images; full information is provided in the 
NEMA lEC body phantom manual (Greer and Perry, 2002). Figure 3.6 is a screen 
shot taken for the commercial NEMA lEC Body Phantom Set™ together with typical 
dimensions.
Table 3.4: Diameters and volumes of NEMA lEC Body Phantom Set 
Compartments, model ECT/IEC-BODY/P (Greer and Perry, 2002).
TM
Compartment
(Spheres)
Diameter (mm) Ideal (Manufactured) volume (ml)
1 10 0.52
2 13 , 1.15
3 17 2.57
4 22 5.57
5 28 11.49
6 37 26.52
Figure 3.6: Demonstrates the commercial lEC NEMA Body Phantom Set™ together 
with typical dimensions, adapted from manufacturer manual (Greer and Perry, 2002).
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A  different preparation setup was performed for each imaging modality, based on the 
physical principle from which each image is generated. For CT scans the NEMA 
phantom was filled to the top (i.e. to a volume of approximately 9.7 L) using water, 
the spheres being left empty. For MRI scans, the study was divided into two parts: 
first a check of the accuracy of registration and fusion, and secondly to explore 
different MRI contrast reagents; in both parts the phantom spheres were left empty. 
Copper sulphate (CUSO4.5 H2O) solution has been recommended by Daisne et al. 
(2003) and Mutic et al. (2001) as an efficient MRI contrast reagent. In the present 
work one MRI scan was preformed by filling the phantom with CUSO4.5 H2O solution 
at 0.205 mol/L using 500 g CUSO4.5 H2O and made up to 9.7 L, whereas, in the 
second scan the phantom was filled with 9.7 L of water. Finally, for PET scans the 
phantom was filled with [^^F-FDG] as were the spheres, unfilled spheres being 
undetectable in scans. In the present study, to ensure sphere visualization, the chosen 
activity of both the spheres and background were filled with ^^F-FDG (lOOMBq), with 
a sphere to a background activity concentration ratio of 4:1.
ProSoma™ 3D Registration and Fusion Package
Further to earlier discussion, ProSoma™ supports manual, semi-automatic and full 
automatic registration methods. The different registration methods will be described 
in brief below.
(A) Manual registration: In this mode transformation of the secondary data set is 
made by eye through translations along the set of axes (x, y, and z) and 
rotations around (0 , 9  and \^^ ).
(B) Marker registration: This method is based on identifying at least four 
common marker points on each data set to allow the transformation matrix to 
be generated. In this study, the centre of each sphere has been considered to 
be the location of a particular marker (Figure 3.7A).
(C) Automatic registration: This method considers volume element information, 
as in for instance voxel intensity as used herein, in terms of gray level, and 
the associated surface geometry information for both sets of acquired data. As
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an aside, in clinical situations, the boundary boxes (ROI in which the gray 
levels are investigated) supported by ProSoma™ are found to be a 
particularly useful tool, allowing the operator to avoid any potential 
misalignment caused by artifact structures such as stereotatic frames, teeth 
fillings and the treatment table surface.
(D) Volume registration: This is based on drawing a ROI that verifies a common 
target for both sets of acquired data. While the system allows for defining all 
possible common ROIs, even one ROI can be involved in generating the 
translated data (Figure 3.7B).
3.3 Present Study Findings
In the present study magnification as well as the window level (in terms of gray level) 
was checked for each of the acquired CT, MR and PET imaging sets, so that phantom 
features were clearly defined; assessment of window level effect will be presented at a 
later stage in this chapter. More formally, the mean signal level should be > 2ob, 
where ob is the standard deviation on the background, ensuring at the least a 95 % 
probability of detection.
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Figure 3.7: Screen shots taken from ProSoma™ workstation in the radiotherapy 
department at the RSCH, where the boxes show examples of marker registration (A) 
and volume registration (B). Marker registration of CT and water MR images was 
made using the centre of each sphere, as shown in (A), to generate a transfer matrix, 
so that CT and MR images can be fused. Volume registration of the CT and MR 
images was made by drawing a ROI that verifies the common target of each sphere, as 
shown in (B), however, even one ROI can be use to generate the translated matrix.
Assessing Sphere Diameters
For ProSoma™, diameter measurements are usually very simple, use being made of 
the ruler accessed via the ‘tool bar’ menu or by drawing a ROI on each sphere for the
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maximum cross sectional area, as shown in Figure 3.7B; in ProSoma™ the area is 
given in cm^. Each imaging modality produced a different response in terms of 
observed diameter values, with CT images providing a perfect match for sphere 
diameters in the range of 17 -3 7  mm but producing an under estimation of up to 10% 
for the smallest sphere (10 mm). For MR images both types of contrast reagent 
(CUSO4.5 H2O and water) provided very similar diameter measurements compared to 
actual values (to ~ 1 mm or better). Of note is that different window levels were 
chosen for the two types of contrast reagent, as noted in Table 3.5, the choice of level 
being made to obtain the clearest possible edge to each object.
Conversely for PET images, these showed a consistent over-estimate in sphere 
diameter, particularly for the larger spheres (28 -  37 mm), where a difference of up to
4.3 ± 0.05 mm was observed. It is of note that the PET images were typically highly 
blurred at the edges; current observation showing blurring to contribute as much as 2 
-  3 mm to the diameter of all spheres larger than 13 mm. Figure 3.8 demonstrate the 
current observation of blurring that is particularly associated with PET images, if 
compared to CT and MR images.
Table 3.5: Diameter correlation of CT, water MR, copper sulfate MR and PET 
images, with all measurements quoted in mm, use being made of typical window 
levels (in terms of minimum, maximum and central values for each imaging 
modality).
Actual
diameter
CT
Window level 
min ■ = - 577 HU, 
max =194 HU, 
centre =191 HU. 
mean ± SD, n = 3
MRI (water) 
Window level 
min = 8, 
max = 49, 
centre = 29. 
mean + SD, n = 3
MRI (copper)
Window level 
min = 1, 
max = 59, 
centre = 30. 
mean + SD, n = 3
PET
Window level 
min = 10, 
max = 68, 
centre = 39. 
mean + SD, n = 3
10 9.0 ± 0.0 10.0 + 0.0 10.0 + 0.0 11.0 + 0.0
13 12.5 ± 0.6 13.3 + 0.6 13.0 + 0.0 14.7+1.2
17 17.0 + 0.0 17.0 + 0.0 17.3 + 0.6 19.0 + 0.0
22 22 .0 ± 0.0 22.0 + 0.0 23.0 + 1.0 24.3 + 1.5
28 28.0 + 0.0 28.0 + 0.0 29.3 + 0.6 31.3 + 2.3
37 37.0 + 0.0 37.3 + 0.6 38.3 + 0.6 41.3 + 0.6
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Figure 3.8: Screen shots taken from ProSoma™ workstation in the radiotherapy 
department at the RSCH, demonstrating the level of blurring on the different imaging 
modalities, with sharp edges being clearly observed on CT and MRI scans; extremely 
blurred edges were observed with the PET scan.
Assessing Contrast Reagent and Noise Level in MRI images
Blurring and noise level are parameters associated with the partial volume effect 
(PVE) and signal to noise ratio (SNR). The relative contrast of an image refers to the 
visibility of an object within a background, defined as:
7 '
% Relative contrast = ^  100
where Is represents the mean intensity of the signal (the sphere signal in this case) and 
I b  represents the mean background intensity. The software Image! (National Institute 
of Health, Bethesda, MD, USA) was used to assess the relative contrast of 
CUSO4.5 H2O and water on MR images. Considering Figure 3.9, copper sulfate 
(CUSO4.5 H2O) solution was observed to produce considerably increased image noise, 
by up to 20%, when compared with images obtained using tap water, particularly in 
regard to the larger spheres. Figure 3.10 quantifies the noise and blurring level using 
both MRI contrast agents, it represents objects with different physical contrast and 
size, Cartesian axes being plotted in reverse order.
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MRI scan
filled water
Figure 3.9: Screen shot taken from ProSoma™ workstation in the radiotherapy 
department at the RSCH, demonstrating the observed level of noise using both MRI 
contrasts, the noise being particularly apparent with the use of copper sulfate.
Blurring an d  n o is e  level in d ifferen t MRi c o n tr a s t
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Figure 3.10: The level of noise obtained using water and copper sulfate, the latter 
being shown to increase image noise by up to 20%, when compared with images 
obtained using water, particularly in regard to the larger spheres. The blurring was 
shown to be insignificant when using water and CUSO4.5 H2O, with a clear overlap for 
the smaller spheres.
Generally, blurring is associated with small objects that appear with relatively high 
contrast. As a consequence, the smallest detail that an image can provide is principally
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controlled by the blurring artifact. Similarly, but yet different, is the noise that effects 
visibility on medical images, leading to the same effect (limitation of detail detection) 
as blurring, thus increasing the level of difficulty to assess and analyze details of small 
features in the image. Of particular note is that noise greatly effects the detection of 
large objects that appear with relatively low contrast (Figure 3.11).
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Figure 3.11: A representation of objects of different physical size and contrast, the 
Cartesian axes being plotted in reverse order. The left-hand panel maps the effect of 
noise on detectability, presented in term of contrast and size, whereas the right-hand 
panel maps the effect of blurring on detail detectability, also presented in terms of 
contrast and size (adapted from Sprawls, 2007).
Assessing Fiducial Marker Registration
Fiducial marker registration potentially provides the most precise positioning 
information; the method is simply based on locating a number of markers, each 
exactly at the same position on each scan, regardless of the scanning modality, the 
position of these markers being unaffected by movement, sensitivity and resolution of 
the imaging system (Chao et al., 2001; Mutic et al., 2001). The form of the fiducial 
markers will obviously be different for the different imaging modalities, based on the 
particular physics of image formation. In the present study, and in regard to visibility, 
successful use was made of metal seeds of 2 mm in diameter as a CT reference 
marker, while high specific activity ^^ F (43.7 MBq/ml) sources and CUSO4 .5 H2O 
solution (0.205 mol) were effective as markers in PET and MR images respectively. 
MRI and PET fiducial markers were provided by small-sized centrifuge ampoules of 
3 cm length, reducing to a pointed tip from its initial 0.5 cm diameter. For PET scans, 
use was made of a procedure initiated by Chao et al. (2001), the experience of this 
group being that the pointed tip of the ampoule can be dipped into concentrated ^^ F,
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with no subsequent evidence of contamination. The method was validated on an 
ECAT-EXACT 31 PET scanner located in the Physics Department of the University 
of Birmingham (a scanner now used only in non clinical studies). Figure 3.12 
illustrates a typical setup using and centrifuge ampoules placed on the surface of 
Jaszczak phantom™ (i.e. Jaszczak phantom was used in assessing the efficacy of the 
fiducial marker for ^^ F only). For MRI studies the ampoule was filled with the 
CUSO4.5 H2O solution of concentration as above, it also being important to note that to 
encompass the ampoules the MRI body coil had to be used. In the present studies, an 
eight channel body coil was used due to the rather large size of the NFMA phantom.
In general, the accuracy of the fiducial markers, assessed in terms of total conjugate 
deviation and reported in terms of the mean value ± SD for n = 3, was found to be 3.0 
± 0.7 mm (x-axis), 0.9 ± 0.6 mm (y-axis) and 2.0 ± 0.3 mm (z-axis).
Jaszczak phantom
E C A T  E X A C T  31 P E T
Figure 3.12: Demonstration of the geometry of typical centrifuge ampoules that have 
been used to check and validate the initial procedure of Chao et al. (2001). The 
pointed end of the ampoules were dipped in high specific activity solutions (43.7 
MBq/ml) using ^^ F, ampoules being arranged as displayed above and scanned using 
an FCAT-FXACT 31 PET scanner located in the Physics Department of the 
University of Birmingham (a scanner now used only in non clinical studies).
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Assessing Spheres Volume
Volume estimation of a spherical object produces concern, due to limitation in slice 
thickness. For a perfectly spherical object, the sphere volume can be estimated using 
the standard relation of
Sphere volume = ^  ;r r^, (1)
where r is the radius of the sphere. However, if the sphere is segmented into sections 
with zero gap separation, being the typical clinical situation, then one simple way of 
estimating the segmented sphere volume is to multiply the cross sectional area of each 
sphere with the slice thickness (Alyafei et ah, 1999), being exactly correct for a 
cylindrical shape and close to the actual value for slice thicknesses of less than 1 mm. 
To reduce the inaccuracy, and within the constraints placed upon the method by a 
given fixed slice thickness, the sphere can simply be divided into a number of slices, 
either even or odd, the resulting volume of each slice being estimated as:
v ,= K T -o .5 (A „ „ -A . )r | ,  (2)
where Am is the cross sectional area for slice number m, Am+i is the cross sectional 
area for the adjacent slice and T is the slice thickness. Consequently, the whole sphere 
volume will be given by
Whole volume = , (3)
/2=1
In a series of studies, investigation has been made of the correlation between sphere 
volume using all of the different imaging modalities applied herein, CT, MR and PET. 
The results are illustrated in Figure 3.13, where the estimated sphere volumes, 
obtained using the standard relation of equation 1 , are displayed together with typical 
manufacturer volume values. Volume estimation based on segmentation using 
equation 3 was explored with CT images, where sphere volume estimation based upon 
use of the standard relation (equation 1) revealed an under estimation of up to 26% in 
the smallest sphere sizes of 1 0  and 13 mm, while volume estimation based on 
segmentation using equation 3 revealed an under estimation of up to 48% for the same 
spheres. Good correlation (< 5%) has been obtained for the rest of the sphere sizes, as 
shown in Figure 3.14.
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Volume correlation between the different imaging modalities
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Figure 3.13: Demonstration of sphere volume correlation between different imaging 
modalities. Generally good correlation was obtained, particularly with large spheres 
of 17 and 37 mm using the imaging modalities CT and water MRI contrast, when 
compared with typical manufacturer spheres volume values. Herein, sphere volume 
was estimated using the standard relation of equation 1; however, generally poor 
correlation was seen in all spheres using PET images.
Comparison betw een volum e based calculation and segm entation on CT
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Figure 3.14: Results of present study show there to be good correlation (< 5%) 
between calculated and segmented based volume estimation, particularly in regard to 
the larger spheres (1 7 -3 7  mm), whereas an under estimation of up to 26% and 48% 
were associated with volume estimation using calculated and segmented bases, 
respectively. The under estimation was particularly seen with small spheres of 10 and 
13 mm.
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Assessing the Different Registration Methods Provided by ProSoma™
Generally the highest accuracy fusion was seen for the radiotherapy CT and the 
Loadstone CT (CT^^/CT^) imaging systems, regardless of the type of registration 
(manual, semi-automatic, automatic), however radiotherapy CT and water contrast 
MRI (CT^^/MRI^) revealed up to 0.5 ± 0.05 mm difference on fused images 
registered manually and up to 1.5 ± 0.05 mm difference in the automatic registration 
mode, in particular for the small spheres <13 mm. Manual registration for CT^^/PET 
showed good fusion response (~ 1 mm) for the large spheres (Table 3.6), while for 
small spheres <13 mm evaluation was not possible due to blurring. Similarly for the 
other types of registration, CT^^/PET demonstrated up to 1.5 ± 0.05 mm difference on 
the fused images when compared to the actual sphere diameter, as shown in Table 3.6. 
Marker based registration in ProSoma™ has been presented in terms of the centre of 
gravity of the markers, obtained as the weighted mean of marker points. The accuracy 
of registration has been determined using the total conjugate discrepancy of the 
marker points; a representative sample of results for the present situation of analysis is 
provided in Table 3.7.
Based on present findings for phantoms (devoid of artifacts such as those found in 
clinical situations), boundary boxes and rotational transformation were found 
unhelpful. Indeed, in regard to rotation, this was found to produce increased 
discrepancy, being true for all of the acquired CT, MR and PET images. Likewise in 
regards to boundary boxes, the particular choice of level of precision revealed no 
significant contribution to fusion. Computational timing increases with the level of 
precision required, increasing from a typical registration time of a few seconds up to a 
few minutes.
Table 3.6: Analysis of the effect of different registration methods on measured sphere 
diameter, with all measurements presented in nun.
Fusion type Actual diameter Primary data Secondary data Fusion data
Manual 28 C f  = 28.0 PET^ = 31.3 29.0
Marker 37 CT""' = 37.0 PET"^ = 41.3 3&5
Automatic 37 CT^^ = 37.0 PET^ = 41.3 38.0
Manual 37 CT^^ = 37.0 C T^ = 37.0 37.0
Volume 9 CT^^ = 9.0 M R f=  10.0 10.0
Automatic 10 CT^^ = 9.0 M R r=  10.0 8.5
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Table 3.7: Marker-based registration in terms of centre of gravity, the accuracy of 
registration being presented using total conjugate values and accuracy of fusion.
Data set Centre of 
gravity
Total
conjugate
Actual
diameter
A
(in nun)
Fusion
diameter
F
(in mm)
Fusion
accuracy =yxlOO
X . y z X y z
Ct ^^/CT^ 0.2 0.3 0.1 1.7 0.7 1.2 37.0 37.0 100%
CT^^/MRT 0.2 0.0 0.3 0.8 0.0 1.3 10.0 10.5 95%
CT^^/PET 0.2 0.4 0.3 1.4 0.9 1.8 37.0 3&5 96%
This phantom based study using the NEMA body phantom and ProSoma^^ was 
extended to assess factors that potentially effect the appearance of features (i.e. 
spheres) size on all medical imaging modalities used. Those factors can be divided 
into two main categories (1) subjective based (operator dependent) factors and (2) 
systematic based (technical dependent) factors. A good example for a subjective 
based factor is choice of window width and level adjustment and the effect of such a 
choice, such capability being considered an advantage in using computer based soft 
copy images over the traditional film images. A good example for a systematic based 
factor is the partial volume effect (PVE), such a factor being directly related to the 
mathematical reconstruction concept from which the image being formed. The 
following is an explicit introduction to window width and level effect, supported with 
experimental findings. This will be followed by a brief presentation of the principle 
concept of PVE.
Assessing Window Width and Window Level Effect
The concept of window width and level is fully introduced in Figure 3.15, where the 
range of shades (i.e. pixel intensity values) in this given example varies from 0 -  
4096. The method to define the intensity range for a certain object in the images is 
called “window” and the distance between the two ends of window is called the 
“window width”. Thus, any pixel value that is.out of the window width, i.e. beyond 
one end point, will be mapped in black while that beyond the other end point will be 
mapped in white. Further to our discussion earlier, and in regard to the smallest 
features that add details in medical imaging, it is largely due to the limitation of the 
human eye in distinguishing pixel intensities that are very similar that the concept of 
pixel mapping within the window was introduced. Pixel mapping within the window
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is a mathematical function that defines each pixel intensity value in terms of display 
luminance. Such a mechanism is called “level”.
Luminance
Output
Level Function
1023
I Pixel 
Intensity 
Value
600 700100 140141 Window Width
Figure 3.15: Illustration of the concept of windowing (based on the range of shades in 
the image), in this case the image includes up to 4096 shade ranges, it also introduces 
the concept of window width, whereby an object is completely mapped in white (e.g. 
below a pixel intensity value of 80) or completely mapped in black (e.g. above a pixel 
intensity value of 600). In addition, it is clear that a window width difference of 1 
pixel intensity value introduces a large difference in luminance output (i.e. level), 
adapted from Webb (2000).
The limitation of conventional 2-dimensional imaging has been the need to adjust the 
gray scale window and level during image capturing of specific structural features 
(Kurims et ah, 2003). The diagnostic accuracy of 2-D sectional imaging techniques 
such as CT, MRI as well as PET may be influenced by the suitability of window grey 
scale selection. This in part reduces the potential diagnostic value of the technique as 
it also reduces the accuracy of target delineation.
Typically the CT, MRI and PET window levels will not be the same, the gray level 
for each imaging method being created from different image formation principles.
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where CT images represent electron density distribution, MR images represent proton 
density and PET images demonstrate radioisotope uptake. In order to seek a consistent 
system of measurement, the choice has been made to maintain the same window level 
for each imaging modality. Changes in window level were found to significantly 
effect all of the CT, MR and PET images, producing discrepancies of up to 2 mm 
compared to the actual diameter; Figure 3.16 shows that spheres appeared smaller by 
up to 2 mm on CT images, the discrepancy being greater for spheres that range from 
1 0 - 1 7  mm in diameter, while Figure 3.17 illustrates the effect of window level on 
MR images, a discrepancy of up to 2 mm being found for the largest spheres of 
nominal diameter 37 mm due to stretching of the luminance level function. Similarly, 
Figure 3.18 illustrates the effect of window level on PET images, where a discrepancy 
of up to 2 mm was seen.
Effect o f window level on CT Images
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Figure 3.16: CT images and illustration of the effect of window scale on sphere 
diameter xxûng ProSomcF^. The line shows when the actual diameter equals the 
measured diameter.
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Figure 3.17; Illustration of the effect of two different window widths in MR images. 
The image on the right shows the largest sphere diameter to be 37 mm for a central 
window scale 29; the image on the left shows sphere diameter of 39 mm for a central 
window scale 78. The manufacturers’ given diameter is 37 mm.
Effect of window level on sphere diameter on PET im ages
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Figure 3.18: PET images and effect of window level on spheres diameter using
ProSoma™ produced a discrepancy of up to 2 mm.
Partial Volume Effect
The term partial volume effect (PVE) represents differences in intensity values in the 
image and actually refers to two distinct phenomenon (1) finite spatial resolution of 
the imaging system, which leads to 3-D image blurring, a phenomenon that is
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particularly associated with PET images and (2) tissue fraction effect, a phenomenon 
that effects all imaging modalities, CT, MRI and PET.
The finite spatial resolution of PET, typically > 5 mm, causes spillover between 
regions leading to 3-D blurring on PET images, which directly influences the 
appearance of objects on the image, particularly in regard to object sizes that are three 
times less than the full width half maximum of the PET system (i.e. small objects). In 
this case part of the signal from the object will spill out and hence is seen outside the 
actual object dimensions (Figure 3.19) making small objects appear larger.
100
signal typically 100 %
10 mm
signal reduced  to  85 %
spillover betw een ragions 
Actual Object size 10 mm M easured  object size > 10 mm
spillover betw een ragions
Actual objet in non-radioactive background
M easured  object
Figure 3.19: Demonstration of a uniform activity at 100% of an object of 10 mm in 
diameter; the object is located in a non-radioactive background yielding the measured 
object with part of the signal emanating from the object being seen outside the 
radioactive object, given a maximum activity of only 85% and a larger appearance of 
the object than true (adapted from Soret et al., 2007).
The second phenomenon causing PVE is the so-called tissue fraction effect also 
known as image sampling. This is due to the mathematical concept from which each 
voxel element in the image is produced. The signal intensity of each voxel element in
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the image represents the average signal intensities of the underlying objects (Figure 
3.20) in the subject under examination (in this case a phantom). Such phenomenon 
effects all imaging systems including those that have high spatial resolution such as 
CT and MRI. These factors will lead to an over or under estimation of the volume 
element value (voxel intensity). PVE compensation is beyond the scope of this thesis; 
for detailed information the reader is referred to Soret et al. (2007).
Step 1 : actual activity distribution Step 2; spill out signal
Step 3; spill in signal Step 4; final sigani (sum of 2& 3)
! :50r i
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Figure 3.20: Shows the mathematical processing steps of image sampling, starting 
from step 1 (top left box) that demonstrates the distribution of actual activity of a hot 
object in an active background (i.e. PET imaging); step 2 (top right box) demonstrates 
the spill out mechanism, whereby the signal from the active object will spill out, 
leading to signal loss; step 3 (lower left box) demonstrating the spill in, where signal 
from active background will spill in, leading to a degraded object signal, and finally 
step 4 (lower right box) demonstrating the measured signal, which is produced as a 
result of summation of both signals of spill out and spill in.
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3.4 Summary
From, present observations, objects of < 10 mm diameter are difficult to evaluate in 
PET imaging, being directly related to the problem of PVE. It has been suggested that 
this problem typically occurs when the size of the object is less than three times the 
value of the full width half maximum. Thus, small tumours would appear larger but 
probably less aggressive than actually presenting, due to signal loss as shown in 
Figure 3.19. Volume estimation based segmentation has revealed an improvement in 
results, especially for object sizes greater than 17 mm. However, uncertainty increases 
for small objects due to the relatively thick slices from which reconstructed images 
are obtained (~ 5 mm). Volume estimation using equation 2 revealed not only the 
most superior approximation of sphere volume in 3-D but was also shown to be valid 
for rods and cube-like features (with Vn = AmT in equation 2). Improved object 
geometry definition requires reconstructions from small slice thicknesses of 1 mm or 
less, the arc of each spherically shaped segment becoming linear-like with reducing 
thickness.
The accuracy of the fiducial based registration method was found to be poor (> 1 
mm); an improved result is to be expected for finer scale MRI fiducial markers in 
place of the present use of ampoules. For example, Hsu et al. (2007) have used 2 mm 
long, 1 mm internal diameter cylinders, applying these to both MRI and PET. In the 
present phantom studies data transformation by means of rotation was found 
unhelpful; as such, rotation was not made use of in the main body of experiments. 
However, in clinical studies transformation of data through rotation would be required 
in accommodating even the smallest of patient movement.
In this phantom-based study focusing on the inherent capabilities of the registration 
and fusion software, it has been observed that manual, automatic, marker and volume 
based registration are all reliable. The main problem has been the choice of fiducial 
marker, in particular in regard to the size of these. The centre of gravity software- 
based system has been found to be an excellent registration and fusion tool. In 
clinical, patient based studies, our initial experience has been that automatic 
registration offers a good choice, followed by manual adjustment of one millimeter of 
transformation at a time or one degree of rotation at a time. There is a clear need for 
comprehensive clinical studies in terms of registration definition; accurate registration
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provides improved fusion. Fiducial based registration should be excellent in providing 
accurate fusion, making use of for instance bony landmarks or other common 
anatomical features such as the ventricles of the brain, unaffected as the latter are by 
breathing movements.
In summary, for this phantom-based study, making measurements using conventional 
2-dimensional imaging, it is important for consistency that these be referred to a 
particular window and level adjustment, specified in terms of minimum, maximum 
and central values. Given that window level has a powerful effect upon visualization 
of an object and its edges, this should be dealt with carefully when examining objects 
in any imaging modality. The partial volume effect (PVE) is also an important factor 
effecting measured object size, the poor spatial resolution of the imaging system 
inducing 3-D image blurring due to the spillover between regions (Figure 3.19); 
consequently object sizes will appear larger. This can cause considerable problems 
when poor spatial resolution systems such as PET are used to assist in target volume 
delineation. Such influences will be addressed in Chapter 4.
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Target Delineation in PET Imaging
From Chapter 3, it has been demonstrated that image analysis and interpretation in a 
2-D sectional format are highly influenced by the selection of an appropriate window 
and level adjustment. Further to our phantom based analysis in Chapter 3, changing 
the window and level adjustment allows low-contrast lesions to be better visualised, 
but also changes the apparent size of the lesion, causing it to appear larger. Besides 
the window and level effect, medical imaging is affected qualitatively and 
quantitatively by the partial volume effect (PVE), where PVE not only affects the 
apparent size but also the local contrast of features in the image. This is particularly 
significant with PET imaging, having further major impact in terms of its poor spatial 
resolution. Therefore, accurate and precise target delineation is a critical issue and 
should be dealt with carefully, especially in regard to the use of PET imaging in 
radiotherapy treatment planning. In this chapter, the focus is toward pointing out the 
different target delineation methods that are used with PET at the present time, 
together with support from visual and semi-automatic based studies. In this work 
visual based assessment has involved experts from the departments of nuclear 
medicine and radiotherapy at the Royal Surrey County Hospital (RSCH), while a 
semi-automatic based study has involved profile analysis at full wide half maximum 
using the commercial image manipulation software ImageJ.
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4.1 Target Delineation Methods
To date various methods are currently in use to determine the outline of tracer uptake 
in PET imaging. The most well known and commonly applied method is visual 
interpretation of the PET scans and the definition of contours as judged by the 
experienced specialist (Nestle et al., 2005). However, such a method remains observer 
dependent; it is highly subjective, leading to the potential for considerable inter­
observer variation. This method will be discussed in greater detail shortly, following 
this introduction. Both the lack of reliability and consistency associated with the 
visual based method raises the need for more dependable methods such as 
thresholding the segmented lesion using either a fixed standardised uptake value 
(SUV), or a percentage of the maximum SUV.
Technically, a well applied method for most PET and radiotherapy planning software 
is the use of an absolute value (i.e. threshold value) to define the gross target volume 
(GTV). A threshold standardised uptake value of 2.5 enjoys the greatest use for such 
application in radiotherapy. However, a recent review by Nestle et al. (2009) explains 
the reasons behind the unsuitable use of a fixed SUV threshold as a cut-off value to 
define the GTV contouring for every case. Primarily, the absolute SUV of 2.5 
isocontour was evaluated for diagnostic purposes, where the SUV of the highest (i.e. 
maximum) voxel intensity within a lesion (SUVmax) might give a better impression of 
its malignancy. The mathematical representation of SUV will be introduced and used 
together with other thresholding methods in Chapter 5.
The SUVmax method is readily applicable to PET and radiotherapy planning systems, 
where a threshold relative to a percentage of the maximum uptake value in the lesion 
is used instead of an absolute value. Technically, the maximum uptake of the lesion is 
measured and a percentage of this maximum, e.g., 40% or 50 % is applied for 
contouring the GTV. Nevertheless, it has been observed that small lesions can require 
a higher threshold value in order to reproduce the true lesion size (Nestle et al, 2005). 
This is a manifestation of the partial volume effect. This in turn might lead to 
substantial overestimation of the true volume, which is particularly significant in head 
and neck patients (Daisne et a l, 2003).
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However, due to the biological and physiological differences between individuals, use 
of fixed values to define the GTV contouring, either by an absolute or maximum 
intensity of voxel for every case is not ideal. This is particularly so in regards to 
circumstances when background activity (e.g. uptake in normal organs) lies above the 
fixed threshold value.
More recently, attention has been shifted toward automatic thresholding methods. One 
instance is the automatic thresholding method developed by Daisne et al. (2003), with 
use of a threshold value that varies according to signal-to-background (S/B) ratios or 
the local contrast in the reconstructed image.
To date a number of different algorithms have been used, describing the relationship 
between source and background signals, whereby most of these have been derived 
from phantom based measurements. However some studies have revealed 
underestimation of the target size, with clinician input being required. Others have 
reported validation in phantoms and work on evaluating patient data (Nestle et al.,
%)09X
A relatively simple automatic method has been developed by van Dalan et al. (2007), 
the purpose of which was lesion delineation and volumetric quantification from PET 
images. The optimal relative threshold level in this model is background signal 
dependent and relates to the signal-to-background ratio (SBR). The method has been 
shown to be applicable in phantom and in patient studies. In addition, it was 
considered a promising tool for lesion delineation and volumetric quantification of 
PET lesions.
The Theoretical Model of van Dalen et al. (2007)
In 1-D the 50% level of the image signal (S) after background (B) subtraction should 
usually indicate the optimal image cut-off value, see Figure 4.1. However, because a 
sphere’s diameter (D) is sufficiently larger than the FWHM of the point-spread 
function (PSF) and the PSF is symmetrical, the use of 50% as a cut-off value is not 
absolutely valid.
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Figure 4.1: Illustrates the blurring in the image due to the mathematical operator (i.e. 
convolution) using the point-spread function. The 50% level of the difference S-B 
usually indicates the optimal image cut-off value, however to obtain the true size of 
the sphere use of other cut-off values might be used (image adapted from van Dalan et 
a/., 2007).
In 3-D the mathematics become more complex. In this case, the optimal relative 
threshold level {RTL) to obtain the true volume for a sphere with diameter D, is 
obtained through convolution of the sphere diameter with a Gaussian PSF. This is to 
determine the amount of overlap (i.e. the integral) between the PSF and the sphere 
diameter. The overlap is expressed as a function of the distance between the PSF and 
sphere diameter centres. Thus, the activity concentration, after background 
subtraction is written as
A, (x^,S,FW HM ) = ^j^O {D)xPSF(x^,FW HM )dxdydz, 4.1
where PSF(xp, FWHM) is the point-spread function centred at a location xp along the 
x-axis, with a full width half maximum value, FWHM, and 0(D) is the sphere with 
diameter D, centred at % = y = z = 0.
The maximum amount of overlap between the sphere and the PSF is obtained when 
both are co-centred, xp=0. Thus, the image signal after background subtraction 
becomes
S-B = A ^  (% =0,D,FWHM ) , 4.2
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Similarly, the optimal threshold {T) is obtained when xp is equal to the radius of the 
sphere. Therefore, the optimal threshold after background subtraction is written as
T -B = A X x ^ = ^ ,D jm iM ),
Finally, the optimal relative threshold level (RTL) is given as
4.3
RTL-- T - B
S - B
4.4
The theoretical derivation in equation 4.4 shows that the optimal RTL is a sphere 
volume (or diameter) dependent. This is shown in Figure 4.2, where very large 
spheres acquired a RTL (i.e. a cut-off value) of 50%, whereas for spheres with a 
diameter between approximately 15 and 50 mm a RTL of typically 40% is acquired. 
Finally, for spheres with a small diameter, the RTL becomes larger than 50%.
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Figure 4.2: The optimal relative threshold level (RTL) defined by van Dalan et al. 
(2007) as a function of sphere size, where the FWHM of the point spread function of 
their acquired PET system is 9.2 mm.
This theoretical derivation was validated experimentally, where spheres with voxel 
values above some predefined threshold were selected. In this case the threshold was 
varied until the volume of the clustered voxels corresponded to the true sphere 
volume. This cut-off threshold (T) was translated to the RTL as in equation 4.4.
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In the present phantom-based study, designed to assess both visual and semi­
automatic based delineation methods, use was made of the NEMA body phantom as 
described in Chapter 3. A PET scan was performed using a Philips Gemini GXL 
PET/CT system with a transaxial resolution of 5.4 mm FWHM at the centre of the 
field of view. 3-D images were acquired for 3 minutes in a single bed position and 
the images were reconstructed using the method of Ordered Subsets Expectation- 
Maximization (OSEM), with PET images being displayed and processed using two 
commercially available software packages: (1) the 3-D image registration and fusion 
software ProSoma™, available for use in the radiotherapy department at the RSCH 
and (2) the navigation and visualization multi-modality and multi-dimensional image 
software OSiriX, available for use in the nuclear medicine department at the RSCH. 
For the semi-automatic method the software image! was used for profile analysis 
study.
4.2 Visual Based Method
To consider subjective influences, a group of eight experienced observers were 
involved: two radiologists, two oncologists and four physicists, each making 
independent manual assessment of sphere diameter. A simple protocol was used in 
which the observers were asked to measure the horizontal and the vertical diameters 
of each sphere using the linear measurement tools (a ruler) available in both the 
software packages ProSoma™ (a radiotherapy workstation software) and OSiriX (a 
nuclear medicine workstation software). The sphere diameter was assessed by taking 
the mean of the horizontal and the vertical measurements for all contributors. In 
addition, a full window and default level was used for consistent measurement and to 
prevent any influence of window and level adjustment on analysis output.
Manual assessment (Figure 4.3) has revealed considerable differences in evaluated 
sphere size using the two software packages. With ProSoma™ there is closer 
agreement obtained between observer evaluations and actual diameters than that 
obtained in using OSiriX; the details of this analysis are presented in Table 4.1. In 
particular, OSiriX was shown to produce a constantly lower estimation of sphere 
diameter. This observation requires further investigation to fully address and explain 
the significant differences associated with OSiriX data measurement. In table 4.1, the 
subjective influence in assessing sphere diameter on PET images is responsible in
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large part for a discrepancy of ± 2.4 mm in smallest sphere size evaluation in using 
ProSoma™. and up to ± 4 mm in other spheres. This largely results from the 3-D 
blurring effect.
Influence o f manual delineation on sphere diameter
4 5  -1 
4 0  - 
S' 3 5 -
— ♦—  ProSom a  
— n— OSiriX  
— i,----A ctual
2 5  -
20 -
3 0
Actual diameter (mm)
Figure 4.3: Observer assessment of sphere diameter, with eight participants using data 
from ProSoma™ and two participants using that from OSiriX. Generally, an 
underestimation of sphere diameter has been observed using the OSiriX workstation. 
In addition, an underestimation of small spheres was also typical using ProSoma™, 
due largely to the 3-D blurring effect.
Table 4.1: The influence of visual based measurements on sphere diameter 
assessment, sphere assessment size being through use of the nuclear medicine 
workstation software OSiriX and the radiotherapy workstation software ProSoma™.
Sphere Manufacture ProSoma™ OSiriX
specification mean ± SD, n = 8 mean± SD, n = 2
1 10 9.4 ±2.4 7.6 ±1.6
2 13 12.8 ±2.6 10.1 ±3.0
3 17 17.4 ±2.8 12.0 ±2.4
4 22 22.1 ±4.0 14.9 ±2.0
.5 28 27.4 ±2.2 20.7 ±0.6
6 37 38.9 ±3.2 29.0 ±1.8
Statistical analysis between the results for the physicists and clinicians was also 
obtained (Figure 4.4), diameter assessment and statistical significance of the 
differences being addressed using an independent T-Test. It is apparent from
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comparing the visual based delineation between the two groups that such analysis is 
not straightforward, the discrepancies being shown to vary from less than + 0.5 mm 
up to ± 3.1 mm for the clinicians, while it is less than ± 0.9 mm up to ± 4.6 mm for 
the physicists. Nevertheless, statistical analysis using the T-Test have shown that 
statistical differences between physicists and clinicians measurements are significant 
(p < 0.05), particularly in regard to spheres 1 & 2 with typical diameters of 10 and 13 
mm (i.e. p = 0.042 and 0.02, respectively); while differences were statistically 
insignificant for the rest of the spheres.
bü -1
4 5  -
F 4 0  -
E
c 3 5  ■
1 3 0  -
E ? 5  -n
•D
u 2 0  -
p
o 15  -
■g.
W 10
5
0
3  4
Spheres nurr±>er
□  Typical (D )
□  p h y s ic is t
□  c in ic ia n s
Figure 4.4: Visual based assessment between the two groups, physicists and 
clinicians.
Similarly, statistical group analysis involving nuclear medicine and radiotherapy 
experts were also obtained (Figure 4.5). Here, the first group consists of two nuclear 
medicine physicists and two radiologists, while the second group includes two 
radiotherapy physicists and two oncologists. Diameter assessment and statistical 
group analysis using the independent T-Test has shown considerable discrepancy in 
this visual based measurements study of the two groups. Thus said, the statistical 
difference between the two groups was shown to be insignificant (p > 0.05). Both 
statistical group analyses ideally require the contribution of more observers, so that 
more significant results can be seen.
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Figure 4.5: Visual based assessment between the two groups, nuclear medicine (NM) 
and radiotherapy (RT) personnel.
4.3 Present Study Semi-automatic Method
The semi-automatic assessment was made using profile analysis, where a vertical and 
a horizontal profile were drawn through the centre of each sphere, followed by profile 
analysis and mathematical interpolation along the x-axis at the full width half 
maximum (FWHM) value to determine sphere diameter in mm. Profile analysis was 
carried out using the image manipulation software ImageJ.
Technically, to define the accurate cut-off value for each sphere diameter, first the 
background signal needs to be subtracted from the total signal value in order to obtain 
the true signal, as was shown in Figure 4.1. A simple and also practical way to do this 
is by taking a reasonably long profile (either vertical or horizontal) at the maximal 
cross section of each sphere. In this way the background signal is included (i.e. from 
both ends on the profile). This is followed by definition of the background signal; one 
way to obtain this is by averaging the gray value of the first two points on the right 
side of the tail and the last two points on the left side of the tail. Finally, the averaged 
background signal is subtracted from the total signal (i.e. a point by point process). 
This step was followed for all of the six spheres, see Figure 4.6, where the total signal 
appears in blue and the true signal appears in pink.
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Vertical profile of sphere 2, w lh  and without BGVertical profile of sphere 1, with a n  without BG
O SiC
Vertical profile of sphere 3. w lh a x iw ith o u r  BG Vertical profile of sp h ere* , v .i h  and without BG
S 10CCO
Vertical profile of sphere 5. w lh  and without BG Vertical profile of sphere G. w lh  and without BG
Figure 4.6: The difference between the total signal including background (with BG) in 
blue and the true signal where the background has been subtracted (sub BG), shown in 
pink.
Profile analysis using a cut-off value of 50% (i.e. FWHM) of the true signal is fully 
represented in table 4.2, where it is clear that the small sphere diameters of 10 and 13 
mm have been over estimated while the larger sphere diameters, typically from 22 
mm up to 37 mm, were underestimated. In this analysis the use of a cut-off value of 
50% was shown to be reasonable for the sphere diameter of 17 mm. Further to the 
rather comprehensive discussion of Soret et al. (2007), the complications of PVE are 
apparent for a feature size less than three times the FWHM of the acquired system 
resolution. Thus one can classify sphere diameter into three groups: (1) sphere
79
Chapter 4. Target Delineation on PET Imaging
diameters that are less than 3 times the FWHM (i.e. 3 times 5.4 = 16.2 mm), (2) 
sphere diameters that are very close to 3 times the FWHM and (3) sphere diameters 
that are more than 3 times the FWHM. In the present case, group one includes spheres 
of 10 and 13 mm diameter, group two includes the sphere diameter 17 mm and group 
three includes spheres of 22, 28 and 37 mm diameter. From present observations 
(Table 4.2), it seems reasonable to predict that group one would require a larger cut­
off value than 50%, while group three would require a smaller cut-off value than 50%.
As a first attempt, this was carried out by varying the Cut-off value for each sphere 
until the measured diameter corresponded to the true sphere diameter. Table 4.3 
shows the different cut-off values that have been used to produce a more accurate 
estimation of the different sphere diameters.
Table 4.2: Illustration of sphere diameters that have been estimated using a general 
cut-off value of 50% for all spheres, where the mean of a horizontal profile (HP) and a 
vertical profile (VP) was taken at the FWHM of each sphere.
Sphere Actual
diameter
HP W mean± SD
1 10 17.9 19.1 18.5 ±0.9
2 13 16.2 18.5 17.4+1.6
3 17 15.9 18.3 17.1 + 1.2
4 22 17.8 21.1 19.4 ±2.3
5 28 24.3 24.1 24.2 ± 0.2
6 37 33.0 33.9 33.5 ± 0.6
Table 4.3: Illustration of sphere diameters estimated using different cut-off values, 
ranging from 75% down to 40%, based on sphere diameters for which spheres smaller 
than 3 times FWHM acquire the large cut-off value and spheres larger than 3 times 
FWHM acquire the small cut-off value.
sphere
no.
Actual
diameter
Threshold HP VP Measured diameter 
Mean ± SD, n=2
1 10 75% of the FWM 10.5 11.2 10.8 ± 0 .5
2 13 65% of the FWM 12.7 14.1 13.4 ± 1.0
3 17 50% of the FWM 15.9 18.3 17.1 ± 1.2
4 22 40% of the FWM 20.3 24.3 22.3 ± 2.3
5 28 35% of the FWM 27.3 26.9 27.1 ± 0 .3
6 37 35% of the FWM 35.7 37.1 36.4 ± 1.0
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However, in this work we have derived a more general formula that shows reasonable 
agreement with our finding in table 4.3. In a similar way to van Dalen et al. (2007) 
mathematical representation of the optimal RTL, herein we define the percentage 
optimal cut-off value (COV) as
COV%=^ ^ ^ ^  ^ xlOO =50% , 
Max g —B
4.5
where Maxs is the maximum voxel intensity of the signal, FWHMs is the voxel
Maxc
intensity of the signal at half maximum (i.e. ) and B is the averaged voxel
intensities of the background signal. This formula is only valid when the sphere 
diameter is approximately 3 times the FWHM of the PSF of the PET system. Thus, 
spheres diameters that are smaller or bigger than 3 times the FWHM of the PSF of the 
PET system would require a use of a different cut-off value than 50%. In equation 4.5 
the optimal COV% would always be constant and equals' 50% and in order to vary 
and change the optimal COV% according to sphere diameter a factor that is sphere 
diameter dependent needs to be applied. Equation 4.5 represents sphere diameters that 
approximately equal in this case 16.2 mm, dividing this value by a given sphere 
diameter represents the influence of sphere diameter on the optimal COV%, see table 
4.4. Thus, the general formula of equation 4.5 becomes
D MaXg - B
4.6
Table 4.4: Shows the optimal COV% for each sphere diameter, where use is made of 
equation 4.6.
Actual 
diameter (mm)
FW HMs~B  
Max g -  B
Optimal COV%
10 group one 0.4998 81%
13 group one 0.4998 62%
17 group two 0.4998 48%
22 group three 0.4998 37%
28 group three 0.4998 28%
37 group three 0.4998 22%
8 1
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Our finding (table 4.3 and 4.4) concerning the different cut-off values seems to be in 
good agreement with the finding of van Dalan et ah (2007), see Figure 4.2. This is 
illustrated in detail in Table 4.5, where a cut-off value greater than 50% was used for 
spheres less than 12 mm and a cut-off value of 50% was used for very large spheres 
(i.e. greater than 100 mm). On the other hand, sphere diameters ranging from less than 
20 mm and below 40 mm acquired a cut-off value less than 50%.
Table 4.5: Illustrates a comparison between van Dalen optimal cut-off values as a 
function of sphere diameter and present study findings.
Observers Sphere diameter (mm) Optimal threshold
(van Dalen etal., 2007) 
Present study first attempt 
Present study using eq. 4.6
< 11.04 mm 
10, 13 and 17 mm 
10, 13 and 17 mm
RTL >50%
Threshold = 75%, 65% and 50% 
COV% = 81%, 62% and 48%
(van Dalen et al., 2007) 
Present study first attempt 
Present study using eq. 4.6
(20 -  60) mm 
22, 28 and 37 mm 
22, 28 and 37 mm
RTL =35%
Threshold = 40%, 35% and35% 
COV% = 37%, 28 % and 22%
(van Dalen et al., 2007) 
Present study first attempt 
Present study using eq. 4.6
Very large spheres 
inapplicable 
inapplicable
RTL = 50%
The differences in sphere measurements using visual and profile analysis is 
represented in Table 4.6, where measurements are provided in terms of the mean and 
standard deviation (SD). From Table 4.6 it is apparent that sphere diameter 
assessment using profile analysis yields higher accuracy when compared with the 
visual analysis method. The higher standard deviation of the visual method is related 
to the eye adjustment of the individual and therefore to judgment. Conversely, profile 
analysis usually provides smaller standard deviations; those measurements associated 
with a relatively high SD (i.e. sphere number 4) are related to an inconsistent sphere 
shape.
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Table 4.6: The difference in sphere measurement given by the two different methods
of visual based analysis that included eight observers on ProSoma™ and profile 
analysis through use of vertical and horizontal profiles.
Sphere
no.
Actual
diameter
mm
Measurement
methods
Measured diameter 
mm 
mean ± SD
1 10 ProSoma ruler 
Profile analysis
9.4 ±2.4 , n = 8  
10.8±0.5,n = 2
2 13 ProSoma ruler 
Profile analysis
12.8 ±2.6 , n=  8 
13.4 ± 1.0, n = 2
3 17 ProSoma ruler 
Profile analysis
17.4 ± 2.8, n = 8 
17.1±1.2,n=2
4 22 ProSoma ruler 
Profile analysis
22.1 ±4.0 , n=  8 
22 .3±2.3 ,n=2
5 28 ProSoma ruler 
Profile analysis
27.4 ±2.2,  n=  8 
27.1 ± 0.3, n - 2
6 37 ProSoma ruler 
Profile analysis
38 .9±3.2 ,n=8
36 .4±1.0 ,n=2
4.4 Summary
Determination of a sphere diameter and delineation of a target using PET imaging is a 
critical step. The contours of a lesion on a PET image may encompass more than the 
real metabolic activity of the tumour (due to background contribution). In the absence 
of background activity, which is not the case in clinical practice, PVE does not affect 
the total tumour activity.
In the literature various basic approaches have been developed to accurately contour 
the GTVs on PET imaging. Visual contouring by experts is technically and easily 
applicable and is a well-established method. Nevertheless, visual contouring remains 
observer dependent and is therefore unreliable and highly subjective. In the present 
observer study (section 4.2), assessment of sphere diameter was substantially 
influenced by such subjectivity and variation in the measurements was up to ± 4 mm. 
In clinical practices such variation would significantly affect the quantified GTV 
contouring on one side, with normal tissue complications to be expected on the other 
side.
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Conversely, our proposed method using profile analysis has shown not only good 
agreement with typical manufacturer specification of sphere diameter (table 4.6) but 
also has been shown to be in reasonable agreement with the findings of other phantom 
based studies (table 4.5). Further to our phantom based study, use of the profile 
analysis method to define sphere diameter has been shown to be more accurate and 
reliable than the visual based analysis method (table 4.6). However, a wider spectrum 
of spheres or features size should be explored in order to confirm the different 
proposed cut-off values. Here, experimental finding have been shown to be 
satisfactory when a cut-off value greater than 50% has been used for spheres less than 
3 times the FWHM of the acquired PET system. Similarly a cut-off value of 50% has 
been used for spheres approximately equal to 3 times the FWHM and a cut-off value 
of less than 50% has been used for spheres greater than 3 times the FWHM.
In clinical practice lesions are not spherical and may not even be uniform, likewise the 
accumulated uptake may not be uniformly distributed within the lesion, a reason that 
substantially increases the level of difficulties in assessing and quantifying feature 
size.
In association with this, the process of target delineation and volumetric quantification 
on a PET image raises the need for a protocol that offers more consistent and reliable 
analysis. In addition, a specific mathematical algorithm should be used for a given 
PET system, as PVE or image blurring is a point spread function dependent. This 
algorithm is width dependent and is also likely to vary between the different PET 
systems.
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The importance of the structure and function of tumour microvasculature in 
determining hypoxic cells within the tumour vasculature was outlined in Chapter 2. It 
is evident that the random location of leaky vessels is associated with tumour hypoxia. 
Indeed, of particular importance to the work herein is that the reliability and accuracy 
of determination of the spatial extent of the hypoxic cells poses a considerable 
challenge. Although the PET imaging technique allows for a wide choice of hypoxia 
selective marker tracers, the challenge for hypoxia imaging is to demonstrate a 
phenomenon that occurs at a much smaller scale than that achieved with PET imaging 
techniques, the latter having a spatial resolution typically greater than 5 mm. To 
understand such complicated phenomenon a number of studies have attempted to 
describe tissue oxygenation based on theoretical methods. Thus, in the present chapter 
a development to Kelly and Brady’s (2006) reaction diffusion model will be 
introduced, with representation of both supply and drainage terms included in the 
model instead of using a single representative value of supply.
5.1 Modeling Tissue Oxygenation
The theory of an analytical re-presentation of oxygen diffusion from one blood vessel 
(i.e. the capillary) into tissues was established by Krogh (1919). This was followed by 
the work of Hill (1928) and Thomlinson and Gray (1955), describing systems of
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simple geometry for which only analyses of individual vessels was feasible or 
tractable. While these simple models can predict oxygen distribution due to a single 
capillary, the ability to solve the governing equations using analytical approaches 
enables relationships between tissue thickness and oxygen gradients to be 
characterized quantitatively without the need for simulation. The solutions presented 
in the following section are for the steady-state condition. This turns the problem from 
being one dependent on space and time to being only space dependent.
Hill (1928) produced an analytical study of the influence of oxygen concentration in 
blood vessels, the diffusion coefficient of oxygen and the rate of oxygen consumption 
in tissue. A simple geometry of a block of tissue bounded by a nascent blood vessel 
(Figure 5.1) was considered as a first attempt to estimate the maximum diffusion 
distance from a single blood vessel. In this work, oxygen axial diffusion was 
neglected
Tissue
Source
Figure 5.1: The model geometry used by Hill (1928), where a block of tissue is 
bounded by an infinite plane blood vessel and the distance from the blood vessel (i.e. 
the source) is given by %.
With such geometry the rate of oxygen concentration change with respect to time was 
expressed as:
Cq2{x, t) = D- 02 5.1
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where C0 2  is the oxygen concentration in the blood vessel in units of mois/ cm^, D is 
the diffusion coefficient of oxygen in unit of cm^/s, q is the rate of oxygen 
consumption in unit of mols/cm^ s, and % is the distance firom the blood vessel (cm).
By solving equation 5.1 in the steady state, the term  ^^^gj-efore equation
5.1 will be reduced to equation 5.2 that depends only on space.
D - ^ = q ,  5.2
JC
Solving equation 5.2 requires integration twice, with the first integration giving the 
rate of change of oxygen concentration with respect to the distance (equation 5.3), 
while the second integration gives the oxygen concentration at a given distance % 
(equation 5.4):
= H  + j3 5.3
d x D
where f  & y integration constants, each of which needs to be estimated in order to 
solve equation 5.4 quantitatively. At the blood vessel boundary where x = 0, the 
oxygen concentration at this given distance represents the initial oxygen concentration 
(i.e. Co2(0) = Co). It is also well known that at some distance Rmax (i.e. oxygen 
maximum diffusion distance) the oxygen concentration drops down to zero. Thus at % 
= 0 equation 5.4 become C^2(0) = 7 =Coand at R^ax all of equation 5.3 and 5.4 
becomes:
^ ^ 2 2 iV ,0 a n d C o 2 ( / im a ,)= 0 , 5.5ax
So that equation 5.3 can be written as:
= = Q ^  A = , 5.6
d x D  D
Similarly equation 5.4 can be written as:
Cc>2(^max) = ^  + Cq =0 , 5.7
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From equation 5.7 the maximum diffusion distance of oxygen is given by
•^ max ^
2 D C n 5.8
A
In general, oxygen concentration at a given distance % can be represented as 
.2
Cnii^) =
qx 2gCo
X + Cq, 5.9
2D \ D
Hill has also reproduced the above analytical analysis for geometry defined using 
polar coordinates. The work of Hill was followed by Thomlinson and Gray (1955), 
where they explained the appearance of the tumour necrotic (i.e. dead) region that 
develops as a consequence to oxygen diffusion limits. Mathematically this has been 
approached considering a cylindrical tumour core of radius ro, which develops a 
necrotic region of radius that is surrounded by the tumour core when the radius of 
the latter (i.e. ro) exceeds a certain distance (i.e. the oxygen maximum diffusion 
distance), see Figure 5.2.
(a) (b)
Tissue
blood vessel blood vessel
Figure 5.2: Tumour core geometry, where (a) represents a cylinder of radius r ,^ while 
(b) represents an expanded tumour core that develops a necrotic region (i.e. dead 
tumour core) of radius r„ when the tumour core exceeds a certain distance (i.e. the 
oxygen diffusion limit).
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The most significant assumption that the Thomlinson and Gray model makes is that 
oxygen consumption is at a constant rate regardless of the oxygen gradient in tissue 
cells. More recently, Pogue and co-workers (2001) adopted the same assumption 
using the oxygen consumption rate estimated by Dewhirst et al (1994). The latter 
group estimated the oxygen consumption rate in rat mammary adeno-carcinoma to be 
between 0.83 to 2.22 cm^/100 g/min, which can be equivalently expressed as 6 to 16 
pM/s, given that tissue density is similar to water. This in turn can be expressed in 
mmHg/s using Henry’s law, see Appendix A for the detailed conversion.
However, examination of histological sections has supported the suggestion of a 
Michaelis-Menten consumption type (Lin, 1976), which results in an oxygen 
consumption gradient that is a function of the initial oxygen concentration level in the 
tissue cells. Typically, under normal conditions, most biological reactions proceed at 
very slow rates, slower than cells demand in order to maintain growth and normal 
cellular functions. One way to increase the rates of biological reactions is by raising 
the temperature of the cellular environment or lowering the activation energy of the 
reaction. Because the majority of biological systems have a low tolerance for high 
temperatures, temperature regulation requires a high input of energy into the 
biological system. Increasing the rate of biological reactions evolve enzymes, 
otherwise known as biological catalysts. In chemistry, a catalyst is a chemical 
substance that will either increase or decrease a specific chemical reaction. The 
function of such is to control the activation energy of specific chemical reactions, 
thereby allowing the reactions to proceed at rates faster than under standard 
conditions.
As enzyme-catalysed reactions are saturable, the rate of catalysis does not show a 
linear response to increasing substrate. Thus if the initial rate of the reaction is 
measured over a range of substrate concentrations denoted as [S], the reaction rate (v) 
increases as [S] increases, as shown in the corresponding graph of Figure 5.3. 
However, as [S] increases further, the enzyme becomes saturated with substrate and 
the rate reaches Vmax, the maximum rate for the enzyme. Mathematically this is 
represented as:
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Vn =_  ' max
Km + [*5]
5.10
where Km is the coneentration of substanee at which the enzyme reaction rate is at half 
maximum. For more deltaied information the reader is referred to the excellent text of 
Laidler (1978).
Enzyme's reaction
m a x
max
Figure 5.3: Demonstrates Miehaelis-Menten enzyme-catalysed reactions, where Km is 
a constant representing the substance concentration at which the enzyme reaction rate 
is at half maximum.
Secomb and co-workers (1993) have studied the influence of multiple vessels 
geometry on both oxygenation level and distribution. Typically, more realistic 
vasculature architecture will imply a more complicated geometry, with blood vessels 
forming a non regular network. Thus the group of Secomb proposed two types of 
vasculature geometry: (1) an actual vascular geometry that was observed in a tumour 
using confocal microscopy, where vessels were represented as cylinders of variable 
radii and random geometry, as shown in Figure 5.4a and (2) a uniformly spaced stack 
of identical cylinders with a constant inter-vessel distance, as shown in Figure 5.4b. 
The inter-vessel distance for the uniform geometry is therefore constant, whereas in 
the true geometry this varies. The two geometries were used to obtain steady state
90
Chapter 5. Simulation o f Oxygen Heterogeneity
profiles of p02. The cumulative frequency distributions of tissue pÜ2 for both 
geometries are shown in Figure 5.4e, where the actual vascular geometry represented 
in Figure 5.3a produces a very different oxygenation profile.
(a)
(c)
(b)
Tissue
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Figure 5.4: The different vasculature geometries formed by (a) a misshaped 
cylindrical geometry where cylinders vary in radii; (b) uniformly spaced cylinders of 
a single radius. Both geometries supply the same volume of tissue. The graphs 
represent the cumulative frequency of p 0 2  values that result from both vascular 
geometries (adapted from Secomb et al., 1993).
The tissue cylinder model was built on the basis of having a constant blood vessel 
density, while a true vasculature model results in regions of both high and low blood 
vessel density. Low pÜ2 values are usually associated with a low density of blood 
vessels. However, high densities of blood vessels do not appear to produce values 
higher than those obtained with the tissue cylinder model. This suggests that deviation 
from a uniform vascular geometry increases the extent of hypoxia.
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The study by Seeomb highlighted the importance of considering the geometry of 
vessels when estimating the degree of tissue hypoxia, thus similarly Pogue et al. 
(2001) has developed a numerical model to predict the capillary oxygen supply within 
and near hypoxic regions in radiation-induced fibrosarcoma tumour (RIF-1), where 
use has been made of histological sectional analysis of immunohistochemieal 
imaging. From this is allowed the identification of blood vessels and hypoxic regions; 
the latter stained with Hypoxyprobe-1, the commercially available preparation of 
pimonidazole (i.e. a hypoxic marker).
Mathematical representations of vasculature in simulation models enables 
characterization of the relationship between vascular geometry and oxygenation, 
where parameters can be systematically varied. Among those parameters, the inter­
vessel distance (i.e. distance between two vessels) has a significant impact on oxygen 
heterogeneity. The study of Dasu and co-workers (2003) describes a simple model of 
tumour vasculature where discrete vessels have been evenly distributed and assumed 
to run perpendicular to the plane, with each represented as a circle of a fixed radius of
7.5 pm. In this study an attempt was made to investigate the influence of the vascular 
geometry on tissue hypoxia through the systematic variation of the mean value of 
inter-vessel distances. Dasu represents oxygen heterogeneity in 2-D as following:
5 2 5 2 ^ = 0  2pO ,-q ipO ,), 5.11
at
where p02  is the partial pressure of oxygen in mmHg, D is the oxygen diffusion 
coefficient in mm'^s"  ^ and qipOi) is the oxygen consumption rate in mmHgs'\ In this 
work the oxygen consumption rate, is different from that of Pogue et al., (2001), 
where Dasu considers the use of Michaelis-Menten kinetics. Therefore, the oxygen 
consumption rate using the standard Miehaelis-Menten equation will be given as:
PO2 + h
where qmax is the maximum oxygen consumption rate in mmHgs'^ and h is the partial 
pressure of oxygen at which consumption is half maximum, in units of mmHg.
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Equation 5.11 is then solved for the steady-state. In this work a number of reasonable 
assumptions were made, such as the negligible local oxygen production of oxygen. 
Furthermore, diffusion is the dominant mode of oxygen transport, thus transport 
through convection is also neglected.
In the previous discussion consideration been made of an investigation of discrete 
representations of vasculature, where typically tissue is classified to be either ‘vessel’ 
or ‘not vessel’. The drawback of such representation is that blood vessels have been 
implicitly represented; an advanced mathematical representation of typical tumour 
vasculature geometry would rather define blood vessels as an explicit source term. 
This idea was initially explored by Kelly and Brady (2006); such source term 
representation enables the use of a continuous vascular representation. In addition, 
Kelly and Brady (2006) introduced the mathematical representation of the source term 
to the reaction diffusion model of Dasu et al. (2003), which had previously been 
defined by Baxter and Jain (1991). With this addition, the reaction diffusion model 
simulating oxygen heterogeneity in 2-D can be described as:
where p02 is the oxygen tension (mmHg) in tissue, Dq^ is the diffusion coefficient of
oxygen (mm^ s'^), q^ax is the maximum rate of oxygen consumption (mmHg s'^), and 
h is the oxygen tension (mmHg) at which the rate of oxygen metabolism as a function 
of oxygen tension is at half-maximum, Pttiq^ is the capillary membrane permeability
of oxygen (mm s'^), S/V is the surface area to volume ratio of the capillary (mm'^), 
p02vessei is thc oxygcu tcuslon in the capillary and R(x,y) is a function that describes 
the location of capillaries in the plane i.e., R = l i î  there is a capillary at that point and 
R is otherwise zero. In this work all simulation was adopted in 2-D and coded using 
finite-difference methods; a single value was used to represent the source term and 
blood supply was assumed to be venous (i.e. 40 mmHg). Equation 5.13 was solved 
numerically for the steady-state, where use was made of an array of parallel blood 
vessels randomly distributed with unevenly spaced distance. From a mathematical 
perspective the generation of the 2-D vascular architecture in Kelly and Brady’s work 
raises a number of issues: (1) their vasculature computation was carried out on a fixed
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mesh size, based on the vessel radius, and refinement of the mesh leads to 
homogenization of the vascular map, a situation that is not desirable. In contrast, the 
smaller the mesh intervals the more detailed the simulation will be; while this would 
increase the computational time it reduces the numerical uncertainty; (2) the diffusion 
operator is defined for continuous functions, such that the carrying out of a 
computational discrete mesh leads to inconsistent solutions.
5.2 Reaction Diffusion Model Refinements
Further to the discussion on oxygen movement along the capillary in section 2.1 of 
Chapter 2, it is clear that oxygen may diffuse into tissue at any point along the 
capillary. Thus, a 2-D cross section taken from a tumour vasculature would be a 
combination of a supply and drainage component. Thus, our mathematical 
representation of the reaction diffusion model becomes equation (5.14):
+  +  (5.14)
where Ss represents the oxygen supply side and So the oxygen drainage side, 
mathematically represented by equation 5.15 and 5.16, respectively:
Pnify S
S s =  f  i i p O s -  PO^).  y ) )  (5.15)
P r r i o  S
^D ~  Y  ~ P ^ 2 ^ ’^drainers^^^yy) , (5.16)
where pO^is the oxygen partial pressure at the supply side (mmHg), pO^is the 
oxygen partial pressure at the drainage side (mmHg), RsuppUers is the proportion of 
suppliers in the 2-D vascular environment and Rdraimrs is the proportion of drainers 
within the same vascular region. Given that the supply and drainage term is now 
represented, one can address the two existing scenarios (1) oxygen supplied through 
the arteriole end and drained through the venule end, the case when new blood vessels 
originate from pre-existing vasculature and (2) oxygen supply and drainage through
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venules, an occurrence that is associated more in tumours, where new blood vessels 
generate from neovasculature. The mathematical representation through equation 5.15 
and 5.16 allow for varying the proportion of suppliers (whether arterioles or venules) 
to drainers (i.e. venules) and arrive at different scenarios that enable the visualisation 
of the cellular behaviour of tumour vascular architecture. This in turn enables one to 
study the different regions in the tumour vasculature. We will now define the
c o n t in u o u s  f u n c t io n s  RsuppUers a n d  Rdrainers-
Vascular Architecture Refinements
Of note is that vascular structures and geometry play a significant role in the amount 
of oxygen that is being delivered to the cellular region, it also results in oxygen 
heterogeneity. In this work the vascular architecture is defined in 2-D with vessels 
passing perpendicularly through the eross-sectional 2-D plane. The location of the 
capillaries in the plane (the vascular map) is described by the function R(x,y), which is 
the summation of all capillaries (i.e. both suppliers and drainers). Capillaries are 
randomly distributed (i.e. unevenly spaced) in the imaging plane on a fixed equally-
spaced Cartesian mesh, {xi,yj), known as the vascular mesh:
(Xi, y j)= (iA x,jA y),i, j= 0,l,........  ,N
where Ax = Ay = L/N  is the mesh step size, (N+1 f  is the total number of possible
capillary sites and L  is the length of the domain. The grid points on the vascular mesh 
are randomly assigned a value Rÿ of 1 with a probability of p  (for a vessel) or zero 
with a probability of (1 -  p) (for no vessel). This random assignment of zeros and 
ones is known as a Bernoulli process i.e., P{R^j = \) = p and P{R.j= 0) = l - p ,
where p is defined as:
MVD X  71 r'^p = -----— ------- , (5.17)
M
where MVD is the micro-vessel density (number of vessels per unit area), r is the 
capillary (blood vessel) radius and M  is the area of the vascularity, in this case 1 mm^. 
The vascular map, R(x,y), is then defined as
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R (x ,y )= Y ,Y jR ijf(x -X i,y -y j)  (5.18)
W ;-0
where Xi are the vascular mesh points and the function f  describes the shape of the 
capillary at (xi,,yj) normalized so that at the centre of the capillary/fO,Oj=7. Several 
possible choices for/are:
/(0 ,0) = 1 and zero otherwise
f ( x ,y )  = e “ , where a  is the radius of the capillary
• f { x ,y )  = e ^ ^ , where «  and are the semi-major and semi-minor axes
of an elliptical capillary.
For the last two possibilities, we require a  and p  to be very much smaller than the 
vascular mesh step size Ax and Ay so that the capillaries are well defined and 
maxR(x,y) 1. For the purpose of this thesis, we choose the second possibility for 
the function/.
The proportion of supplier (e.g. arterioles) and drainers (e.g. venules) of the 
capillaries in the tissue is defined using another Bernoulli process at each of the 
vascular mesh grid points, A/j. i.e., f(A;-  ^=\) = p^ if a grid point is a supplier (either
arteriole or venule) and PiA^ j =0) = l - p s  if the grid point is a drainer (i.e. venule).
With such a representation, one can vary the individual probability of ps and arrive at 
different tumour vascular capillary distributions. In this work we only consider the 
case where p^ = 0.5. We can now define supplier (i.e. arteriole or venule) and drainer 
(i.e. venule) distributions as
M N  (x-Xf Ÿ  + {y -y j  Ÿ
i=0 ;= 0
N N  (x-x , Ÿ  + (y -y j Ÿ
Pi^^y).enules=Y^ (1“  A .;) ’ ‘ ^
1=0
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where is the width of the Gaussian and gives the radius of the blood vessel (P = 
2 (1  ) and x/j are the random locations of the capillaries (noting that they do not have to 
be uniformly distributed). In this work, a was defined as:
(  4 / K - D l
y J  /
where is the length of the domain, in this ease 1 mm^, % is the number of grid 
points, in this case 25 and p is a constant that is > 2, in this case 6. With such 
arrangement one can vary this quantity, p, (e.g., 4, 7 and 8) and come up with 
different scenarios, aiming to understand the influence of tumour vasculature 
geometry on oxygen and tracer heterogeneity. However, typical inter-vessel distance 
associated with normal vasculature usually ranges from 40 -  100 pm (Beckman et al., 
2007).
Simulation Conditions
In this work, simulation for a 2-D sectional tumour is considered. A simplified 
schematic diagram is shown in Figure 5.5, with the number of miero-vessels per unit 
area or volume in a tumour varying according to location from the tumour surface. 
Although this is not a universal tumour vessel arrangement, it was observed (Schor et 
al, 1998) in two lung tumour masses. The blood vessel population depicted in Figure
5.5 is a representation of a combination of suppliers (i.e. arterioles or venules) and 
drainers (i.e. venules).
All simulations have been coded in 2-D for a vasculature size of 1 mm^, use being 
made of Matlab 2007b; see Appendix B for computational code. We discretize the 
Laplacian operator using central finite differences on a computational mesh and time 
step using the alternating direction implicit (ADI) method; see Li et al, (2009). The 
computational mesh is different from the vascular mesh but with the grid points of 
both meshes aligned. Taking into consideration the size difference between capillaries 
and tissue cells, the choice for the vascular mesh has been made so that Ax and Ay = 
0.04 mm, i.e. the typical blood vessel radius, for a mesh size of (25 x 25). 
Conversely, the choice for the computational mesh has been made so that Ax and Ay = 
0.003 mm, so that the numerical solution has an absolute error of 10'^.
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Hypoxic region 
m iddle
Oxygenated regjon
T u m our su r fa ce
Necrotic regon 
T u m our co r e
Figure 5.5. Schematic illustration of differing blood vessel density with regional 
location within the tumour, with the peripheral region usually representing the highest 
MVD, the centre region representing the lowest MVD and the midway region 
representing an MVD between that of the tumour periphery and the centre. Sueh MVD 
heterogeneity within tumour regions was observed in two lung tumours by Schor et 
a/. (1998).
In this simulation, the oxygen diffusion coefficient D^^is assumed to be spatially
constant in tissue cells, which implies tissue heterogeneity, i.e. one makes the 
assumption of bulk diffusion. Typically, this is not absolutely valid, however the use 
of an average diffusion coefficient approximation has been shown to be satisfactory 
(Korgh, 1919; Pogue et ah, 2001; Dasu et ah, 2003; Kelly and Brady, 2006). Oxygen 
movement is assumed to be dominated by diffusion. Diffusion is an important means 
of passive membrane transport for all tissue cells. In the present work axial diffusion 
along the capillaries is neglected and the net diffusion at the tumour edges is set to 
zero. The spatial distribution of the heterogeneity of oxygen tension is achieved by 
evolving the solution of equation (2) to a steady state. The random distribution of 
blood vessels (capillaries) through the 2-D cross sectional vasculature would appear to 
be a reasonable basis upon which to simulate the vascular shunt relaxation and 
contraction (i.e., opened and closed vessel) mechanisms and the typical heterogeneous 
distribution of blood vessel in tumour vasculature
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Data Assessment
All dataset analysis is evaluated with respeet to the two given scenarios: (1) 
generation of an oxygen map using supply through arterioles and drainage through 
venules and; (2) generation of an oxygen map using supply and drainage through 
venules only, as presented in equation 5.13. In addition, oxygen maps are also 
generated using supply through venules with no representation of the drainage 
contribution (i.e. as depicted in Kelly and Brady’s work). This in turn allows 
comparison with the stated second scenario. The level of oxygenation within a tumour 
region is expressed in terms of the mean and a mean variation given by the standard 
deviation.
A comparative analysis of oxygen heterogeneity is also discussed by demonstrating 
the different tumour-bearing regions that can be seen in our simulated system of 
vasculature, based on what is seen in a typical EF5 immunostaining image (Yuan et 
al, 2006). Regions in EF5 immunostaining image vasculature can be classified into 
blood vessels (i.e. arterioles and venules) and tissue cells, with the latter being further 
classified into hypoxic regions and necrotic regions.
Of note is that the level at which hypoxia in human cancers becomes clinically 
significant depends on the cancer type and the method of measurement. Clinical 
investigation of hypoxic tissue areas, typically with p02 values of < 2.5 mmHg have 
been shown to be a characteristic pathophysiolgical feature of locally advanced solid 
tumours and to occur across a wide range of human malignancies of the breast, uterine 
cervix, head and neck, rectum and pancreas, brain tumours, soft tissue sarcomas, and 
malignant melanomas (Vaupel and Harrison, 2001; Vauple and Mayer, 2005). 
However, a study by Hockel et al. (1996) on 106 cervical caner patients used a cut-off 
value of 10 mmHg, while a similar study on 103 cervical cancer patients used a cut­
off value of 5 mmHg (Fyles et a l, 2002). In this study we define oxygen threshold 
values to express the level of hypoxia in respeet of different tumour types, with 
hypoxia represented by areas of less than 5 mmHg. This allows comparison with the 
findings of other theoretical work, for instance Kelly and Brady (2006). Herein 
hypoxic fraction is defined by binary datasets (with pixel values of 1 and 0). One way 
to do this is by thresholding the simulated vasculature into two regions: (1) hypoxic 
regions where oxygen tension is for example < 5 mmHg, represented in white, and (2)
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the rest of the vascular regions, accounting for areas of oxygen tension, for example > 
5 mmHg, represented in black. This arrangement in white and black allows 
calculation of the hypoxic fraction (HP), which is given by the area of hypoxic tissue 
divided by the total simulated vascular area. This metric of hypoxia extent can also be 
defined as the area of hypoxic tissue as a percentage of the total tissue area.
In addition, the maximum oxygen diffusion distance is evaluated by calculating the 
number of pixels in the simulated datasets given that point grid intervals Ax and Ay 
are known. Oxygen diffusion distance herein will be defined as the distance from a 
blood vessel to wherever oxygen tension drops to zero mmHg. Similarly, coexistent 
regions of hypoxia are defined as the distance from a blood vessel to wherever oxygen 
tension is below 5 mmHg.
5.3 Present Study Findings 
Baseline Values
As previously mentioned, all physical and biological baseline parameters applied in 
this work were determined from an exhaustive literature search and are given in Table 
5.1. The surface area to volume ratio was calculated as:
= = (5.19)
y  Ttr L r
where r  is the capillary radius.
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Table 5.1: Baseline parameters applied in the model.
Parameters Present choice of values Reference
Diffusivity of oxygen into 
tissue (D^^)
2 X 10’^  mm^ s'^ (Dasu et al., 2003, Kelly and 
Brady, 2006)
Permeability of tumour to 
oxygen ( P/Mo J
0.03 -  0.3 mm s"^ (Fletcher and Schubert, 1987, 
Kelly and Brady, 2006)
blood vessel radius (r) 8 - 1 0  pm (Marieb, 2004)
Surface area to volume ratio 
(iW), measured in human 
tumours
170-285 mm'^ (Yuan gt a/., 1995)
Maximum rate of oxygen 
consumption {qmaf)
15 mmHg s'^ (Dasu et al, 2003, Kelly and 
Brady, 2006)
Oxygen tension at half 
maximum rate Qi)
2.5 mmHg (Dasu et al, 2003, Kelly and 
Brady, 2006)
Evaluation of Simulated Oxygen Partial Pressure
The simulated mean and range (in terms of maximum and minimum level) of oxygen 
partial pressure in 2-D tumour-bearing vasculature is addressed with respeet to the 
following scenarios: (1) supply in pre-existing tumour vasculature, (2) supply in 
neovaseulature tumour and (3) oxygen supply through venules (exeluding the 
drainage term).
Influence o f the two supply phenotype on tumour oxygenation 
The results of the simulation are depicted in Figure 5.6, illustrating significant 
differences in tumour oxygenation level with respeet to the two different but yet 
existing tumour vasculature supply phenotypes, leading to changes in tumour 
oxygenation level. The upper curve represented in Figure 5.6 signifies oxygen tension 
in a tumour vasculature that is supplied through arterioles (i.e. blood p 0 2  = 100
mmHg) and drained through venules (i.e. blood = 40 mmHg), while the lower
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curve implies oxygen tension in a tumour vasculature that is supplied through venules 
(i.e. pÜ2 = 40 mmHg) and drained through venules (i.e. pC>2 = 20 mmHg).
The simulation results depicted in the upper curve show a wide range of oxygen 
tension within tumour vasculature based on the variable micro-vessel density, with a 
mean oxygenation of 19.25 ± 1.10 mmHg and up to 50.89 ± 1.69 mmHg in micro­
vessel density of 60 to 240 vessels mm'^, respectively. Conversely, the simulation 
results depicted in the lower curve show a mean pÜ2 of 5.00 ± 0.76 mmHg and up to
18.04 ± 0.57 mmHg in similar micro-vessel density of 60 to 240 vessels mm'^, 
respectively. In general high MVDs are usually associated with higher oxygen tension 
in a given tumour section regardless of supply type. Typically, as MVD increases the 
intravascular distance decreases, thus fewer cells are dependent on the limited oxygen 
supplier. The other major observation is the significant lower oxygenation level on the 
lower curve (the neovasculaturization supply) if compared to the upper curve (pre­
existing vasculature supply). This is directly related to the low level of oxygen in the 
blood at the supply side (i.e. venule in the case of neovasculature supply).
Influence of two supply and drain scenarios on tumour oxygenation level
supply(art)&drain(ven.)
supply&drain(\en.)
60 1
50 -
S) 20 -
10 -
300200 250100 150
MVDs
Figure 5.6: Illustration of the significant differences in oxygen level in 2-D tumour- 
bearing vasculature with respect to the type of supply, where the top curve represents 
simulation results of vasculature supplied through arterioles and drained through 
venules, while the lower curve represents simulation results of vasculature supplied 
and drained through venules.
The simulated mean and range of oxygen partial pressure in 2-D tumour-bearing 
vasculature, given the two possible patterns of oxygen microcirculation, are herein
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compared with results reported by a number of clinical trials, involving cervical and 
head and neck carcinomas. In pre-treatment polarographic p02 measurements in 133 
patients with squamous cell carcinoma of the head and neck and 109 patients with 
locally advanced cervical cancer, significant differences in oxygenation between the 
primary tumours of head and neck (median pÜ2 = 1 2  mmHg, ranging from 0 - 5 8  
mmHg) and cervical cancer (mean and median pÜ2 = 1 6  nmiHg and 10 mmHg, 
respectively) was reported by Vaupel and Harrison (2004). Similarly, Vaupel et al. 
(1989) reported median values in patients with adenocarcinoma, cervix cancer 
and breast cancer to be 10 -  12 mmHg, 15 and 17, respectively. In addition, 
Eppendorf oxygen measurements (Pogue et al., 2001) for seven fibrosarcoma 
tumours, determined mean and median pÛ2 of 10.4 ± 2.5 mmHg and 12.9 mmHg, 
respectively.
Simulation results indicate that oxygenation in primary tumours of head and neck is 
consistent with simulation results obtained with neovascularization supply, with an 
agreement within 2 mmHg, generated using a MVD of 120 vessels mm'^. Similarly, 
oxygenation level in locally advanced cervical cancer also seems to be dominated by 
neovasculature supply, with a discrepancy of ± 1 mmHg from clinical evaluation, 
generated using a MVD of 200 vessels mm'^.
Influence o f drainage term on neovasculature oxygenation level 
The Simulation results depicted in Figure 5.7 illustrate the difference between supply 
through venules or supply and drainage through venules (i.e. neovasculature supply). 
The upper curve is generated with respect to microcirculation that is supplied and 
drained through venules and the lower curve is formed using the supply term only. In 
Figure 5.7, the upper curve shows a wide range of oxygen tension spectrum in 
neovasculature, with mean oxygenation of 5.00 ± 0.75 mmHg and up to 18.09 ± 0.57 
mmHg in micro-vessel density of 60 to 240 vessels mm" ,^ respectively. Conversely, 
simulation results presented on the lower curve show a mean oxygenation of 7.98 ± 
1.10 mmHg and up to 26.7 ± 0.76 mmHg in similar micro-vessel density of 60 to 240 
vessels mm'^, respectively. The significantly lower oxygenation level in 
neovasculature supply is related to the continuous reduction of oxygen in the blood, 
even if the continuous development of new blood vessels through angiogenesis is still
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in progress. The model-based study of Pogue and co-workers (2001) using a MVD of 
92 vessels mm"  ^allows comparison with our present model-based findings. With our 
present study using a MVD of 92 vessels mm'^ better, agreement is obtained when 
involving neovaseulature supply rather than supply through venules only. Our present 
study shows oxygen tension levels ranging from 0 - 1 8  mmHg; the Pogue study 
obtained oxygen tension ranges from 0 - 2 0  mmHg.
Tumour oxygenation level with respect to supply and drain through venules 
and supply through venule with no drain
30  -I
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g  20  -
suppDy&drain (\e n .)  
supply(\ein)________
200 25 0 3 0 0150100
MVD
Figure 5.7: Demonstration of the significant influence of the drainage term in oxygen 
level in 2D tumour-bearing vasculature conducted by neovaseulature supply, with the 
upper curve generated using blood p02 = 4 0  mmHg and 20 mmHg at the supplier 
and drainer venule, respectively; the lower curve is generated using blood pÜ2 = 40 
mmHg at the supplier venule.
The validity of the simulation finding herein is dependent on the normal bounds of 
biological variation magnitude of parameters used to obtain simulation figures. 
Quantitative values of oxygen transvascular permeability presented in Table 5.1 by 
Fletcher and Schubert (1987) is a representation of different brain tumour regions. 
Changes of transvascular permeability figure, typically from 0.03 -  0.3 pm, would 
influence simulation outcome; see Figure 5.8. In Figure 5.8, the potential impact of 
variation between transvascular permeability for two given MVDs (i.e. 60 and 170 
vessels mm'^) on the average mean of oxygen tension is addressed, where higher 
transvascular permeability leads to higher oxygen tension with almost a factor of ~
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2.8 on highly permeable tumour vasculature (i.e. ranging from 0.1 -  0.3 mm s'^) and a 
factor of ~ 4.8 on low permeable tumour vasculature (i.e. less than 0.07 mm s'^). The 
trend of oxygen tension increase is almost linear; however, beyond the lower limit of 
transvascular permeability (i.e. 0.03 mm s'^) the impact on oxygen tension may no 
longer be linear, particularly in regard to small MVDs.
The impact of transvascular permeability on oxygen tension
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Figure 5.8: Impact of the transvascular permeability condition on the mean oxygen 
tension in 2-D tumour bearing vasculature.
Oxygen Heterogeneity
The heterogeneous distribution of oxygen in a 2-D simulation of tumour-bearing 
vasculature is shown in Figure 5.9 and is compared with typical EF5 immunostaining 
images in Figure 5.10 (Yuan et al., 2006). The scale in Figure 5.9 demonstrates the 
different level of pÜ 2 in the simulated vasculature; the higher the scale reading of a 
contour the greater the oxygen tension. Contours are viewed against a tissue 
background oxygen tension that appears in white. Figure 5.9 has been generated using 
fixed blood vessel distribution with the neovaseulature arrangement, supply and 
drainage through venules (panel A); the pre-existing vasculature arrangement, supply 
through arterioles and drainage through venules (panel B) and venules supply only 
(panel C) and a MVD of 60 vessels/mm^. Figure 5.10 allows discussion of the 
similarity of regions of organization in real tumour-bearing vasculature (right side) 
and simulated vasculature (left side). In the simulated vasculature the points represent
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blood vessels (i.e. suppliers and drainers); the brighter a point the greater the oxygen 
tension. Blood vessels are viewed against a tissue background oxygen tension; for 
visual contrast, the darker the background the lower the oxygen tension.
In the real tumour-bearing vaculature (right side of Figure 5.10) the blood vessels are 
represented on a colour wash scale from cold to hot: cold areas are arterioles which 
have more circular shape and venules which have a semi elliptical shape. In the 
simulation very bright point sources represent the arterioles and less bright sources 
represent the venules; in this case the MVD is approximately 60 vessels mm'^, with a 
proportion of arterioles to venules of 0.5:0.5. In addition, hypoxic regions in the real 
vasculature are represented in orange and are seen to occur at certain distances from 
existing blood vessels (either arterioles or venules), while necrotic (i.e. dead) regions 
appear in black and occur close to regions of high venule population. It is also 
important at this stage to point out the different physiological blood vessel 
arrangements, where real vasculature includes open and closed vessels (i.e. arterioles 
and venules), while the simulated vasculature depicts only open vessels, either 
arterioles or venules.
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Figure 5.9: Simulated oxygen map in 2-D tumour-bearing vasculature of dimension 1 
mm^ and mesh size of (300 x 300); (A) shows the generation of pÜ2 involving an 
arterioles supply and venule drain (pre-existing supply); (B) shows the generation of 
pÜ2 involving supply and drainage through venules (neovaseulature supply) and (C) 
shows generation of pÜ2 involving venule supply only. The MVD is approximately 60
vessels mm'^.
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Oxygen map in Mv/Ds- 63 vessel/mm2
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Figure 5.10: The similarity of organization in the different regions of a typical system 
of tumour-bearing vasculature and simulated 2-D tumour-bearing vasculature. The 
right panel shows the 2-D cross sectional view of EF5 immunostaining images taken 
from an adenocarcinoma tumour line vasculature (Yuan et a l,  2006). Blood vessels 
are represented in blue, with arterioles taking on more circular shapes and venules 
taking on a semi elliptical shape. Hypoxic regions are represented in brown and 
appear to occur close to arterioles, while necrotic regions in black occur close to 
venules. The left hand panel shows simulated 2-D tumour-bearing vasculature with 
the same regional arrangement, although on a smaller scale. The immunostaining 
image is adapted from Yuan et al. (2006).
Hypoxic Fraction (HF)
The simulated hypoxic fraction datasets represented in Figure 5.11 demonstrate the 
significance of the MVD  on the hypoxic level. The model illustrates how different 
HFs may occur in different tumour regions, with HF increasing significantly with low 
MVD  tumours while it dramatically decreases with high MVD tumours. Tumours that 
show a pattern of high MVD  near the surface and low MVD near the core would 
develop larger hypoxic regions near the core, as seen in some histological studies. 
Furthermore, Figure 5.11 illustrates a nonlinear relation with MVD, which in turn 
explains the significant level of hypoxia that is associated with large size tumours. In 
addition. Figure 5.11 demonstrates the influence of blood vessel origination and level 
of oxygen at the supply and drainage side of a blood vessel. In this case a hypoxia 
threshold value of 5 mmHg is used.
108
Chapter 5. Simulation o f Oxygen Heterogeneity
Influence o f supply type on HF
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Figure 5.11: A plot of Hypoxic Fraction (HF) versus MVD. The trend lines point to 
an inverse nonlinear relationship between hypoxia fraction and number of blood 
vessels per unit area or volume; in this case the data is presented using a threshold 
value of 5 mmHg.
Detailed results are tabulated in Table 5.2. Simulated hypoxic fraction datasets, 
represented in Figure 5.12 are compared herein with results reported by Yuan et al. 
(2006) using EF5 immunostaining imaging and ^"^Cu-ATSM autoradiography imaging 
for a glioma cell line. Real values range from 0.165 ± 0.041 up to 0.208 ± 0.051 using 
EF5 immunostaining and 0.166 ± 0.067 up to 0.441 ± 0.094 using ^^Cu-ATSM. 
Simulated results using pre-existing supply (MVD of 240 vessels mm'^) are 0.17 ± 
0.007. Using a neovasculature supply with MVD of 90 vessel mm"  ^ the results are 
0.459 ± 0.030. The upper plots in Figure 5.12 are the binary oxygen distribution 
dataset, with black representing areas of oxygen tension > 5 mmHg and white 
representing areas of oxygen tension < 5 mmHg. The potential hypoxic areas in the 
top right panel in Figure 5.12 have been generated using arteriole and venule supply, 
with a proportion of arterioles to venules of 0.5:0.5.
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Table 5.2. The influence of blood vessel origination and blood oxygen level on HF, 
with a decreasing influence revealed with high MVD. Herein hypoxia fraction (HF) 
has been represented in terms of the mean and standard deviation (SD).
MVD
(vessels/ mm^)
Data generated as Hypoxia fraction, HF < 5 
mmHg
(mean ± SD, n = 10)
240 venule supply 
pre-existing vasculature 
neovasculature
0.030 ± 0.001 
0.017 ± 0.007 
0.061+0.012
200 venule supply 
pre-existing vasculature 
neovasculature
0.044 + 0.012 
0.021 + 0.009 
0.086 + 0.019
170 venule supply 
pre-existing vasculature 
neovasculature
0.069 + 0.020 
0.036 + 0.019 
0.0131+0.045
120 venule supply 
pre-existing vasculature 
neovasculature
0.190 + 0.040 
0.065 + 0.046 
0.296 + 0.046
90 venule supply 
pre-existing vasculature 
neovasculature
0.292 + 0.068 
0.113 + 0.039 
0.459 + 0.030
60 venule supply 
pre-existing vasculature 
neovasculature
0.500 + 0.060 
0.265 + 0.052 
0.685 + 0.052
Our study presents results for HF using a threshold value of < 5  mmHg and results are 
in good agreement with previous model based studies of Pogue et al. (2001), Dasu et 
al. (2003) and Kelly and Brady (2006). In Pogue et al. (2001) the hypoxia fraction in 
well oxygenated regions (i.e. pre-existing vasculature) using a MVD of 92 vessels 
mm'^ was less than 15%. In well oxygenated regions in our study (i.e. MVD of 90 
vessels mm'^) the HF is < 12%. Likewise the finding of Dasu et al. (2003) show HF 
percentage ranging from 2.2% up to 40.3% in different tumour regions. In our study 
HF ranges from 1.7% up to 26.5% for different MVDs in pre-existing vasculature.
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whereas neovasculature supply has a higher HF percentage ranging from 6.1% up to 
68.5% for different MVDs.
Figure 5.12: Mapping of hypoxic fraction areas. The upper maps represent simulated 
data (of linear extent 1000 pm), while the lower maps represent real data (linear 
extent unknown). The areas in white represent hypoxic tissue cells in a 2-D cross 
sectional mapping of tumour-bearing vasculature. The simulated data at the top right 
panel have been generated using arteriole and venule supply whereas in the top left 
panel the data has been generated using arteriole supply only. The real data in the 
lower maps are taken from Yuan et al. (2006), the lower left panel being an 
autoradiography image traced with ^"^Cu-ATSM while the lower right panel is an EF5 
fluorescent stained image.
Oxygen Diffusion Distance
The analytical solution of the simplest reaction diffusion model, introduced by Hill 
(1928) to estimate the maximum oxygen diffusion distance from one blood vessel, 
show a maximum diffusion distance of 143 pm. In contrast, in vivo and in vitro 
analyses have shown a wide diversity of values when measuring maximum oxygen 
diffusion distance, ranging from 70 -  200 pm. The wide range of oxygen diffusion
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distance is directly related to the major impact of oxygen consumption rate. The latter 
usually varies from 4.44 -  11.85 mmHg s'^  (Pogue et al., 2001).
In this work comparison has been made between oxygen diffusion distance data taken 
from Hill (1928), Padhani et al. (2005), Isa et al. (2006) and simulated values. Real 
values vary from 70 -  200 pm, whereas simulated results of neovasculature with 
MVD of approximately 120 vessels/mm^ are 43 -  168 pm. Simulated results of 
neovasculature with MVD of approximately 60 vessels/mm^ are 46 -  198 pm. In the 
studies from Ljungkvist et al. (2002) and Padhani (2005), hypoxic cells appear to 
occur 50 -  100 pm from blood vessels, whereas in simulated results for a 
neovasculature supply and MVD of approximately 60 vessels/mm^, hypoxic cells are 
33 -  125 pm from blood vessels.
5.4 Summary
Hypoxia and oxygen distribution are a heterogeneous problem. Therefore, tumours 
that appear identical in clinical and radiographic examination may vary significantly 
in the extent of their hypoxia, as demonstrated in Figures 5.9 and 5.10. Tumour- 
bearing vasculature can be classified into three major regions: (1) diffusion related 
chronic hypoxia, caused by the increase of oxygen diffusion distances as a result of 
tumour expansion; (2) necrotic regions, known as the dead region, and; (3) blood 
vessels. These have been represented in Figure 5.10 as follows: red point sources are 
simulated suppliers (arterioles in pre-existing vasculature and venules in 
neovasculature) and light yellow point sources are simulated drainers (venules in pre­
existing vasculature and neovasculature). In this study we have employed the 
available measurements of spatially averaged tissue oxygen partial pressure, together 
with the spatial images of hypoxia between capillaries, to validate our prediction of 
tumour vasculature oxygen heterogeneity. Comparison has been made between real 
and simulated values of oxygen tension in head and neck cancers and cervical 
cancers, where oxygen tension in advanced head and neck cancer is < 10 mmHg.
The simulation of tumour-bearing neovasculature is shown to be in good agreement 
with real values for cases in which the mean oxygen tension in regions with high 
MVD is less than 19 mmHg. For regions with low MVD the agreement is good for 
areas in which the mean oxygen tension is approximately 5 mmHg. Our development
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of the reaction diffusion model, as described in equation 5.14, allows for quantitative 
analyses of oxygen spatial distribution in tumours. It also enables areas of necrotic 
and acute hypoxia in different tumour regions to be established. With the 
representation of supply and drainage, one is able to vary blood vessel density 
together with changing the proportion of suppliers to drainers, allowing different 
scenarios to be examined and enabling visualization of the microcellular behaviour of 
tumour-bearing vascularity. In tumours that show a regular pattern of MVD 
distribution, ranging from the tumour periphery (with a high potential for growth in 
micro-vessel density, supporting the idea of tumour angiogenesis) to the tumour core 
(with severe lack of blood vessels), one can relate tumour vasculature geometry to 
oxygen heterogeneity and predict potential hypoxic regions within tumour.
This finite difference based simulation model can be used to examine the typical 
range of vasculature oxygen concentrations in hypoxic tumour and provide 
information about the realistic oxygen concentration heterogeneity existing in tumour 
tissues. However, the major limitation with theoretical based studies is that actual 
regional data is incomplete and validation of results is difficult. The use of stained 
sectional images or microelectronic oxygen probes to provide input data usually 
results in partial regional data. Thus, estimation of capillary oxygen concentration is a 
probability estimate rather than the exact value. However, with these calculations one 
can visualize factors that influence tumour vasculature oxygen heterogeneity. In 
addition, the representative variability between micro-vessels density in the same 
tumour can help in understanding tumour vasculature heterogeneity.
We note that oxygen diffusion distance for our model is within an order of magnitude 
to that seen experimentally. However, all current models of oxygen partial pressure 
fail to give oxygen diffusion distances of the correct order of magnitude and further 
work is required to ascertain the best model. In the current study, the simplified 2-D 
simulation assumes that oxygen diffuses only within the plane and that all the 
capillaries are oriented orthogonal to the 2-D plane section. However, capillaries are 
randomly distributed in the domain. Further work is required to develop a 3-D model.
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Tissue Activity Curve (TAG)
In section 3.1, we reviewed the substantial advantages of positron emission 
tomography (PET) imaging over anatomical imaging modalities. This was taken to 
further depths in section 4.1, where the semi-quantitative standardized uptake value 
(SUV) was introduced as a quantity to characterize the gross target volume (GTV) for 
radiotherapy treatment planning purposes. Today there is considerable interest in PET 
for measurements of regional tracer concentration in hypoxic tumour-bearing tissue. 
In order to understand the complicated behaviour of the cellular uptake and washout 
mechanism, a number of theoretical studies have attempted to describe tracer uptake 
in tissue cells. More recently, a novel computerized reaction diffusion equation 
method was developed by Kelly and Brady (2006), where they managed to simulate a 
realistic tissue activity curve (TACs) of ^^F-FMISO. The model was developed over a 
multi-step process. Here we present a refinement to the work of Kelly and Brady, 
such that the model allows simulation of a realistic TAG of any hypoxia selective PET 
tracer, in a single step process. In this work we show particular interest in simulating 
the TAG of possibly the most promising hypoxia sensitive tracer to-date, ^"^Gu-ATSM. 
In addition, we demonstrate its potential role in hypoxic tumour sub-volume 
delineation for use in the dose painting approach.
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6.1 Quantitation of PET Data
The unique feature of the PET imaging modality is that it allows measurements of 
regional tracer concentration in tissue and different body organs, quantitatively and 
non-invasively (Huang et al, 1998). PET data is generated with counts being 
integrated over a period of time known as the frame. Typically, this may vary from a 
few seconds up to an hour, with static data being denoted for a single frame of data 
record. Conversely, dynamic data presents counts over a series of time frames of 
varying length. Therefore, while static data only varies spatially, dynamic data is 
obtained sequentially, forming a stack of static scans at different time intervals. The 
temporal profiles of activity in plasma and tissue are known as the plasma activity 
curve (PAC) and the tissue activity curve (TAG) respectively, providing information 
about the kinetics of tracer concentration in the plasma and tissue under study. In 
addition, it provides information concerning the degree of oxygen perfusion, vascular 
geometry and hypoxia fraction (Kelly and Brady 2006). Determining the relationship 
between the TAG shape and the underlying tumour physiology is of fundamental 
importance, as knowledge of tumour environment may help determine the most 
sensible course of action in treatment. Given that hypoxia imaging is challenged by 
the typically poor spatial resolution of PET, therefore in order to understand such a 
complicated phenomenon a number of theoretical studies have attempted to describe 
tracer uptake in tissue cells; to-date the conventional compartment model of Sokoloff 
et a l (1977) has been considered the standard technique.
Compartment Analysis
The compartment analysis is a set of theoretical processes that for present interests 
allows description of the behaviour of a biological system in terms of a mathematical 
model (Benyo et a l, 1997). It is a representation of a group of tissues that have 
similar blood and tracer flow. A tracer may therefore move from one compartment to 
another, reversibly or irreversibly, whereby movement is governed by rate constants, 
as illustrated in Figure 6.1. In using a compartment model, three main assumptions are 
made. The first is that the system response is stationary, thus the response is the same 
if a tracer is injected at time t = 0 minutes or t = 5 minutes (i.e. physiological effects 
are not considered). The second is that within each compartment the tracer is
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homogenous. Finally, the binding/metabolism kinetics of the tracer are homogeneous 
within each compartment.
Tracer in plasma
* T r''p la s m a
Ts
T1
Unbound tracer
k on
kog bound
Figure 6.1: Illustrates the three compartment model of tracer kinetic in plasma, in 
intracellular (unbound tracer) and in tissue cells (bound tracer). The rate of movement 
between these compartments is governed by the rate constants, Tg (tracer gain), T1 
(tracer loss), kon (tracer binding) and koff (tracer washout).
A steady state system is usually considered to be linear, thus transfer and 
transformation are described by first order linear differential equations (DFEs). In 
such a case, the amount of substance of the components (in this case tracer 
concentration in plasma) and the rate constant Tg, Tl, kon and koff are constant and in 
a linear relation. In biological systems diffusion can be modelled as a random 
movement that transports particles from regions of high substance concentration to 
regions of lower concentration. This is governed by Tick’s first law that is represented 
in equation 6.1:
J = - D
dx
6.1
where /  is the diffusion flux in units of (mol/m^ s), D is the diffusion coefficient or 
diffusivity in units of m^/s, T is the concentration of a tracer in units of (mol/m^) and x 
is the distance or position in units of (m). In non-steady or continuously changing 
state diffusion, typically when tracer concentration is changing with respect to time. 
Tick’s second law is used:
6.2
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Thus for a closely steady state system the mathematical models that govern the rate of 
tracer concentration in the interstitial space (free tracer) and in the tissue cells (bound 
tracer) is given by equations 6.3 and 6.4 respectively:
^Trfree
dt
-■TgTrpi^,^^-{Tl+kon)Trj,,^+koffTr^^^^ 6.3
where Trpee is the concentration of tracer in the interstitial space, Tg, Tl, kon and kojf 
are rate constants, Trpiasma is the concentration of tracer in plasma, and Trbound is the 
concentration of bound tracer in tissue cells. The general procedure that is followed in 
order to study the behaviour of a system using a tracer first requires the knowledge of 
tracer concentration that is introduced into one of the compartments, usually the 
plasma compartment. The other required information is the coefficients (i.e. rate 
constants) of one differential equation and the initial and boundary conditions. On the 
other hand if they are unknown, an inverse problem (identification) must be carried 
out.
Thus stated, the standard technique of conventional compartment models are limited 
as each compartment is assumed to be a mathematical abstraction, independent from 
its location, which means effects relating to the movement of tracer between physical 
locations, such as diffusion, are not considered (Kelly and Brady, 2006). As a result 
the spatial factor in such models is not considered and the distribution of the diffusible 
tracer is assumed to be homogeneous across the vasculature, which is far from reality. 
Thus, compartmental models are an oversimplification of the real kinetics within an in 
vivo environment, where typically the stmcture and geometry of tumour vasculature is 
the key factor behind tracer retention and heterogeneity.
Reaction Diffusion Model of Kelly and Brady 2006
More recently, a novel computerized reaction diffusion method was developed by 
Kelly and Brady (2006) to simulate the realistic dynamic TAG of ^^F-FMISO, with 
representation of vasculature architecture and tracer kinetics. Following the same 
principles of compartment analysis, the spatiotemporal distributions of both free and
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bound FMISO tracer were modeled using the reaction diffusion model as illustrated in 
both equations 6.5 and 6.6, respectively.
dTrf,,,(x,y,t) ^  ^2 Try,,,-  +Tg-Tl 6.5
3Tr,„„Ax, rr,„ -  Tr, ^ , 6.6
where Trpee is the concentration of free tracer in interstitial space, Djr is the diffusion 
coefficient of tracer, kon and koff (biological half-life of are the on and off rates of 
tracer binding, Trtound is the concentration of bound tracer in cells, Tg is the tracer 
gain from the capillary and Tl is the loss of tracer back to the capillary. The 
constitutive equation of Tg is given by equation 6.7.
T g = E a ^  -  rry ,„ ).fi, 6.7
where Trpiasma is the concentration of tracer in the plasma and Pmjr is the permeability 
of the vessel to the tracer.
6.2 Reaction Diffusion Model Refinements
In Chapter 5 we simulated the heterogeneity of oxygen partial pressure in a more 
realistic sophisticated vascular architecture; the ability to solve the governing 
equations was made possible using numerical approaches that enable relationships 
between tissue diffusivity, tissue metabolism and anatomical structure of blood 
vessels. This allows oxygen gradients to be characterized with encouraging results, 
which have been validated against realistic values taken from the existing literature. In 
this Chapter we simulate the realistic dynamic TAG of ^"^Gu-ATSM, with 
representation of the complexity of vascular architecture, tracer diffusivity, tracer 
binding rate, transvascular permeability and blood vessel densities. Thus, the reaction 
diffusion model that simulates '^^Gu-ATSM heterogeneity in 2-D can be described as:
d T r   ^ p  S
g /  =  D t,  V "  T r -  k,„  , 5.8
where Tr is the concentration of tracer, ^"^Gu-ATSM, in tissue cell pGi/ml, D tv is the 
diffusion coefficiènt of tracer in mm^ s"\ kon is the binding rate of ATSM in s"^  ,
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Trpiasma IS the Concentration of tracer in the plasma in pCi/ml, Pm is the permeability 
of the vessel to the tracer in mm s"\ S/V is the surface area to blood vessel volume in 
mm‘  ^and R is the proportion of vessels covering the vasculature.
Simulation Conditions
In this work we consider a 2-D sectional tumour to appear as in Figure 6.2, where the 
number of micro-vessels per unit area or volume in tumour vary according to their 
location. All simulations have been coded in 2-D, for a vasculature size of 4 mm^, 
using Matlab 2007b and finite difference methods; see Appendix C for the 
computational code. In this work two meshes were created, one to denote the random 
distribution of blood vessels while the other expresses tissue cells. The choice is made 
to account for the considerable size difference of blood vessel diameter to tissue cells. 
The scale intervals of the blood vessel mesh was made so that Ax and Ay = 10 pm, 
typical for a blood vessel radius, and for a mesh size of (50 x 50), whereas the scale 
intervals of the cellular mesh was made so that Ax and Ay ~ 7 pm, a typical tissue cell 
diameter, and mesh size of (300 x300).
Figure 6.2: A schematic diagram showing the variation in blood vessel densities at 
different tumour regions, with well perfused areas generally at the tumour edge.
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Data Assessment
■64A comparative analysis of Cu-ATSM intra-tumour distribution and cellular uptake is 
discussed by demonstrating the different tumour-bearing regions that can be seen in a 
simulated system of vasculature, based on that observed in a typical case (Obata et al, 
2003; Tanaka et al, 2006; Oh et al, 2009). The net percentage (% net) uptake of 
^Cu-ATSM is defined as:
i ^ x l O O ,  6.9
Tr
where Imean is the mean uptake value in the simulated space and Tr is the 
concentration of tracer in plasma. Tissue activity curves (TACs) of ^^Cu-ATSM are 
generated using patient plasma input functions; simulation findings are validated 
using a key parameter, namely the typical tumour to blood ratio of ^"^Cu-ATSM. 
Additionally, a comparison of TACs for all of ATSM and FMISO using arbitrary 
plasma input functions are demonstrated, with the aim of highlighting the high local 
contrast provided by ATSM.
To date and further to our discussion in Chapter 4, the benefit from PET imaging to 
quantify and delineate a volume is challenged by the thresholding method. Indeed, an 
appropriate thresholding method is really yet to be agreed. The tumour sub-volume, 
representing the detected hypoxic cells within the gross target volume QiGTV) for 
dose painting treatment will be herein defined as the area of hypoxic tissue divided by 
the total simulated vascular area; it can also be represented as a percentage value. 
Hypoxia, in turn, will be defined using three different thresholding principles, each of 
them was and still is being considered in clinical oncology. The first quantity used to 
define positive regions of^^F- (fluoro- deoxy- glucose), or FDG uptake, is known as 
the standard uptake value (SUV). This quantity was fully introduced in Chapter 4. The 
maximum voxel intensity in the lesion will be measured and a percentage of this 
maximum, e.g., 40% will be used as a cut-off value for contouring a volume of 
interest (VOI) around the lesion, to be used as the GTV (Jarritt et al, 2005). The SUV 
quantity has been represented by Nestle et al (2006) as:
decay corrected activity ! tissue volume 6 10
injected activity ! body weight
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We herein adjust this quantity and calculate it as:
S U y  =  lmean_ 6.11
Tr
where Imean is the mean pixel intensity in the simulated space and Tr is the 
concentration of tracer in plasma.
A second approach involving the use of signal-to-background ratios was represented 
by Nestle at al. (2005) for the purpose of treatment planning to contour the gross 
target of non small cell lung cancer patients, where the threshold value was defined 
as:
TTzrgfAoM Wwg = (0.15x7^^)+/^^^^^, 6.12
where Imean was calculated as the mean intensity of all pixels surrounded by the 70% 
of the maximum pixel intensity (Jmaximum) within the tumour and Ibackgwund was defined 
as all pixel intensities of organs adjacent to the tumour such as lung, mediastinum and 
liver. In contrast this is calculated here as:
Threshold value = (0.15x1 , 6.13
where Imean will be defined as 70% of the maximum intensity in the simulated space. 
The background intensity in the simulated 2-D tumour-bearing vasculature will be 
neglected. Because the tissue cell intensities in the simulated vasculature is considered 
homogenous, the background intensity (hackgwund) in the simulated space is also 
homogenous and shown to be very close to zero (i.e., hackgwund ~  10'^ )^.
The third approach was proposed using tumour to muscle ratios (T/M), represented by 
Chao et al. (2001), where a threshold of T/M > 2 was chosen to contour hypoxic 
regions in 170 head and neck squamous cell carcinoma and neck nodes. We therefore 
adapt this and use tumour to blood ratio (T/B) as a simulation threshold value.
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6.3 Present Study Results 
Baseline Values
All physical and biological baseline parameters applied in this work were determined 
from the literature, with some being calculated based on known relationships. The 
diffusion of simple FMISO into intracellular space in tumour vascular was 
investigated by Cowan et al. (1996). The group estimated the diffusion coefficient of 
FMISO using an in vitro model for the intravascular compartment of tumours. The 
model was built to study the flux kinetics of FMISO through a multi-cellular 
membrane (MMs) of the Chinese Hamster V79 cell line. The FMISO diffusion 
coefficient through MMs was in the range of 5.5 x 10'  ^ mm^/s, which was 
approximately 13 times lower than in the culture medium (7.15 xlO'"  ^mm^/s). This 
study was subjected to FMISO concentration in mM. However, an earlier study by 
Berk et al. (1993) was carried out to study protein diffusivity as a function of 
substance molecular weight (Figure 6.3); the results were fitted by:
D=3.6xlQ-^(MW)-°^ , 6.14
where D is the diffusion, coefficient in mm^ s"^  and MW  the molecular weight. The 
fitting was obtained using protein substances of molecular weight ranging from 14 -  
600 kDa.
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Figure 6.3: Protein diffusion coefficients as a function of molecular weight (left panel) 
(A), where values determined using spatial Fourier analysis, FRAP, in squares were 
compared with values published by various studies in circles. On the right panel (B) 
Dextran (i.e. a complex made up of many glucose molecules) diffusion coefficients 
are also shown as a function of molecular weight, where values determined with 
spatial Fourier analysis, FRAP, in squares are compared with values published by 
other studies in circles, taken from Berk et al. (1993).
A simple validation method was made to check the validity of the fitting in order to 
justify its use to estimate the diffusivity of ATSM and FMISO by comparing the 
calculated oxygen diffusivity {Doi), using equation (6.14), to values that are well 
established in the literature, as in for example Fischkoff et a t, (1986). The calculated 
oxygen diffusivity has been found to be D0 2  = 1.4 x 10'  ^mm^ s"^  while the literature
value of Do2 is given as 1.5 x 10'  ^ mm^ s '\  a difference from the calculated oxygen 
diffusivity of < 1%. We have also estimated the diffusion coefficient for the 
transportation of ATSM and FMISO in the interstitial space into the tissue cells using 
the same fitting relationship of equation 6.14. This should allow for another simple 
validation method, where the calculated diffusion coefficient of FMISO using 
equation 6.14 can be compared to the findings of Cowan and his group (1996). This 
produces a discrepancy of < 15% between the value of 7.15 xlO’^ ^mmVs diffusivity 
for FMISO in the cellular medium and the value of 6.07 x 10'"^  mm^/s calculated using 
equation 6.14. With such analysis, we suggest the margin of discrepancy in estimation
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of the ATSM diffusion coefficient to be encouraging. Similarly, the transvascular 
permeability coefficient fP f) for ATSM and FMISO, was calculated as (Laidler, 
1978; Cussler, 1984):
6.15
%
where Dxr is the diffusivity of the tracer in the interstitial space in (mm^ s'^), x  is the 
thickness of blood vessel membrane measured in pm and Kjr is the partition 
coefficient of the tracer. The binding rate of ATSM was estimated from Lewis et al. 
(1998), who studied ATSM uptake at different oxygen concentration levels in the 
mammary cell line (EMT6). Their results were validated by the findings of McQuade 
et al. (2005). In both studies the maximum uptake of ATSM was approximately 90% 
after 1 hour of injection, where the oxygen concentration was in the range of 10,000 
ppm. The binding rate can be converted into mmHg by dividing by 1317, where 1 
mmHg = 1317 ppm (Vavere and Lewis, 2007). The surface area to volume ratio can 
be calculated as:
S iT trL  2
where r is the blood vessel radius. Real values are also presented for comparison; see 
table 6.1 for the complete set of baseline values.
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Table 6.1: Baseline parameters applied in the model, together with the main physical 
and biochemical properties of ATSM and FMISO.
Property ^Cu-ATSM "^F-FMISG
Molecular weight 
(MW)
322gmoL 
(Basken and Green, 2009)
188.15 g mol''
Partition coefficient 
(K)
2.20
(Basken and Green, 2009)
0.43
(Kelly and Brady, 2006)
Redox potential Thiosemicarbazone group range 
from 
- 570 to -590 mV 
(Vavere and Lewis, 2007)
Nitroimidazole group 
range from -380 to -390 mV 
(Barthel et al, 2004)
Diffusion coefficient 
(calculated)
5.05 X10"^  mm  ^s'^  
(B&rketal, 1993)
6.07 X10"^  mm" s'' 
(BerketflZ., 1993)
Thickness of blood 
vessel membrane (x)
0.2 - 1  pm 
(Marieb, 2004)
0 .2- 1 pm 
(Marieb, 2004)
Permeability
calculated
1.12-5.61 mm s'^  
(Laidler 1978; Cussler 1984)
0.26 -  1.31 mm s'' 
(Laidler, 1978; Cussler, 
1984)
Blood vessel radius (r) 8 -1 0  pm 
(Marieb, 2004)
8 -1 0  pm 
(Marieb, 2004)
Surface area to volume 
ratio (5/V) '
200 -  250 mm'' 
calculated
200 -  250 mm'' 
calculated
Surface area to volume 
ratio (S/V)
170-285 mm'' 
(Yuan et al, 1995)
170 -  285 mm ' 
(Yuan etal, 1995)
Rate of tracer binding
(fotl)
0.0003 s''
(Lewis et al, 1998; McQuade et al, 
2005) ■
0.0001 s''
(Kelly and Brady, 2006)
Physical half-life 12.7 h 
(Lewis et al, 2001)
1.83 h 
(Cutler er û/., 1999)
Decay method P+(19%), P'(40%) and EC(41%) 
(Cutler e? fl/., 1999)
P+(97%) andEC(3%)
(Cutler eZ fl/., 1999)
Maximum p’ 574 keV 
(Lewis etal, 2001)
None
Maximum p^ 653 keV 
(Lewis et al, 2001)
635 keV 
(Cutler er fl/., 1999)
Gamma energy 1345 keV (0.47%) 
(McCarthy et al, 1999; Obata et al, 
2005)
None
The Heterogeneous Distribution of ^ ^Cu-ATSM
The high spatial resolution of 7 pm provided by the vasculature setup allows analysis 
of cellular uptake of ^"^Cu-ATSM. Simulated results of ^"^Cu-ATSM uptake in a 2-D 
tumour-bearing vasculature are compared herein with results reported by Oh et a l 
(2009), which are in close agreement with the findings of Obata et a l (2003) and 
Tanaka et a l (2006). All studies have agreement on the positive correlation between 
the numbers of proliferation cells using immunohistochemical staining images and
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'^^Cu-ATSM uptake using autoradiography. The immunohistochemical staining image 
using the cells proliferation, BrdU, taken from (Oh et al, 2009), is represented in the 
right panel of Figure 6.4, whereas, the simulation finding is represented in the left 
panel. The cell proliferation in Oh et al, (2009) appears in brown, while the 
maximum cellular uptake of ^ “^Cu-ATSM appears in red.
w m r n s s m
Figure 6.4: Simulation of cellular uptake of “^^Cu-ATSM in a 2-D vasculature of size 4 
mm^ represented in the left panel, with high stained cells appearing in red; typical 
BrdU immunohistochemical staining image in the right panel taken from Oh et a l 
(2009), with proliferating cells appearing in brown.
Similarly, a comparative analysis of simulated intra-tumour distributions of "^^ Cu- 
ATSM was preformed against typical findings of Oh et a l (2009). The experimental 
findings show a greater accumulation of ^'^Cu-ATSM at the tumour edges of Lewis 
Lung Carcinoma Cells (LLCl). The tracer biodistribution was imaged using 
autoradiography; representation of typical intra-tumour biodistributions is in the left 
panel of Figure 6.5. Simulation finding show good agreement with typical intra­
tumour ATSM distribution, where the highest net uptake of “^^Cu-ATSM was seen at 
the tumour surface, with a net percentage uptake of 58%. This reduces to 14% near 
the tumour core. A diagram representing simulation findings is shown in the right 
panel of Figure 6.5.
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Net uptake of ATSM at different tumour regions
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Figure 6.5: Demonstration of the % net uptake with respect to different tumour 
regions. Simulation results are represented in the diagram on the right (C), illustrating 
high uptake at the tumour surface, becoming greatly reduced near the tumour core. 
Simulation results show good agreement with the real bio-distribution of ATSM tracer 
determined using autoradiography; image taken from Obata et a l (2003) panel (A) 
and Oh et al. (2009) panel (B).
Simulated ^^Cu-ATSM and ^^F-FMISO Tissue Activity Curves
Simulated tissue activity curves (TACs) of ^^Cu-ATSM are generated using de­
identified patient plasma input data (Mintun et al, 2000). Representation of simulated 
results using two patient data sets are shown in Figure 6.7; plasma input function (de- 
indentified data) was provided by Drs. Farrokh Dehdashti and Jason Lewis, 
Washington University, St Louis, Missouri, USA. Both curves were validated using a 
key potential characteristic known as the tumour to blood ratio (T/B). Clinically this 
quantity is a key factor in addressing issues of imaging local contrast. With a high T/B 
ratio (T/B >3) the targeting of positive lesions on clinical imaging can be generated 
with high sensitivity and specificity. In Figure 6.6, the simulated results show a very 
similar T/B ratio, with 2.6 and 2.24 for curve 1 & 2 respectively.
Figure 6.7 illustrates the simulated tissue activity curves for “^^Cu-ATSM and ^^ F- 
FMISO, both being generated using one arbitrary plasma input function. Simulated
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results show a significantly higher T/B ratio figure using ATSM if compared to 
FMISO. In the literature, a number of in vivo and ex vivo studies have shown that 
ATSM provides reasonably high imaging contrast, leading to better inter-intra 
variance in the image. A distinguishable tumour to blood ratio in the range of »  2 
was demonstrated in Dence et al. (2008), whereas in Yuan et al. (2006) the tumour to 
blood ratio was up to 5. Simulation findings for ATSM show good agreement if 
compared with finding of those in vivo and ex vivo studies, where simulation results 
for the ATSM tissue activity curves reveals a T/B ratio ranging from 2.24 -  4.1, based 
on transvascular permeability conditions. Using FMISO the simulated T/B >1.4, 
whereas the typical T/B > 1 .2  for FMISO (Rasey et al, 2000; Vavere and Lewis, 
2007). The difference is in part related to the differences associated with the 
biochemical and biophysical properties of each tracer. Among these characteristics the 
partition coefficient, which plays a significant role in tracer cellular perfusion, leads to 
a significant influence on the transvascular permeability; see table 6.1. The 
quantitative analysis presented in Lewis et al. (1998) for real blood to tumour active 
curves, highlights the potential effect of cellular metabolism. It was clearly 
demonstrated that local contrast on the image improves dramatically 5 minutes after 
tracer injection. Thus, real T/B ratios show inconsistent values along the time frame 
intervals, with low T/B ~ 1 immediately after injection, to high T/B >3 after 20 
minutes from injection. However, simulation results reveal a consistent value of T/B 
ratio in general. This in part is related to the tracer washout rate and the metabolic 
activity factor, both of which have been neglected in the main model in equation 6.8.
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Figure 6.6: Simulated TACs generated using two plasma input functions, taken from 
two different patients (data de-indentified), where transvascular permeability was 
chosen to be 1.22 nun/s, and MVDs ~ 121 vessel/mm^.
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Figure 6.7: Tissue activity curve for ATSM and FMISO showing high image contrast 
using ATSM with T/B > 3.0 and lower image contrast using FMISO with T/B > 1.4.
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Tumour Structure and ^^Cu-ATSM Uptake
Of note is that solid tumours are associated with a number of vascular architecture 
disorders, especially in geometry and structure of blood vessel. They are disorganized, 
highly permeable and become leaky, twisted, unevenly distributed with irregular 
diameter and unusual branching patterns (Padhani et al, 2007). This leads to high 
perfusion and limited diffusion areas; see Figure 6.8. This supports the argument 
concerning the heterogeneous condition of blood vessel structure among tumour 
regions. The assumption to build on different transvascular permeability levels at 
different regions of the same tumour is realistic, leading to a significant impact on 
image local contrast as shown in Figure 6.9.
Influence o f  vascu latu re stru cture on TAC sh a p e
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Figure 6.8: Simulated TACs using a single plasma input function, with the argument 
of heterogynous structure of transvascular permeability ranging from 1 .2 - 2  mm s"\ 
MVDs -121  vessel mm" .^
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Figure 6.9: The effect of tumour vascular conditions on local image contrast, with
transvascular permeability varying from 1 .2 -2  mm s '\  The local contrast in terms of
the T/B ratio increases significantly from 2.24 -  3.27 ; MVDs -121  vessel mm'^.
Consideration has been made of tumour sub-volumes determined on the basis of three 
different criteria upon which the threshold value was obtained. The first method using 
evaluation of tumour sub-volume, defined at 40% of the standard uptake value, has 
simulation results which show the largest tumour sub-volume target to be at the 
tumour surface, representing 49% of the whole 2-D tumour-bearing vasculature and a 
hypoxic fraction of 0.22 ± 0.01. Results are presented in terms of the mean and 
standard deviation, for n = 10. However, near the core, simulation results show a 
smaller tumour sub-volume target, with only 20% of the whole 2-D tumour-bearing 
vasculature being considered as a target. In association with this, the hypoxic cells 
detected in such a sub-volume are considerably smaller, at 0.09 ± 0.01. Evaluation of 
simulation results defined using the second and third methods, show very similar 
results to those obtained using the first method. A representation of all simulation 
results using the three different thresholding methods are demonstrated in Figure 6.10. 
More detailed information is presented in Table 6.2. The results of tumour sub­
volume delineation in Figure 6.10, shows good correlation between all of the three 
different thresholding methods, with a larger targeted volume taking place at tumour 
surface and significantly smaller target volume toward the tumour core. These 
findings support our previous observation, where maximum net uptake of ATSM was 
seen at the tumour surface. Simulated results of tumour sub-volume are also a
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representation of the hypoxic level within the 2-D tumour-bearing vasculature. In 
Table 6.2, hypoxia fraction ranges from a maximum of 0.34, down to a minimum of 
0.02. This very wide range is dependent upon difference in thresholding values and 
different tumour regions. More specifically, simulation results, in particular for 
regions at the tumour surface using all three methods, shows the hypoxia fraction to 
be in the range of 0.34 using the second method, down to 0.09 using the third method. 
In general, this is in reasonable agreement with the findings of Yuan et al. (2006), 
where the hypoxia fraction was observed to range from 0.166 ± 0.07 to 0.442 ±0.1, 
given the difference in tumour cell lines. Thus one can speculate that the reported 
findings of Yuan et al. (2006) were obtained from samples taken from the surface 
region of an ex vivo tumour.
tumour sub-volume defined at 40% SUV tumour sub-volume defined at 15% of mean intensity
31%
26%
60%
tumour sub-volume defined at T/B > 2
13%
31% 56%
Q suface □ rridde o  core
Figure 6.10: A comparative analysis showing tumour sub-volume regions within 2-D 
tumour-bearing vasculature. The threshold level was defined using three different 
methods, with data obtained using real plasma input functions and a transvascular 
permeability of 1.2 mm/s. Analysis was made on the frame with the highest ATSM 
uptake.
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Table 6.2; The hypoxic fraction within tumour sub-volume, defined using three 
different thresholding methods. Results are represented in terms of mean ± SD, with n 
=  10.
Tumour region Method 1 Method 2 Method 3
Surface 0.22 ± 0.01 0.34 + 0.01 0.09 + 0.01
Middle 0.14 + 0.00 0.15 + 0.00 0.05 + 0.00
Core 0.09 ± 0.00 0.08 + 0.00 0.02 + 0.00
6.4 Summary
The aim of radiotherapy is to achieve maximum therapeutic benefit in terms of 
adequate local control of the disease while maintaining dose to the surrounding 
normal tissue to a minimum. Techniques such as intensity modulated radiotherapy 
(IMRT) provide the means for radiation dose delivery to achieve the desired dose 
distributions. However, tumour control for locally advanced head and neck squamous 
cell carcinoma has been less than satisfactory with an estimation of the recurrence rate 
of 30% (Goshen et a l, 2006). This in part is due to tumour hypoxia. A hypoxic 
tumour sub-volume guided IMRT technique could be used as a novel approach to 
escalate radiation dose in only selective hypoxic regions within the gross target 
volume (GTV) without compromising the advantage of normal tissue sparing of 
IMRT (Chao et a/., 2001; Thorwarth et al, 2007). However in order to benefit from 
such treatment, knowledge on the severity of hypoxia as well as its spatial extent is 
required. As a result the choice of the radiopharmaceutical that allows examination of 
certain pathophysiology pathways within the tumour is of great importance. 
Nevertheless, confirming the appropriate thresholding method to delineate the 
considered tumour sub-volume is of greater significance. The poor spatial resolution 
of typical PET images (i.e. > 5 mm) and the low image contrast using hypoxia 
sensitive reagents, such as FMISO, are a limitation on improving local control based 
on boosting hypoxic regions. Clinical evidence has shown with a high T/B ratio (T/B 
>3) targeting of positive lesions on PET imaging can be generated with high 
sensitivity and specificity. With such high contrast oncologists and nuclear medicine 
radiologists would be able to image ATSM with satisfactory tumour/muscle contrast 
to identify the hypoxic tumour sub-volume as early as 1 hour after the ATSM 
injection (Dence et a l, 2008). From this, the acquired imaging would therefore 
represent the accumulative changes in tumour oxygenation dynamics during this
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period of time, where ATSM is only present in cells with intact mitochondria (i.e. 
viable tumour cells) and which suffer a lack of electron carriers. Herein the simulated 
tissue activity curves generated demonstrate the potential high contrast of imaging 
using ATSM if compared to FMISO, with an average tumour to blood ratio of > 3  and 
> 1.4, respectively. This implies that ATSM should allow for more accurate and 
reliable delineation of hypoxic tumour sub-volume due to its high local imaging 
contrast. This is in close agreement with expected properties of such tracers and so 
ATSM would provide sufficient knowledge on the severity of hypoxia. Hypoxia and 
likewise tissue activity curves (TACs) are heterogeneous problems. Therefore, 
tumours that appear identical in clinical and radiographic examination may have 
significantly different tumour sub-volume delineation. Simulation findings illustrate 
clearly the influence of transvascular heterogeneity even on the same tumour as in 
Figures 6.8 & 6.9.
At this stage it is important to again state that an appropriate thresholding method has 
yet to be confirmed. Indeed, further to our discussion in Chapter 4, the benefit from 
the unique information that PET imaging offers is challenged by the thresholding 
method.
An early attempt by Chao et a l (2001) was to delineate hypoxic tumour sub-volume 
within regions of GTV in head and neck squamous cell carcinoma and neck nodes, 
using ATSM for the purpose of dose painting approach. A tumour to muscle ratio of > 
2 was used to locate hypoxic sub-volume, where the heterogeneous distribution of 
ATSM within the GTV was identified with no indication for any positive uptake of 
ATSM in the normal tissue of the neck.
Simulation results of tumour sub-volumes generated using three different thresholding 
methods have shown similar findings, with a larger targeted volume determined at the 
tumour surface and significantly smaller target volume toward the tumour core. Using 
the third method to evaluate tumour sub-volume, simulation results shows tumour 
sub-volume target defined at the tumour surface, representing 56% of the whole 2-D 
tumour-bearing vasculature. This is 7% larger than tumour sub-volume target defined 
at the tumour surface using the first method, and 4% smaller than tumour sub-volume
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target defined at the tumour surface using the second method. As for target volume 
toward the tumour core, evaluation of tumour sub-volume using the third method, the 
simulation results show tumour sub-volume target, representing 13% of the whole 2- 
D tumour-bearing vasculature. This in turn is smaller than the findings of the other 
two methods, with 7% and 1% using the first and the second method, respectively. 
Our simulation findings, together with the clinical work of Chao et al. (2001), 
highlight the importance of using tumour to background ratio as a thresholding 
method. In such cases the accuracy of sub-volume delineation is challenged by image 
contrast only.
In addition, the results show reasonable agreement with the typical findings of Yuan 
et al. (2006). Simulation results have shown the hypoxia fraction (HF) to be in the 
range of 0.34 using second method, down to 0.09 using the third method. Such data is 
a representation of HF at tumour surface regions. In general, this is in reasonable 
agreement with the findings of Yuan et al. (2006), where the hypoxia fraction ranged 
from 0.166 ± 0.07 to 0.442 ±0.1, acknowledging the difference in tumour cell lines.
However, to benefit from the effort of the intensity modulated radiotherapy technique 
(i.e. dose painting) delineation of the tumour sub-volume needs to be carried out with 
accuracy. In association with this there is a need for conducting a phantom based 
study, where use of well defined feature volumes would allow quantitative analysis to 
be carried out between the three different thresholding methods. This would lead to a 
comparison of the actual volume of the phantom feature to the measured volume after 
a PET/CT image has been thresholded using any of the above methods. Ultimately, a 
clinical trial to further examine and justify the different thresholding methods would 
be of considerable importance, particularly for advanced techniques of radiotherapy.
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7.1 Summary
The molecular imaging technology of positron emission tomography (PET) offers 
substantial advantages over anatomic imaging modalities in all oncology applications. 
Typically, it enables visualization of the various molecular pathways of tumours 
including, metabolism; oxygen delivery and consumption; proliferation and receptors 
of gene expression. The power of such a non-invasive and real time biochemical and 
biophysical imaging modality provides distinctive clinical information such as early 
detection of recurrence of the disease, disease response to therapy, better definition of 
disease extent leading to more reliable gross target volume (GTV) delineation in 
treatment planning and evaluation of organs functionality.
Today there is much interest in PET for measurements of regional tracer 
concentration in hypoxic tumour-bearing tissue, focusing on the need for accurate 
radiotherapy treatment planning. Generally, relevant data is taken over multiple time 
frames in the form of tissue activity curves (TACs), providing an indication of 
vasculature structure and geometry. This is a potential key in providing information 
on cellular perfusion and limited-diffusion. Thus, the use of multimodality imaging in 
treatment planning provides more reliable tumour volume delineation that eventually
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leads to a better definitive local control, which in turn improves quality of patient 
cure.
Techniques such as intensity modulated radiotherapy (IMRT) provide the means for 
radiation dose delivery to achieve the desired dose distributions. However in order to 
benefit from such treatment, knowledge on the severity of hypoxia as well as its 
spatial extent is required. As a result the choice of the radiopharmaceutical that allows 
examination of certain pathophysiology pathways (i.e. in this case hypoxia) within the 
tumour is of great importance. In Chapter 2, we have introduced the different hypoxia 
PET sensitive tracers with the focus on the advantages and limitations of each tracer. 
Nevertheless, confirming the appropriate thresholding method to delineate the 
considered tumour sub-volume is of great significance. In Chapter 4 we showed how 
subjective influence contributed to the accuracy and precision of a sphere’s diameter 
assessment. The fact is, in clinical practice lesions are not spherical and may not be 
uniform, likewise the accumulation of à tracer within the lesion, each of which 
substantially increases the level of difficulty in assessing and reliably quantifying 
features in PET.
In general, quantifiying target extent in medical imaging can also be effected by other 
factors. One factor is that medical images are analyzed and interpreted in a 2-D 
sectional format, where the diagnostic accuracy and determination of disease extent 
are highly influenced by selecting an appropriate window and level adjustment on the 
display screen. In Chapter 3 we showed how changing of window level enhances the 
appearance of contrast with lesions so they are better visualised, but also changes the 
apparent size and sometimes shape of the lesion, causing it to appear larger and semi- 
spherical. In spite of the window and level effect, the poor spatial resolution of PET 
imaging, which is typically greater than 5 mm on most commercial PET scanners, 
introduces a significant impact on small objects due to the partial volume effect 
(PVE). PVE does not only effect the apparent size, but also the local contrast of 
features in all imaging modalities. However, the relatively poor spatial resolution of 
PET compared to CT and MR makes the image blurring effect more significant in this 
modality.
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In this thesis, we have investigated the relationship between tumour vasculature, cell 
biology and physiology on hypoxia and tracer uptake, with a particular interest on the 
PET sensitive tracer, ^"^Cu-ATSM. This was approached using mathematical modeling 
and computational simulation, where use has been made of Partial Differential 
Equations (PDEs) to describe oxygen diffusivity, the binding of tracer, the 
consumption of oxygen and finally the tumour vasculature architecture and geometry.
Hypoxia develops as a result of deficient vasculature, and in order to generate realistic 
scenarios of hypoxia, some representation of this vasculature is required. In Chapter 5, 
we present a developed model of oxygen heterogeneity in 2-D tumour vasculature 
based on the work of Kelly and Brady (2006). In addition, we provide a refinement to 
the matheniatical representation of vasculature architecture in Kelly’s work. From a 
mathematical perspective the computational generation of the 2-D tumour vasculature 
in Kelly and Brady’s work points to a number of issues: (1) their vasculature 
computation was carried out on a fixed mesh size, based on the vessel radius; 
refinement of the mesh will lead to homogenization of the vascular map, a situation 
that is not desirable. In contrast, the smaller the mesh intervals the more detailed the 
simulation; although this would increase the computational time it reduces the 
numerical uncertainty; (2) the diffusion operator is defined for continuous functions, 
such that the carrying out of a computational discrete mesh leads to inconsistent 
solutions.
In Chapter 6, we have utilised the developed tumour vasculature represented in 
Chapter 5 as the basis of a model to simulate the tissue activity curve of ^"^Cu-ATSM. 
Moreover, we have presented a refinement to the novel computerized reaction 
diffusion equation method developed by Kelly and Brady (2006). Kelly and Brady 
managed to simulate the realistic dynamic TACs of ^^F-FMISO. Their model was 
developed over a multi-step process. In this work we refine their work, such that the 
model allows simulation of a realistic tissue activity curve (TAC) of any hypoxia 
selective PET tracer, in a single step process. The simulated tissue activity curves 
generated demonstrate the potential high contrast of imaging using ATSM if 
compared to FMISO, with an average tumour to blood ratio of > 3 and > 1.4, 
respectively. This is in close agreement with expected properties of such tracers and 
so ATSM would provide sufficient knowledge on the severity of hypoxia. By this.
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ATSM should allow for more accurate and reliable delineation of hypoxic tumour 
sub-volume.
The validity of the simulation finding in this thesis is dependent on the truth of the 
assumptions from which the simulation was based and the normal bounds of 
biological variation on the magnitude of parameters used to obtain simulation figures. 
As has been discussed earlier in Chapter 5, quantitative values of some parameters 
vary considerably not only between individuals but even within a single model or 
cancer type on which they are based. The magnitude of variation in some parameters 
is known, for instance blood vessel radius varies from 8 - 1 0  pm, while its thickness 
varies from 0.2 -  1 pm. In addition, the oxygen transvascular permeability figure 
presented by Fletcher and Schubert (1987) varies from 0.03 -  0.3 pm leading to 
significant variation on the average mean oxygen tension in tumour vasculature. 
Similarly in Chapter 6 we demonstrated how vascular architecture disorders, 
especially in the structure of blood vessels (i.e. permeability) leads to high perfusion 
and limited diffusion areas. This introduces a substantial impact on image local 
contrast as was shown in Figure 6.9.
Sensitivity analysis therefore aims to assess the potential impact of variation in 
parameters, to determine whether or not the imaging outcome would change 
significantly with parameters lying within the normal bounds of biological variation. 
In Chapter 5 and 6 we used sensitivity analysis to predict the effect of some parameter 
variation (i.e. micro-vessels density and blood vessels permeability) on oxygen 
heterogeneity and ATSM image contrast, but further analysis will become necessary 
as new parameters are introduced.
7.2 Future Work
This thesis raises some important questions, which require further experimental 
investigation. First in this respect is that there is significant impact of visual based 
interpretation and delineation methods on the accuracy and reliability of target 
delineation, particularly when PET imaging is involved in oncology applications. This 
raises the question of the appropriate thresholding method, particularly for target 
volume delineation purposes in treatment planning. Further to our phantom based
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study in Chapter 3, the use of a profile analysis method, described in Chapter 4, has 
been shown to be more accurate and reliable than visual based analysis methods. This 
in turn highlights the significant need for a protocol that offers more consistent and 
reliable analysis of target delineation and volumetric quantification on a PET image. 
Consequently a specific mathematical algorithm should be developed and used for a 
given PET system, as PVE or image blurring is a point spread function width 
dependence that in turn has been shown to vary between the different PET systems.
Further to the above, the validity of the simulation results in Chapter 5 and 6 in this 
thesis has been justified with evidence from the literature. In contrast, parameter 
values that we have used or estimated in our simulations (i.e. in Chapter 5 and 6) are 
derived from a number of cancer models and different tumour cell-lines. As a result 
we do not expect that our simulation results exactly reflect the imaging outcome for 
any single cancer model or tumour cell-line. Therefore, the aim of the future series of 
experiments should be to obtain quantitative estimates of model parameters for a 
selection of cell-lines. Thus incorporation of animal models at this stage is of great 
importance. This is needed in order to have (1) a uniform parameterisation from a 
single cell-line, (2) to predict the natural range of potential imaging outcomes and (3)
would aid an understating of the different factors that contribute to the process'of sub-
\  , 
volume delineation of hypoxic regions. Ultimately, this would allow quantitative
validation between ATSM and FMISO parameters with a higher level of confidence.
Further work is also required to develop a 3-D model, as in addition, a third Bernoulli 
factor needs to be established to account for blood vessel relaxation and contraction. 
Another extension to this thesis would be the mathematical linking between oxygen 
heterogeneity and tracer heterogeneity, particularly when tracer distribution is oxygen 
concentration dependent. Based upon our understanding, the binding rate of a hypoxia 
sensitive tracer (i.e. kon in equation 6.8) should be a function of oxygen tension. An 
earlier attempt by Casciari et al. (1995) sought to quantify tumour hypoxia using the 
FMISO tissue activity curve and defined a mathematical formula that represents the 
binding rate of FMISO in rat tissue that is oxygen dependent. This relation was given 
as:
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where kon is the tracer binding rate (s'^), ka is the maximum rate of tracer binding (s’ )^, 
kb the concentration of oxygen at which binding is half maximum (mmHg) and pOz 
the oxygen concentration (mmHg). Replacing the fixed value of kon in equation 6.8 by 
the oxygen dependent function, equation 7.1, would mathematically link oxygen 
heterogeneity in the tumour vasculature, equation 5.14, with ATSM kinetics and 
binding equation 6.8. Calculating the binding rate kon of ATSM in a specific cell-line 
would require estimation of all of ka and kb.
Considering all of the factors highlighted above, it is apparent that there is a need to 
conduct a pilot study that aims to evaluate the cellular uptake of ^"^Cu-ATSM. More 
recently and as a first attempt to explore cellular uptake of ATSM, a simple in vitro 
study was designed as an MSc project, with the author playing a significant part in the 
design and supervision of the project. The study was carried out by an MSc Medical 
Physics student at the University of Surrey, Amar Yassen (2009). The study was 
found to be challenged by a number of the applied methodologies and also by facility 
issues that did not allow the project to progress far beyond a number of important 
calibrations. This project should be taken up and built upon in an effort to take it 
forward.
In the above, and from a practical point of view, the ease of use of element tracer 
analysis of non-active copper was considered. This approach would have found 
present studies making use of the external beam facilities of Surrey Ion Beam Centre 
and the Inductively Coupled Plasma Mass Spectroscopy (ICPMS) at the Chemistry 
department. However, further consideration of use of non-active copper was shown to 
be unsatisfactory, especially in cultured cells studies. This was mainly due to (1) 
copper toxicity, the avoidance of which would only allow limited amounts of copper 
to be introduced to the cells in order to keep them viable and (2) copper is not soluble. 
Calculations indicated that the expected copper concentrations would be below the 
limits of detection for the two analytical systems. As a result the only way to 
overcome this problem would be to use the active copper instead, whereby a much
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more limited concentration of active copper (i.e. 0.15 pg/ml) could be detected using 
a calibrated Gamma counter (Lewis et a l, 1998).
The other issue was incubating cells in a hypoxic environment. This would require 
special lab preparation that would include facilities such as an incubator connected to 
a specific mixture of gas cylinders, making it an exclusive (and hence highly 
expensive) applications facility. The gas cylinder would need to be a mixture of fixed 
concentration of the following gases: oxygen (0%), carbon dioxide (CO2) and nitrogen 
(N2). Studies by Lewis et al. (1998) and Obata et al. (2005) have shown diversity in 
the chosen levels of gas concentration, however they both confirmed the use of 5% 
concentration of CO2. Therefore, an oxygen transmitter or oxygen sensor designed for 
in vitro studies is necessary to monitor oxygen concentration during the experiment. 
The need for such arrangement and facilities is first to control the level of oxygen in 
the cultured cells media, second to provide a healthy environment so that the cells 
keep growing and stay viable otherwise there will be no evidence of tracer uptake in 
the next part of the experiment. Because accessing such facilities was not feasible at 
the time of this project, the use of more easily accessible method was the only 
solution. In the literature, the group of Kamiya et al. (1998) explored the use of an 
anaeropack system to introduce hypoxia for cultured cell samples. In an attempt to 
follow their work and because of ease of use of the AnaeroGen™ sachet 
(Basingstoke, Hampshire, England), this route was the one examined in the pilot work 
defined by the MSc Medical Physics project.
The AnaeroGen™ sachet is filled with an active chemical material that produces 
anaerobic environments when placed in a sealed jar. Such jars are usually known as 
anaerobic jars. The ascorbic acid inside the foil packed sachet reacts rapidly with 
atmospheric oxygen once the foil is opened and the ascorbic acid is exposed to the 
atmospheric air. That in turn results in reducing oxygen concentration in the 
atmospheric air in the jar down to 1% or less and simultaneously producing (i.e. 30 
minutes) up to 13% CO2. Further to our introduction in Chapter 2, while oxygen is 
carried in the blood by haemoglobin, nevertheless the affinity of haemoglobin for 
oxygen is shown to be effected by a number of physiological variables. The most 
important of these are raised partial pressure of carbon dioxide (PCO2), decreased 
acidity (pH), raised temperature and increased concentration of the organic phosphate
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(Shannon et ah, 2003). This has been confirmed by Raghunand et ah (2003), where 
tumour angiogenesis is associated with low pÛ2 , low pH and low glucose. From this 
basis, the research group of Kostourou et ah (2004) have considered the use of pH 
level as a surrogate marker of hypoxia. Based on this a decision was made on 
measuring the pH level in the cultured cell media. Later on these measurements were 
used to estimate oxygen tension in the cultured cell media. For this, use has been 
made of the Helminger et al. (1997) spatial gradient of metabolites in tumours that 
was also adapted by Jain (1999). This spatial gradient including pH,p02 and distance 
from blood vessels is represented in Figure 7.1.
Use of the AnaeroGen™ sachets has shown encouraging results, where 3 hours of 
incubation (appearing in blue) in the anaerobic jars reveal reduction in the pH level in 
the cultured cell media down to 6.8 -  6.95, which is equivalent to ~ 3.8 -  6 mmHg. 
Five hours incubation (appearing in red) reduced oxygen tension further, down to 2 
mmHg, without risking cell viability, whereas the control samples (C) showed a level 
of pH ranging from 7.1 -  7.25, which is equivalent to 9.5 -  11.5 mmHg. Even though 
pH analysis was one way to predict oxygenation status in the cultured cell media, 
there is a need for an absolute method, for instance a calibrated oxygen probe, to 
quantify the oxygen concentration level. With this, evaluation of the cellular uptake of 
^"^Cu-ATSM quantitatively and qualitatively would become the next step.
The work included herein has resulted in a number of International Conference 
presentations and papers that have been published, have been accepted for publication 
or at the time of writing are awaiting the consideration of referees for publication. The 
list of these various items is included in Appendix D.
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Figure 7.1: pH and pÛ2 gradients measured in a tumour section using techniques such 
as fluorescence ratio imaging for pH and phosphorescence for p02. Pilot study 
findings are also included with C representing the range of pH in the control samples, 
the blue line representing the range of pH in the 3 h incubation samples and the red 
line representing the range of the 5 h incubation samples. Herein use was made of 
Chinese hamster V79 tumour cell-lines (adapted from Jain, 1999).
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Appendix
Dewhirst et a l (1994) has estimated the consumption rate in rat mammary adeno­
carcinoma to be between 0.83 to 2.22 cmVlOO g/min, which can be equivalently 
expressed as 6 to 16 pM/s, given that tissue density is similar to water (Ppgue et al, 
2001). The latter can easily be expressed in mmHg/s using Henry’s law.
First we need to convert the concentration from volume (0.83 cmVlOO g/min) to 
molar measure (6 pM/s). Thus we start by converting the rate from min to sec, as 
shown beneath
(0.83 cmVlOOg)/ 60s = 0.0138 cmVlOO g/s
We want the concentration to be per 1000 g instead of 100 g.
1 Q
Thus — x0.0138cm^/100g/j = 0.138 cm^/ 1000 g/s 
10
Assuming that the diluting solvent is water => 1000 g of water = 1000 cm^ of water = 
1 litre (L)
Thus the consumption rate of oxygen can be represented as 0.138 cmV L/s [1],
where 0.138 cm^ is the concentration of the dissolved oxygen in one litre (L) of the 
diluting fluid (in this case, water). As we want the concentration of oxygen to be 
represented in molar measure instead of cm^, we need to convert the concentration.
For this we will apply the ideal gas law
Ideal gas law:
PV = nRT, where P = pressure (atmospheres), V = volume (litres = 1000 cm^), n = 
number of moles of gas (mass in g/molecular weight), R = molar gas constant (0.0821 
liter, atm/mol. Kelvin) andT = temperature (Kelvin).
Thus assuming work was carried out at normal atmospheric pressure = 1 atm and 
room temperature = 298 K (25 C®)
PVn = -----
RT
latmx0.l3Scm^n =
0.0S2l{L.atm lmolK)x29SK
------------------------------------ = 5.64X10-* mol
0.0S2lxl000(cm\atm/mol.K) x  29SK
Thus eq. [1] now becomes 5.64 pmol/ L/s [3]
Given that 1 molar (M) = 1 mol/L, thus the consumption rate of oxygen will now be 
represented as 5.64 pM/s (figure similar to Pogue et a l, 2001).
Now that the oxygen consumption rate is in molar/s we can represent this quantity in 
mmHg/s following Henry’s law.
Henry’s law:
Concentration of dissolved gas = partial pressure of the gas x solubility coefficient of 
the gas.
Thus:
Oxygen consumption rate in unit o f  pressure (mmHg / s) —
Oxygen consumption rate in unit o f  concentration {m olar!s) ,
sohxhility coefficient o f oxygen {a)
where a = 1.35 x 10'^ (mol/cm^) mmHg'^ (Federspiel, 1986)
Therefore, the oxygen consumption rate =
5.6ÀjiiM!s _  5.64xl0~^ (mo//L)/.y
1.35x10"" xlO"(mo//L)mmHg"^ \3 5 x \0 - \m o li  L)mmHg\“6
— = 4.2mmHg I s
The metabolic oxygen 
consumption rate 
pM/s
The metabolic oxygen 
consumption rate 
mmHg/s
Reference
6 - 1 6 4.44-11.85 (Pogue et al., 2001)
3.0x10'" 2.22 xlO'" (Salathe, 1986)
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Computational code to solve oxygen heterogeneity in 2-D vasculature (i.e. equation 5. 
14)
Computation parameters 
Time step
Tend = 15; 
dt = 1/20;
Nstep = round(Tend/dt); 
l.x_vas = 1;
Ly_vas = 1; 
nx_vas = 2 5 ;  
ny_vas = 25;
hx_vas = Lx_vas/(nx_vas); 
hy_vas = Ly_vas/(ny_vas);
alpha = hx_vas/6;
% computational mesh: Note 
Lx = 1;
Ly = 1; 
nx = 300; 
ny = 300; 
hx = Lx/Cnx); 
hy = Ly/(ny);
% Mesh for c a p il la r ie s ,  vasculature  
% length  o f  domain
% number o f  mesh points
% mesh step  s iz e
% width o f  Gaussian fu n ction s
th is  may be d iffe r e n t  from vascular map 
% length  o f  domain
% number o f  mesh points
% computational mesh step  s iz e
Equation parameters - oxygen 
p=60/(nx_vas*ny_vas);
pa = 0 .5 ;  
PmO=0.03; 
5=200;
qmax=15; 
Do=2*10Â-3; 
h=2.5 ;
Pov = 40; 
Poa = 100;
% proportion o f  v e s se ls  covering the vascular = 
MVD/nx_vas*ny_vas,
% mean ~ 60 grid  points out o f  the nx_vas*ny_vas 
p oints are c a p il la r ie s .
% proportion o f  a r te r io le s  v e s s e ls  to  ven u les.
% oxygen perm eability in  u n it o f  mm/s,
% Cs/v) -  ra tio  o f  ca p illa r y  surface area to  
volume in  u n it o f  m m A -l,
% Maximum oxygen tension  in  mmHg/s.
% Oxygen d iffu sio n  c o e ff ic e n t  in  mmA2/s.
% oxygen a t FWHM in mmHg (non linear parameter).
% oxygen p artia l pressure a t the venule ends 
% oxygen p artia l pressure a t the a r te r io le  ends
Code to compute vasculature proportion R(x)
x_vas = 1i  nspace( 0 ,Lx_vas, nx_vas)'; 
y_vas = 1i nspace( 0 ,Ly_vas, ny_vas)';
[xx_vas,yy_vas]=meshg ri d (x_vas,y _ v a s);
loca tion _p o in ts = (ran d(size(xx_vas))< = p); 
ind = f i  n d (locati on_poi n ts= = l);
% Id mesh 
% 2D mesh
% lo ca tio n  o f  v e s se ls
a rter i o le s_ lo c a ti on = (ran d (size(in d ))< = p a); % loca tion  o f  a r te r io le s  
% computational mesh
dx = L x /(n x -l) ; % mesh step  s iz e
dy = L y /(n y -l);
X = 1in space( 0 ,L x,nx)'; % Id mesh
y = 1in space( 0 ,L y,ny)';
Lxx,yy]=m eshgnd(x,y) ; % 2d mesh
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% d efin e the vasculature map 
R = z e r o s (s iz e (x x ) ) ;
Ra = ze ro s(s izeC x x ));
Rv = z e r o s (s iz e (x x ) ) ; 
for  i  =1:s iz e ( in d )
R = ex p (-((x x -x x _ v a s(in d (i))) .A 2  + (yy-yy_vas(in d (i))).A 2)/(2*a1p h aA 2)); 
Ra = Ra + arte ri o le s_ lo c a ti o n (i)* R;
Rv = RV + (1 -a r te  ri o le s_ lo c a ti o n (i) ) *R;
end
Differentiation matrices
Second order differentiation matrices
ex = o n e s(n x ,l) ;  
ey = o n e s(n y .l) ;
Dxx = sp d iags([ex  -2*ex e x ], -1 :1 , nx, nx)/dxA2;
Dyy = sp d iags([ey  -2*ey e y ] , -1 :1 , ny, ny)/dyA2;
D xx(l, 2 )=2;Dxx(nx, n x -l)= 2 ; ^Neumann bcs
D yy(l,2)=2;D yy(ny,ny-l)=2; %Neumann bcs
DOxx = Do*Dxx; % m ultip ly by d iffu s io n  c o e f f
DOyy = Do*Dyy;
Ainv = in v(speye(nx,nx) -  0.5*dt*DOxx);ind = find(A inv<10A -l2);Ainv(ind)=0;Ainv 
= sparse(A in v);
Binv = in v(speye(ny,ny) -  0 . 5*dt*D0yy);ind = find(B inv<10A -l2);B inv(ind)=0;Binv 
= sparse(B inv);
uold =Poa*Ra +Pov*Rv; % oxygen
F_rhs = in lin e('-q m ax .*u ./(u + h ) + PmO*s*( (Poa - u).*Ra + (Pov -
u ).* R v )', ' u ' , ' qmax' , 'Pmo', ' s ' , 'P oa ', 'P ov ', 'h ' , 'R a', 'R v ');
for k=l:Nstep  
t  = dt*k;
fo r  i= l:n x
tmp = ( u o ld ( i , l : n y ) ) '; 
tmp2= DOyy*tmp; 
u y y (i,l:n y )  = tmp2';
end
% s ta r t  ADI scheme
TMPF = 0 . 5*dt*F_rhs(uold,qm ax,Pmo,s,Poa,Pov,h,Ra,Rv);
fo r  i= l:n y  
for i= l:n x
rh su (i) = u o ld ( i , j )  + 0 .5 * d t* u y y (i, j )  + TM PF(i,j);
end
u H af(l:n x ,j) = A inv*rhsu'; 
end
% find  u_xx,v_xx 
fo r  j= l:n y
uxx(1 :nx, j)=DOxx*uHaf(1 :nx, j );
end
for i= l:n x  
for  j= l:n y
rh su(j) = u H af(i, j)+ 0 .5 * d t* u x x (i, j)+TMPF(i, j ) ;
end
u n ew (i,l:n x) = (B inv*rhsu')';
end
%plot so lu tio n  a t each time step  = 1 
. i f  m od(t,l)==0
s u b p lo t (2 ,2 ,l ) ; % p lo t oxygen d istr ib u tio n
pcolo r (x x ,yy , unew);v iew (0 ,90); shading interp;
t i t l e ( [ ' t = ^  num2str(t) ' max u=' num2str(max(max(unew))) ' mean 
u=' num2str(mean(mean(unew)) ) ] ) ; drawnow;
num2str(max(max(vnew)))]);drawnow; 
end
% update for  next time step  
uold = unew; % oxygen
end
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Calculation of Hypoxic fraction
threshold  =5; % threshold  o f hypoxia
Hypoxicl = (uold<=threshold); % lab el "1" each oxygen poin t < thresh old ,
zero otherwise
su bp lot( 2 ,2 ,2 ) ; im a g e sc (H y p o x ic l);t it le (['H y p o x ia l']); %plot
colorm ap(gray); % change colormap to  grayscale
Hypox_fracl = trapz(trapz(H ypoxicl,2),l)*hx*hy/(L x*L y) % Hypoxic fra ctio n
threshold =2.5; % threshold  o f hypoxia
Hypoxic2 = (uold<=threshold); % lab el "1" each oxygen point < thresh old ,
zero otherw ise
subplot( 2 ,2 ,3 ) ; im agesc(Hypoxic2);t i t l e ( [ ' Hypoxia2' ] ) ;  %plot 
colorm ap(gray); % change colormap to  grayscale
Hypox_frac2 = trapz(trapz(H ypoxic2, 2 ) ,l)*hx*hy/(Lx*Ly) % Hypoxic fra c tio n
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Computational code to solve ^"^Cu-ATSM heterogeneity in 2-D (i.e. equation 6.8)
Computation parameters
Time step
Tend = 20; 
dt = 1/20;
Nstep = round(Tend/dt);
% Mesh for  c a p il la r ie s ,  vasculature  
Lx_vas = 3;
Ly_vas = 3; 
nx_vas = 150; 
ny_vas = 150;
hx_vas = L x_vas/(n x_vas-l); % mesh step  s iz e
hy_vas = L y_vas/(n y_vas-l);
% length  o f  domain 
% number o f  mesh points
alpha = hx_vas/6; % width o f  Gaussian functions
% computational mesh: Note th is  may be d iffe r e n t  from vascular map 
Lx = 3; % length o f  domain
Ly = 3;
nx = 400; 
ny = 400; 
hx = L x /(n x -l) ; 
hy = L y /(n y -l);
% number o f  mesh points  
% computational mesh step  s iz e
Equation parameters
p=2169/(nx_vas*ny_vas);
pa = 1;
S=200;
% proportion o f  v e s se ls  covering the  
vascular = MVD/nx_vas*ny_vas,
% proportion o f  a r te r io le s  v e s s e ls  to  
venules.
% ( s /v )  -  ra tio  o f  ca p illa ry  su rface area 
to  volume in  u n it o f  mm-1.
Equation parameters
kon = 0.0003;
Dt = 5.05*10A-4;
Pmt= 1.22;
% maximum rate o f  tracer binding (sA -l)
% d if f u s iv ity  o f  ATSM in  membrane system  
(mmA2/s)
% ATSM perm eability in  u nit o f  mm/s
Code to compute vasculature proportion R(x)
x_vas = lin sp ace(0 ,L x_vas,n x_vas)'; % Id mesh
y_vas = lin sp a c e (0 , Ly_vas, ny_vas)';
[xx_vas,yy_vas]=m eshgrid(x_vas,y_vas); % 2d mesh
1ocation_points = (ran d (size(xx_vas)) <=p); % lo ca tio n  o f  v e s se ls
ind = f i  nd(1ocati on_poi n ts= = l);
a r te r io le s_ lo c a ti on = (ran d (size(in d ))< = p a); % lo ca tio n  o f  a r te r io le s  
% Computational mesh
dx = L x /(n x -l); % mesh step  s iz e
dy = L y /(n y -l);
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X = 1in space( 0 ,L x,nx)'; % Id mesh 
y = lin sp a c e (0 ;L y ,n y )';
Lxx,yy]=m eshgnd(x,y) ; % 2D mesh
% d efin e the vasculature map 
R = zerosC size(xx));
Ra = ze ro sC size (x x )); 
fo r  i  =1: s iz e  (ind)
R = ex p (-((x x -x x _ v a s(in d (i))) .A 2  + (yy -y y _ v a s(in d (i))) .A 2 )/(2 * a lp h a A 2 )); 
Ra = Ra + arte ri o le s_ lo c a ti o n (i) *R;
end
D if fe r e n t ia t io n  m a tr ic e s
Second order differentiation matrices
ex = o n es(n x ,l);  
ey = o n e s(n y ,l);
Dxx = sp d iags([ex  -2*ex ex ], -1 :1 , nx, nx)/dxA2;
Dyy = sp d iags([ey  -2*ey e y ] , -1 :1 , ny, ny)/dyA2;
D x x (l, 2)=2;Dxx(nx, n x -l)= 2 ; %Neumann bcs
Dyy( 1 ,2)=2;Dyy(ny, n y -l)= 2 ; ^Neumann bcs
DTxx = Dt*Dxx; % m ultip ly  by d iffu sio n  c o e f f
DTyy = Dt*Dyy;
c i nv = inv(speye(nx,nx) -  0.5*dt*DTxx);ind = f i  nd(c i nv<10A-l2);c i nv(i nd)=0 ; Ci nv 
= sp arse(Cin v );
Dinv = inv(speye(ny,ny) -  0 . 5*dt*DTyy);ind = find(D inv<10A -l2);D inv(ind)=0;Dinv 
= sparse(D inv);
fo r  k=l:Nstep  
t  = dt*k
x=[0 20 40 60 90];% 120 300 360 420 480 540 600];
y=[0 5.46 1 .01  0.64 0.42];% 0.39 0.38 0 .3  0 .27  0.25 0.23 0 .2 1 ];
T r = in te r p l(x ,y ,t ) ;
void  = Tr*Ra; % fre e  tracer
T_rhs = in lin e ( '-k o n .* v  + Pmt*S*( (Tr -  
v ).* R a )' , ' v ' , 'k on ', 'Pm t', ' s ' , 'T r ', 'R a');
%find u_yy,v_yy 
fo r  i= l:n x
tmp = ( v o ld ( i , l : n y ) ) '; 
tmp2= DTyy*tmp; 
v y y ( i ,l :n y )  = tmp2';
end
% % s ta r t  ADI scheme
TMPT = 0 .5 *dt*T_rhs(void,kon,Pm t,s,Tr,Ra);
fo r  i= l:n y  
for i= l:n x
rh sv (i)  = v o ld ( i , j )  + 0 .5 * d t* v y y (i, j )  + TMPT(i,j);
end
v H a f(l:n x ,j)  = cin v*rh sv ';
end
% % find  u_xx,v_xx
for j= l:n y
vxx(l:n x ,j)= D T xx*vH af(l:n x ,j);
end
fo r  i =1:nx 
for j= l:n y
rh sv(j) = v H a f(i, j)+ 0 .5 * d t* v x x (i, j)+TMPT(i, j ) ;
end
vn ew (i,l:n x) = (Dinv*rhsv') ' ;
end
%plot so lu tion  a t each time step  = 1 
i f  m od(t,l)==0
subplot(2 ,2 ,1 ) ;  % p lo t tracer fre e
p color(xx , yy , vnew);v iew (0 ,9 0 ); shading in te r p ;
163
t i t l e ( [ ' t = '  numZstrCt) ' max v=' 
numZstr(max(max(vnew)) ) ] ) ; drawnow; % ' mean v='
numZstr(mean(mean(vnew)) ) ] ) ;drawnow; 
end
vold=vnew;
end
threshold  = 0 .4 .* (max(max(vold)) ) ;  % threshold  o f  hypoxia
Hypoxic = (vold>=threshold); % lab el "1" each oxygen point <
tnreshold , zero otherw ise
subplot( 2 ,2 ,2 ) ; i  magesc(Hypoxi c ) ;t i  t l e ( [ ' Hypoxi a ' ] ) ;  Xplot
colorm ap(gray); % change colormap to  grayscale
Hypox_frac = trapz(trapz(H ypoxic,2),l)*hx*hy/(L x*L y)
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A B S T R A C T
M ulti-m odality im aging is involved in almost all oncology applications from diagnosis through  
treatm ent planning and follow-up. Commercial im age fusion software packages are becom ing available 
but require com prehensive evaluation to ensure reliability o f fusion and the underpinning registration 
algorithm. This is especially critical for target volum e delineation in radiotherapy. The present work  
seeks to assess such accuracy for a number of available registration m ethods. A National Electrical 
Manufacturers Association (NEMA) body phantom w as used in evaluating com puter tom ography (CT), 
m agnetic resonance (MR) and PET images. In addition, discussion is provided concerning the choice and 
geom etry of fiducial markers in phantom studies and the effect o f w indow  level on target size, in 
particular in regard to the application of m ultim odality imaging in treatm ent planning. In general, the  
accuracy of fusion o f m ulti-m odality images was w ithin  0 .5-1.5 m m  of actual feature diam eters and 
< 2  ml volum e o f actual values, particularly in CT images.
© 2008  Published by Elsevier Ltd.
1. I n tr o d u c t io n
In regard to  m a lign an t tu m o u rs, a ccu ra te ly  d e lin e a tin g  th e  
gross  tu m o u r  v o lu m e (GTV) has a d irec t im p a ct o n  th e  tr e a tm e n t  
reg im e as w e l l  as tr e a tm e n t co m p lic a tio n s  (M cQ uade e t  al., 2 0 0 5 ) .  
In creasin g  d o se  to  th e  w h o le  tu m o u r  targ et can  ca u se  t is su e  
scarrin g  or  n ecrosis  o f  th e  stru ctu re  in  w h ic h  th e  tu m o u r  resid es,  
in crea sin g  th e  com p lica tio n  rate (C hao e t  al., 2 0 0 1  ; M ongioj e t  al., 
2 0 0 6 ) . R ecently , w ith  th e  a d v en t o f  3D  con fo rm a i rad io th erap y  
(3DCRT) an d  in ten sity -m o d u la te d  rad io th erap y  te c h n iq u e s  
(IMRT), i t  h a s b e c o m e  p o ss ib le  to  d e liv er  a h ig h er  d o se  to  th e  
tu m o u r  w h ile  m a in ta in in g  lo w  d o se  ( t is su e  to lera n ce ) to  th e  
su rrou n d in g  t issu e , a llo w in g  sp aring  o f  critical organ s and b etter  
loca l tu m o u r  con tro l (D a isn e  e t  al., 2 0 0 3 ) . In a sso c ia tio n  w ith  th is,  
th ere  is  a d em a n d  for b e tte r  d e fin itio n  o f  d ise a se  e x te n t  and  
v o lu m e  estim a tio n .
In o n co lo g y , it  is  w e l l  a p p recia ted  th a t th e  m erg in g  o f  
an ato m ica l an d  functiona l in form a tio n  h a s a s ig n ifica n t im p a ct  
o n  s e n s it iv ity  and sp ec ific ity  o f  certa in  ty p es  o f  cancer. G régoire  
e t  al. (2 0 0 7 )  h a ve  sh o w n  resu lts  o f  a com p a r iso n  o f  var io u s m u lti­
m o d a lity  im a g in g  te ch n iq u es  n o w  in v o lv ed  in  o n c o lo g y  a p p lica ­
tio n s , T h e focu s o f  su ch  tech n iq u es  is o n  th e  e x te n t  o f  d ise a se  and  
targ et v o lu m e  d e lin ea tion , it  b e in g  u n d ersto o d  th a t m ore re liab le
‘ Corresponding author.Tel.: +441483 689416; fax: +441483686781 . 
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d e fin itio n  o f  th e  lo ca l tu m o u r  v o lu m e  can  lea d  to  b e tte r  loca l 
con tro l (C iernik e t  al., 2 0 0 3 ) .
Initial a ttem p ts  a t  reg ister in g  a n a to m ica l in fo rm a tio n  and  
fu n ction a l in form a tio n  w a s  a lm o st e n tir e ly  carried  o u t  v isu a lly ,  
ty p ica lly  u s in g  a lig h t  b o x  (se e  for in sta n ce . H ill e t  al., 2 0 0 1  ). M ore  
recen tly  so ftw a re  fu s io n  packages h a v e  b e e n  d e v e lo p ed , th e  in te n t  
o f  w h ic h  h a s b e e n  th e  reg ister in g  an d  fu s in g  o f  d ifferen t im a g in g  
m o d a lity  s e ts  o f  data , for  a g iv en  tu m o u r  s ite , for a g iv e n  su b ject.  
H ere it  is  u n d ersto o d  th a t im ag e  r e g istra tio n  is  th e  p r o ce ss  o f  
over la y in g  tw o  or  m o re  im ag es, p o ss ib ly  ta k en  a t d iffer e n t t im e s  
an d  p o ss ib ly  u s in g  d iffer e n t im a g in g  d e v ic e s . Im age reg istra tio n , 
th rou gh  th e  u se  o f  so ftw a r e  p ack ages, can  e ith e r  b e  c o m p le te ly  
m an ual, b a sed  o n ly  u p o n  th e  su b jectiv e  v isu a l e v a lu a tio n , lea d in g  
th e  op era tor  to  tra n sla te  or ro ta te  th e  im a g e s  b y  d isc r e te  
correction a l a m o u n ts , or i t  can  b e  se m i-a u to m a tic , req u irin g  
s o m e  g u id a n ce  from  th e  u se  o f  fid u cia l m arkers. C o m p le te ly  
a u to m a ted  m e th o d s  are a lso  ava ilab le , b a se d  o n  sev era l d ifferen t  
tech n iq u es  su ch  as tran sform ation  o f  p r in c ip a l a x es, sp a tia l or  
freq u en cy-d o m a in  in form a tio n , v o x e l in te n s ity  an d  su r fa ce  sh a p e  
variation , etc . (B an erjee  an d  Toga, 1 9 9 4 ). T h e m a jor ity  o f  th e s e  
reg istra tion  m e th o d s  rely  o n  fea tu re  d e te c tio n , fea tu re  m a tch in g ,  
transform  m o d e l e s t im a tio n  and im a g e  sa m p lin g  and  tran sform a ­
tio n , ea ch  w ith  its  o w n  sp ec ific  p ro b lem s. M on g io j e t  al. ( 2 0 0 6 )  
h ave p o in ted  o u t th a t  in  ord er to  a ch ie v e  h ig h ly  a ccu ra te  im a g e  
reg istra tion  th ere  is  a n e e d  to  a ccu ra te ly  d e fin e  v a lu e s  for  n in e  
param eters, n a m e ly  th e  tran sform ation  v a lu e s  d e fin e d  b y  th e  
th ree  rota tion  a n g le s  (0 , tp and  ij/) and  th e  th r e e  C artesian
0 9 6 9 -8043 /$ - s e e  front matter © 2008  Published by Elsevier Ltd. 
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tran sla tion  v a lu es  (x, y, z), co m p le m e n te d  by th e  v o x e l s iz e  o f  th e  
im ag in g  d ev ice .
In regard to  ea se  o f  u se  o f th e  various available im age  
registration softw are packages, clinicians have reported  a con sider­
ab le degree o f d ifficu lty  in registering im ages for anatom ica l sites  
oth er than th e  brain, th e  problem s bein g  associa ted  w ith ; 
(a) differences in p a tien t p osition  u sing  different im ag in g  facilities, 
even  in com b in in g  o n e  CT im age w ith  that o f  anoth er CT im age  
tak en  on a d ifferent facility, and a lso in the u se  o f  an in tegrated  PET/ 
CT facility w h ere  th e  p osition in g  problem  w o u ld  have been  
m in im ized  (V ogel e t  al., 2 0 0 4 ); (b) m isregistration  related  to th e  
particular scanning  protocol (e.g. breath ho ld  w ith  rem ain ing  
internal organ m o v em en t) (Crum e t  al., 2 00 3; Griffeth, 2 00 5);  
(c) deform ation  o f  so ft t is su e  (Crum e t al., 2 00 3); and (d) d ifferences  
in  voxel in ten sity  (gray v a lu es) resulting from  th e  d ifferent im age  
form ation p rocesses  invo lved  in  m u ltim od ality  im aging.
C onsidering  th e se  factors, co m p reh en sive  e x a m in a tio n  o f  
com m ercia l fu s io n  p a ck ag es has b een  su g g e ste d  to  b e  o f  
im p o rta n ce  in e sta b lish in g  con fid en ce  in th e  re liab ility  o f  th e se  
in  th e ir  rou tin e  a p p lica tio n s  in oncology, particu larly  in  tr e a tm e n t  
p lan n in g  (D a isn e  e t  al., 2 0 0 3 ;  M utic e t al., 2 0 0 1 ) . A lth o u gh  a 
n u m b er  o f s tu d ie s  h a ve  ex p lo red  various app roaches in  a sses s in g  
th e  accuracy o f  r e g ister in g  d ifferen t se ts  o f  data, e sp ec ia lly  
in tegrated  PET/CT data, to  th e  b e s t  o f our k n o w le d g e  th ere  ex ists  
l it t le  in  th e  p u b lish ed  literatu re w h ich  a ctu a lly  e sta b lish e s  
co n fid en ce  and th e  re liab ility  o f  various ava ilab le  packages, 
in c lu d in g  A n alyze  (M ayo Clinic, M inn esota , USA), AcQ Sim  (O n co- 
d iag n o stic  S im u la tion /L oca lisa tio n  System , M arconi, C leveland , 
OH), and ProSoma™  (O n co lo g y  S y stem s Lim ited, Shropsh ire, UK), 
as w e ll as reg istra tio n  so ftw a re  su pp orted  by  in d iv id u a l tr e a tm e n t  
p lan n in g  sy s tem s, in c lu d in g  PLATO (N u cletron  B.V., V een en d a al, 
th e  N eth erland s).
In regard to  th e  m e th o d o lo g y  for a ssess in g  th e  accuracy  o f  
reg ister in g  d ifferen t s e ts  o f  data, Kagawa e t  al. (1 9 9 7 )  h a ve  u sed  
th e  tota l co n ju ga te  d e v ia tio n  m eth o d , eva lu atin g  th e  accuracy  o f  
reg ister in g  CT/MR im a g es  u s in g  fiducial m arker reg istra tion , w h ile  
in regard to  PET/CT v o lu m e  registration  th is has b e e n  ex a m in e d  by  
Chao e t al. (2 0 0 1  ), a fter  draw ing  regions o f  in terest (ROl) on  th e  
c o m m o n  targ et v o lu m e  p resen ted  in  both  data se ts . M u tic e t  al. 
( 2 0 0 1 ) exp lo red  tw o  reg istra tion  m eth o d s  to  reg ister  m u lti­
m o d a lity  im ag es: a p o in t m a tch in g  sy stem  w h e r e  at lea st  th ree  
c o m m o n  p o in ts  n e e d  to  be se le c te d  on  b o th  data se ts  and  
in teractive  im ag es, w h e r e  a co lou r w a sh  o f  o n e  s e t  is d isp layed  
over th e  g raysca le  o f  th e  other. Sim ilarly, th e  reg istra tion  accuracy  
o f  CT. MR and PET im a g e s  have b een  eva lu ated  by th e  grou p  o f  
D aisne e t  al. (2 0 0 3 )  u s in g  th e  d ifferen ce in  tran sla tio n  (in  m m )  
and  rotation  ( in  d eg rees). L ikew ise, Ciernik e t  al. (2 0 0 3 )  a ssessed  
targ et reg istra tion  o f  PET/CT data b a sed  on  tran sla tio n  a lo n g  th e  x - 
and  y -a x es .
In th e p resen t stu dy, p h a n tom -b ased  in v es tig a tio n s  h a ve  b een  
m ad e, seek in g  to  e sta b lish  th e  accuracy and reliab ility  o f  th e  
ProSoma™  reg istra tio n  and fu sio n  package. The package in c lu d es  
m anual, s e m i-a u to m a tic  and a u tom atic  fa c ilities  as d escrib ed  
b elow . P h an tom  reg istra tio n  and fu sion  has b e e n  a ss e s s e d  u sin g  
th e  fo llo w in g  d e v ic e s , all o f  w h ic h  are available at th e  Royal Surrey  
C ounty H osp ita l (RSCH); com p u ter  tom ograp h y  (CT); an in te ­
grated PET/CT; and a m a g n etic  reson an ce  im ag in g  s y s te m  (MRI).
2 . M a ter ia ls  a n d  m e t h o d s
2.1 Imaging facilities
2.1.1. GE Discovery LS PET/CT system
The in teg ra ted  GE D isco very  PET/CT sy s tem  in vo lv ed  in th is  
stu d y  m ak es u se  o f  a con ven tio n a l B ism uth  G erm an ate  (BGO)
d ete c to r  b lock  sy stem , o fferin g  a v ariab le  in tr in s ic  fu ll-w id th  ha lf­
m a x im u m  (FW HM ) reso lu tion  o f  4 .8  and 5 .6  m m  for 2D  and 3D  
im ag es, resp ectively . T he sy s tem  c o m p le te ly  re lies  on  th e  
corrected  CT data to  correct for th e  a tte n u a te d  511 keV p h o ton s. 
In our case , a 2D  im ag e  m o d e  w a s  acq u ired  for lO m in /2  fram es  
( 2  b ed  p o s it io n s)  u s in g  a m atrix  o f  128  x  1 28  p ixels, th e  im ag e  
b e in g  recon stru cted  to  an average th ick n e ss  o f  4 .2 5  m m .
2.1.2. GE Lightspeed RT/16 CT scanner
CT sca n s  w e r e  perform ed w ith  an  a b d om in a l p ro toco l u s in g  th e  
GE L igh tsp eed  RT/16 CT scan n er (CT'^^/CT''^) for a recon stru cted  
s lice  th ick n e ss  o f  5 m m  and a p itch  o f  0 .7 5 . Im ages w e r e  acquired  
u sin g  a m atrix  o f  512 x 512 p ixels, and  reco n stru cted  w ith  a final 
r eso lu tio n  at FW HM o f  0 .8  x 0 .8 m m ^.
2.1.3. GE SIGNA MR/I 1.5 T MRI scanner
MRI sca n s w ere  p erform ed  w ith  a p e lv ic  p ro to co l MRI 
a cq u is itio n  u s in g  th e  GE SIGNA MRI for recon stru cted  s lice  
th ick n e sse s  o f  5 and a lso  10 m m  ( it  b e in g  su g g e ste d , b a sed  u p on  
th e  p rev io u s  exp er ien ce , th a t th e  b e s t  r eso lu tio n  for th is  d e v ic e  is 
ava ilab le  at 10 m m ). Im ages w e r e  acq u ired  u s in g  a m atrix  o f  
2 5 6  X 2 5 6  p ixels.
2 .2 . Phantoms and registration software
2.2.1. Phantom details
All th e  qu a lity  a ssu ran ce (QA) te s ts  w e r e  carried  o u t u s in g  th e  
c o m m erc ia lly  ava ilab le N ational E lectrical M an u factu rers A sso c ia ­
t io n  (NEM A) standard body  p h a n to m  (G reer e t  al., 2 0 0 2 )  
rec o m m e n d e d  b y  th e  International E lec tro -tech n ica l C o m m issio n  
(lEC). T he NEMA lEC b o d y  p h a n tom  c o n s is ts  o f  s ix  f illa b le  sp h eres  
o f  v a r io u s s izes  and diam eter, th e  a rra n g em en t a llo w in g  th e  u se  in  
e v a lu a tio n  o f CT, MR and PET im a g es; fu ll in fo r m a tio n  is p rov id ed  
in th e  NEMA lEC b o d y  p h an tom  m a n u a l (G reer e t  al., 2 0 0 2 ) , Fig. 1 
sh o w s  th e  com m ercia l NEMA b o d y  p h a n tom .
2.2.2. ProSoma™ 3 0  registration and fusion package
Further to  earlier d iscu ssio n , ProSoma™  su p p o rts  m an u a l, 
s em i-a u to m a tic  and fu ll a u to m a tic  reg istra tio n  m e th o d s . The 
d ifferen t reg istra tion  m e th o d s  w ill  b e  d escr ib e d  in b r ie f  b e lo w .
Manual registration: In th is  m o d e  tr a n sfo rm a tio n  o f  th e  
seco n d a ry  data s e t  is m a d e  b y  e y e  th rou gh  tra n s la tio n s  a lo n g  
th e  s e t  o f  a xes (x, y, and z ) and ro ta tio n s  arou n d  ( 0 , cp and  i/>).
Fig. 1. Photograph o f  the commercial NEMA body phantom.
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Marker registration: This m e th o d  is b a se d  on  id e n tify in g  at 
lea st four c o m m o n  m arker p o in ts  on  ea ch  data  s e t  to  a llo w  th e  
transform ation  m a tr ix  to  b e  g en era ted . In th e  p r esen t w ork, th e  
cen ter  o f  each  sp h ere  has b e e n  c o n sid ered  to  b e  th e  lo ca tio n  o f  a 
particu lar m arker.
Automatic registration: T h is m e th o d  co n sid ers  v o lu m e  e le m e n t  
in form ation , as in  for in sta n c e  v o x e l in te n s ity  as u sed  h erein , in  
term s o f  gray lev ej, and th e  a sso c ia te d  surface g eo m etry  
in form ation  for b o th  s e ts  o f  acq u ired  d ata. As an  a sid e , in  clin ica l 
situ a tio n s, th e  b o u n d ary  b o x es  (ROI in  w h ic h  th e  gray  lev e ls  are  
in vestig a ted ) su p p o rted  b y  ProSoma™  are fou n d  to  b e  a 
particu larly  u se fu l to o l, a llo w in g  th e  op era tor  to  avo id  any  
p oten tia l m isa lig n m e n t c a u sed  b y  artifact stru ctu res su ch  as 
stereo ta tic  fram es, t e e th  fillin g s an d  th e  tr e a tm e n t ta b le  surface.
Volume registration: This is b a se d  o n  d raw in g  a reg ion  o f  
in terest (ROI) th a t v er ifies  a c o m m o n  ta rg e t for b o th  se ts  o f  
acquired data. W h ile  th e  sy s te m  a llo w s  for d e fin in g  a ll p o ss ib le  
c o m m o n  ROIs, o n ly  o n e  ROI can  b e  in vo lv ed  in g en era tin g  th e  
tran sla ted  data.
2 .2 .3. Phantom preparations
For CT scan s th e  NEMA p h a n to m  w a s  f illed  to  th e  top  (i.e . to  a 
v o lu m e o f  a p p rox im ate ly  9 .7  L) u s in g  w ater , th e  sp h eres b e in g  left  
em pty .
For MRI scans, th e  s tu d y  w a s  d iv id ed  in to  tw o  parts: first a 
ch eck  o f  th e  a ccu racy  o f  reg istra tio n  and fu sio n , and sec o n d ly  to  
exp lore d ifferen t MRI co n tra st reag en ts; in  b o th  parts th e  
p h a n tom  sp h eres w e r e  le ft  em p ty . C opper su lp h a te  (CUSO4  • 5HzO) 
so lu tio n  has b e e n  rec o m m e n d e d  (D a isn e  e t  al., 2 0 0 3 ;  M u tic e t  al., 
2 0 0 1 )  as an e ffic ie n t MRI c o n tra st reagen t; for o n e  o f  th e  tw o  
scan s th a t w e r e  m a d e  in  th e  p r e se n t stu d y , th e  p h a n tom  w a s  filled  
w ith  cop p er  su lp h a te  (CUSO4  ■ SFIgO) so lu tio n  a t 0 .2 0 5  m ol/L  u s in g  
5 0 0  g  CUSO4  • 5 H 2 O a n d  m a d e  up  to  9 .7  L, w h ile  for th e  o th er  sca n  
th e  p h a n tom  w a s  filled  w ith  9 .7  L o f  w ater .
For PET scan s, th e  p h a n to m  w a s  filled  w ith  [’®F-FDG] (h a lf-life  
109 .8  m in ) as w e r e  th e  sp h eres  (u n filled  sp h eres  b e in g  u n d e te c t­
a b le  in  scans). In th e  p r esen t stu dy, to  e n su re  sp h ere  v isu a liza tio n , 
th e  ch o sen  a ctiv ity  o f  sp h eres  (4 0  M B q /48  m l) w a s  so m e  1 50  t im e s  
h igh er  th a n  th e  backgrou nd  a ctiv ity  in  th e  [’^F-FDG] filled  
p h a n tom  (51 .36  M B q /9.7L ).
2.3. Assessing sphere diameters
M agn ifica tion  as w e l l  as w in d o w  lev e l (in  term s o f  gray lev e l)  
w e r e  ch eck ed  for ea c h  o f  th e  acq u ired  CT, MR and PET im ag es  and  
set, so  th a t p h a n to m  fea tu res w e r e  c lea r ly  d efin ed ; m ore form ally, 
th e  m ea n  s ig n al lev e l sh o u ld  b e  ^ 2 o-b, w h e r e  ctb is  th e  standard  
d ev ia tio n  on  th e  backgrou nd , e n su r in g  >95%  p rob ab ility  o f  
d etec tio n . T yp ica lly  th e  CT, MRI an d  PET w in d o w  lev e ls  w ill  n o t  
b e th e  sam e, th e  gray  lev e l for ea ch  im a g in g  m e th o d  b e in g  created  
from  d ifferen t im a g e  form ation  p r in c ip les, CT im ag es  rep resen tin g  
e lec tro n  d e n s ity  d istr ib u tio n , MR im a g e s  rep resen tin g  proton  
d e n s ity  and  PET im a g es  d e m o n stra tin g  rad io iso to p e  up take. In 
ord er to  see k  a c o n s is te n t  sy s te m  o f  m ea su rem en t, th e  c h o ic e  has  
b e e n  m a d e to  m a in ta in  th e  sa m e  w in d o w  lev e l for each  im ag in g  
m od ality . For ProSoma™, d ia m ete r  m ea su r e m e n ts  are u su a lly  
v ery  s im p le , u se  b e in g  m a d e o f  th e  ru ler a cc e sse d  v ia  th e  ‘to o l bar’ 
m e n u  or by  d ra w in g  a ROI o n  ea ch  sp h ere  for th e  m a x im u m  cross-  
sec tio n a l area; in  ProSom a™  th e  area is  g iv en  in cm^. O f n o te  is 
th a t CT, MR an d  PET im a g es  are a ll sp a tia lly  a ffected  b y  th e  partial 
v o lu m e  e ffec t (PVE), d u e  to : (i) th e  fin ite  sp atia l reso lu tio n  o f  th e  
im a g in g  sy s tem , lea d in g  to  3D  im a g e  blurring, and; (ii) th e  t is su e  
fraction  e ffect (th e  fraction  o f  a tte n u a tin g  m ed iu m  th a t o ccu p ies  a 
v ox el e le m e n t, w h ic h  w ill  r e su lt in  an  average op tica l d e n s ity  for 
th a t v ox el). T h ese  factors w il l  lea d  to  over  or u n d er e st im a tio n  o f
th e  v o lu m e  e le m e n t  v a lu e  (voxel in ten sity ). C on seq u en tly , it can  
s ig n ifica n tly  a ffec t th e  perce iv ed  s iz e  o f  an ob ject, e sp e c ia lly  in  
p o o r  sp atia l r eso lu tio n  im ag in g  sy s tem s  su ch  as SPECT an d  PET. 
M ore d e ta ile d  in form a tio n  o n  PVE can  be fou n d  in  S oret e t  al. 
(2 0 0 7 ) .
2 .4 . A ssessin g  volum e
V o lu m e e stim a tio n  o f  a sp h erica l o b jec t p ro d u ces con cern , 
d u e  to  lim ita tio n  in  s lic e  th ick n ess . For a p e r fec tly  sp h er ica l 
o b ject, th e  sp h ere  v o lu m e  can  b e  ca lcu la ted  from  th e  rad ius  
o b ta in ed  in  th e  p ro jection . If th e  sp h ere is s e g m e n te d  in to  
se c t io n s  w ith  zero  gap  sep aration , b e in g  th e  ty p ica l c lin ica l 
s itu a tio n , th e n  o n e  s im p le  w a y  o f  e s t im a tin g  th e  s e g m e n te d  
sp h ere  v o lu m e  is to  m u ltip ly  th e  c r o ss-sec tio n a l area  o f  ea ch  
sp h ere  w ith  th e  s lice  th ick n ess  (A lyafei e t  al., 1 99 9 ), b e in g  e x a c tly  
correct for  a cylin d rica l sh a p e  and  c lo se  to  th e  a ctu a l v a lu e  for  
s lic e  th ic k n e sse s  o f  le s s  th a n  1 m m . To red u ce  th e  in accu racy , and  
w ith in  th e  con stra in ts  p laced  u p on  th e  m e th o d  b y  a g iv e n  fixed  
s lice  th ick n e ss , th e  sp h ere  can  s im p ly  b e  d iv id ed  in to  a n u m b e r  o f  
s lices , e ith e r  e v e n  or odd , th e  resu ltin g  v o lu m e  o f  e a c h  s lic e  b e in g  
e stim a te d  a s
— l^ mT — 0.5(Am+i — Am)Tj (1 )
w h e r e  A ^ is  th e  cro ss-se c tio n a l area for s lice  n u m b er  m , A^+i is 
th e  c r o ss-se c tio n a l area  for  th e  ad jacen t s lic e  an d  T is  th e  s lice  
th ick n ess . C onsequ ently , th e  w h o le  sp h ere  v o lu m e  w i l l  b e  g iv en  
b y  th e  a p p ro x im a tio n
w h o le  v o lu m e  =  ' ^ V „ (2)
It is  a lso  im p o rta n t a t th is  sta ge  to  a ssess  th e  accu ra cy  o f  th e  z -  
a x is  m e a su r e m e n ts . H ere th e  filler  caps o f  th e  p h a n to m  (w ith  its  
w e ll-d e f in e d  g eo m e tr y ) w e r e  u se d  to  d e te r m in e  A z o n  CT im a g e s  
only , as th e y  d o  n o t ap p ear for o th er  im ag in g  m o d a lit ie s .
2 .5 . A ssessin g  fiducial marker registration
Fiducial m ark er reg istra tio n  p o ten tia lly  p r o v id es  th e  m o s t  
p rec ise  p o s it io n in g  in form ation ; th e  m e th o d  is  s im p ly  b a se d  on  
lo c a tin g  a n u m b er  o f  m arkers, ea c h  e x a ctly  a t  th e  s a m e  p o s it io n  
o n  ea c h  scan , regard less  o f  th e  sca n n in g  m o d a lity , th e  p o s it io n  o f  
th e se  m arkers b e in g  u n a ffec ted  by m o v e m e n t, s e n s it iv ity  and  
r e so lu tio n  o f  th e  im a g in g  sy s tem  (Chao e t  al., 2 0 0 1  ; M u tic  e t  al., 
2 0 0 1  ). T he form  o f  th e  fid u cia l m arkers w ill  o b v io u s ly  b e  d ifferen t  
for th e  d ifferen t im a g in g  m o d a litie s , b a sed  on  th e  p articu la r  
p h y sics  o f  im a g e  form ation . In th e  p resen t stu d y , a n d  in  regard  to  
v is ib ility , su c ce ssfu l u se  w a s  m a d e  o f  m eta l s e e d s  o f  2  m m  in  
d ia m ete r  as a CT re feren ce  marker, w h ile  h ig h  sp e c if ic  a c tiv ity  
[18 f](43  7 M B q /m l) so u rces  and CUSO4  - 5 H2 O s o lu t io n  (0 .2 0 5  m o l)  
w e r e  e ffe c tiv e  as m arkers in  PET an d  MR im ag es, r e sp e c tiv e ly . MRI 
an d  PET fid u cia l m arkers w e r e  p rovided  b y  s m a ll-s iz e d  c en tr ifu g e  
a m p o u le s  o f  3 cm  len g th , red u cin g  to  a p o in te d  t ip  from  its  in itia l 
0 .5  c m  d iam eter . For PET scan s, u s in g  a p ro ced u re  in it ia te d  b y  
Chao e t  al. (2 0 0 1 ) , th e  ex p er ie n c e  o f  th is  g ro u p  b e in g  th a t  th e  
p o in te d  t ip  o f  th e  a m p o u le  can  b e  d ip p ed  in to  c o n ce n tr a te d  [^^F], 
w ith  n o  s u b se q u e n t e v id e n c e  o f  con ta m in a tion .
For MRI s tu d ie s  th e  a m p o u le  w a s  filled  w ith  th e  CUSO4  • 5 H 2 O 
s o lu tio n  o f  c o n cen tra tio n  as above, it a lso  b e in g  im p o rta n t to  n o te  
th a t to  e n c o m p a ss  th e  a m p o u le s  th e  MRI b o d y  co il h a d  to  b e  u sed . 
In p r e se n t s tu d ie s , an  e ig h t-c h a n n e l b o d y  c o il w a s  u s e d  d u e  to  
rather large  s iz e  o f  th e  NEMA p h an tom .
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2.6: Relationship between contrast reagent and noise on MR images
B lurring and n o ise  lev e l are p aram eters  a sso c ia te d  w ith  PVE 
an d  SNR as d isc u sse d  earlier. T he rela tive  con tra st o f  an  im a g e  
refers to  th e  v is ib ility  o f  an o b jec t w ith in  a background, d e fin ed  as
% relative con tra st =  =  x  1 0 0  h (3)
w h e r e  Is rep resen ts  th e  m ea n  in ten sity  o f  th e  s ig n a l ( th e  sp h ere  
sig n a l in  th is  ca se ) and 7g rep resen ts  th e  m e a n  backgrou nd  
in ten sity . The so ftw a re  Im age] (N ation al In stitu te  o f  H ealth , 
B eth esd a , MD, USA) w a s  u se d  to  a ssess  th e  re la tive  c o n tr a st  o f  
CUSO4  • 5 H2 O an d  w a te r  on  MR im ag es.
to  26% in  th e  sm a lle s t  sp h ere  s iz e  ( 1 0  m m ), w h ile  v o lu m e  
e stim a tio n  b a se d  o n  s e g m e n ta tio n  u s in g  Eq. (3 )  revea led  an  
u n d erestim a tio n  o f  u p  to  48% for th e  sm a ller  sp h eres. G ood  
correla tion  (< 5% ) h as b e e n  o b ta in ed  for  th e  rest o f  th e  sp h ere  
s iz e s , as s h o w n  in  Figs. 3  and 4 . T he accu racy  o f  m ea su rem en ts  on  
th e  z -a x is  w a s  w ith in  0 .3 3 + 0 .0 5  m m  o f  th e  e x p ec te d  h e ig h t o f  th e  
filler caps.
3 .3. Contrast reagent and noise level in MR images
CUSO4  • 5 H2 O s o lu tio n  w a s  o b serv ed  to  p rod uce con sid era b ly  
in crea sed  im a g e  n o ise , b y  u p  to  2 0 %, w h e n  com p ared  w ith  im ag es  
o b ta in ed  u s in g  w a ter , particu larly  in  regard to  th e  larger sp h eres.
3 .  R e su lts
3.1. Assessing target diameter
C hanges in w in d o w  lev e l w e r e  fou n d  to  s ig n ifican tly  a ffe c t all 
o f  th e  CT, MR and PET im ag es, p ro d u cin g  d iscrep an cies  o f  u p  to  
± 2  m m  com p ared  to  th e  a ctu a l d iam eter . As an  exa m p le , Fig. 2  
i llu stra tes  th e  e ffe c t  o f  w in d o w  lev e l o n  PET im a g es. Each im a g in g  
m o d a lity  prod uced  d ifferen t re sp o n se  in  te r m s  o f  o b served  
d ia m ete r  va lu es, w ith  CT im a g es  p ro v id in g  a p er fec t m a tch  
for sp h ere  d iam eters  in  th e  range 1 7 -3 7  m m , b u t p rod u cin g  
a n  u n d e r e s tim a tio n  o f  up to  1 0 % for th e  sm a lle s t  sp h eres  ( 1 0  and  
13 m m ). For MR im ag es  b o th  ty p e s  o f  co n tra st rea g en t  
(C U SO 4 - 5 H2 O and w a ter ) p rov id ed  c lo se ly  s im ilar  d ia m eter  
m e a su r e m e n ts  com p ared  to  a ctu a l v a lu e s  (to  ~ 1  m m  or b etter). 
O f n o te  is  th a t d ifferen t w in d o w  le v e ls  w e r e  c h o se n  for  th e  tw o  
ty p e s  o f  con tra st reagent, as n o ted  in  Table 1, th e  ch o ic e  o f  lev e l 
b e in g  m a d e  to  o b ta in  th e  c le a r e st  p o ss ib le  e d g e  to  ea ch  ob ject. 
C o n v erse ly  for PET im ag es, th e se  s h o w e d  a c o n sis te n t over­
e s t im a te  in  sp h ere d iam eter, p articu larly  for th e  larger sp h eres  
( 2 8 - 3 7  m m ), w h e r e  a d ifferen ce  o f  u p  to  4 .3  ± 0 .0 5  m m  w a s  
o b served . It is o f  n o te  th a t th e  PET im a g es  w e r e  ty p ica lly  h igh ly  
blurred  a t th e  e d g es , cu rren t o b serv a tio n  s h o w in g  b lurrin g  to  
c o n tr ib u te  as m u ch  as 2 - 3  m m  to  th e  d ia m ete r  o f  a ll sp h eres  
larger th a n  13 m m .
T able 1 sh o w s  th e  typ ica l w in d o w  le v e l u sed , in  term s o f  
m in im u m , m a x im u m  and cen tra l v a lu e  for  ea ch  o f  th e  m o d a litie s  
CT, MR and PET.
3 .2 . Volume evaluation
For CT im ag es, sp h ere v o lu m e  e stim a tio n  b a sed  u p o n  u se  o f  
th e  stand ard  re la tio n  (Eq. (1 ))  rev ea led  an  u n d e r e s tim a tio n  o f  up
3.4. Assessing registration using fiducial markers
T he accu racy  o f  th e  fou r fid u cia l m arkers, a sse s se d  in  term s o f  
to ta l con ju g a te  d e v ia tio n  and  rep orted  in  te r m s  o f  th e  m ea n  
v a lu e ± S D  for n =  3 , w a s  fou n d  to  b e  3 .0  ± 0 .7  m m  (x -a x is),
0 .9  ± 0 .6  m m  (y -a x is)  an d  2 .0 ± 0 .3  m m  (z-ax is).
3 .5 . Assessing the different registration methods provided by the 
software Prosoma™ ■
G en erally  th e  h ig h e s t  accu racy  fu s io n  w a s  s e e n  for CT^^/CT^ 
im ag in g  rega rd less  o f  th e  ty p e  o f  reg istra tio n  (m a n u a l, s e m i­
a u tom a tic , a u to m a tic ), h o w ever , CT^^/MRI'^ revea led  up  to
Effect of window level (WL) on spheres diameter on 
PET images
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Fig. 2 . Effect o f  w indow  level on spheres diam eter using ProSoma.
Table 1
Diam eter correlation o f CT, water MR, copper sulfate MR and PET im ages, all dim ensions being measured in m m
Actual diameter CT
W indow level 
min =  -5 7 7  HU, 
max — 194 HU, 
centre =  191 HU. 
m ean±SD , n =  3
MRI (water) 
W indow level 
min =  8, 
max =  49, 
centre =  29. 
m ean±SD , n =  3
MRI (copper) 
W indow  level 
m in = l ,  
max =  59, 
centre =  30. 
m ean IS O , n =  3
PET
W indow  level 
m in =  10, 
m ax =  68, 
centre =  39. 
m ean 1 SO, n =  3
10 9 .0 + 0 .0 10.0+ 0 .0 lO.OlO.O ll.O iO .O
13 12 .5+ 0 .6 1 3 3 1 0 .6 13 .0 1 0 .0 1 4 .7 1 1 .2
17 17.0+0.0 17.010.0 17 .310 .6  ■ 1 9 .0 1 0 .0
22 22 .0 + 0 .0 2 2 .0 1 0 .0 2 3 .0 1 1 .0 2 4 .3 1 1 .5
28 2 8 .0 + 0 .0 2 8 .0 1 0 .0 2 9 .3 1 0 .6 3 1 3 1 2 3
37 37 .0+ 0 .0 37 .310 .6 3 8 .3 1 0 .6 4 1 .3 1 0 .6
The uncertainties are the SO o f the dispersion in the data.
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0.5  ± 0 .0 5  m m  d ifferen ce  o n  fu sed  im a g es  reg istered  m a n u a lly  and  
u p  to  1 .5 + 0 .0 5  m m  d ifferen ce  in  th e  a u to m a tic  reg istra tio n  m o d e, 
in  particu lar for  th e  sm a ll sp h eres  <  13 m m . M an ual reg istra tio n  
for CT'^^/PET sh o w e d  g o o d  fu s io n  resp o n se  ( ~ 1  m m ) for  th e  large  
sp h eres (Table 2 ), w h ile  for sm a ll sp h eres  <  13 m m  ev a lu a tio n  w a s  
n o t p o ss ib le  d u e  to  b lurring . S im ilarly  for th e  o th er  ty p es  o f  
registration , CT'^^/PET d em o n stra te d  u p  to  1.0 ± 0 .0 5  m m  differ­
e n c e  on  th e  fu sed  im a g es  w h e n  com p ared  to  th e  actu a l sp h ere  
diam eter, as s h o w n  in  T able 2 . M arker-based  reg istra tio n  in  
ProSoma™  has b e e n  p r e se n te d  in  term s o f  th e  ce n te r  o f  gravity  o f  
m arkers, o b ta in ed  as th e  w e ig h te d  m e a n  o f  m arker p o in ts . T he  
accuracy  o f  reg istra tio n  h as b e e n  d e term in ed  u s in g  th e  to ta l 
con ju ga te  d iscrep an cy  o f  th e  m arker po in ts; a rep resen ta tiv e  
sa m p le  o f  resu lts  for th e  p r e se n t s itu a tio n  o f  a n a lysis  is  illu stra ted  
in  Table 3 .
B ased on  p resen t fin d in g s  for p h a n to m s (d e v o id  o f  artifacts  
su ch  as th o se  fou n d  in  c lin ica l s itu a tio n s), b ou n d ary  b o xes  and  
rota tional tran sform ation  w e r e  fou n d  u n h elp fu l. In d eed , in  regard  
to  rotation , th is  w a s  fou n d  to  p rod u ce in crea sed  d iscrepan cy , 
b e in g  tru e  for a ll o f  th e  acq u ired  CT, MR an d  PET im a g e s . L ikew ise  
in  regard to  b o u n d ary  b o xes , th e  p articu lar c h o ic e  o f  le v e l o f  
p rec is io n  rev ea led  n o  s ig n ific a n t con tr ib u tion  to  fu s io n . C om puta­
tio n a l tim in g  in crea ses  w ith  th e  lev e l o f  p rec is io n  required, 
in crea sin g  from  a ty p ica l reg istra tio n  t im e  o f  f e w  sec o n d s  up  to  
fe w  m in u tes .
4 .  D is c u ss io n
In m ak in g  any  m e a su r e m e n ts  u s in g  ProSoma™, it is .im p orta n t  
for c o n sis te n c y  th a t th e s e  b e  referred  to  a particu lar w in d o w  lev e l,  
sp ecified  in  term s o f  m in im u m , m a x im u m  an d  cen tra l va lu es.  
G iven th a t w in d o w  le v e l  h a s a p o w erfu l e ffe c t  u p o n  v isu a liz a tio n  
o f  an  o b jec t an d  its  ed g es , th is  sh o u ld  b e  d e a lt w ith  carefu lly  w h e n  
e x a m in in g  o b jects  in  a n y  im a g in g  m o d a lity . T he PVE is a lso  an  
im p o rta n t factor in  a ffec tin g  o b ject s ize , th e  p o or  spatia l  
reso lu tio n  o f  th e  im a g in g  sy s te m  in d u c in g  3 0  im a g e  b lurring  
d u e  to  th e  sp illo ver  b e tw e e n  reg ion s; c o n se q u e n tly  o b ject s iz e s  
w ill app ear larger. T his ca n  c a u se  con sid era b le  p ro b lem s w h e n  
p oor sp atia l r e so lu tio n  s y s te m s  su ch  as PET are u se d  to  a ss is t  in  
tr e a tm e n t p lann in g . A s su ch , PVE n e e d s  to  b e  eva lu ated  and  
a cco u n ted  for before any  PET a p p lica tion  is in v o lv ed  in  clin ica l
Table 2
The effect o f different registration m ethods on spheres diameter, all measurem ents 
being in mm
Fusion type Actual Primary data Secondary Fusion
diameter data data
Manual 28 Cr'^ =  28.0 PET*  ^=  31.3 29.0
Marker 37 CT'^ =  37.0 PET^ =  41.3 38.5
Automatic 37 CT'^ =  37.0 PET^ =  41.3 38.0
Manual 37 CT'^  =  37.0 CT'  ^=  37.0 37.0
Volume 9 cr '^  =  9.0 M R r =  10.0 10.0
Automatic 10 cr'^^ =  9.0 M R r =  10.0 8.5
d e c is io n s  regarding  a target. G enera lly  PVE has b e e n  id en tified  as 
a m ajor sou rce  o f  b ias in  PET brain  im a g in g , th erefore , m o st o f  th e  
w o rk  in d e v e lo p in g  PVE correction  h a s  b e e n  p erform ed  for  
PET brain  im ag es. W h ile  free so ftw a r e  ‘PVEOut’ (N eu ro b io lo g y  
R esearch U nit, C openhagen , D en m ark) is a va ilab le  for research  
p u rp o ses, no  g en era lly  a ccep ted  so lu t io n  to  th e  c lin ica l PVE 
p rob lem  h a s y e t  b e e n  defin ed .
From  p r e se n t ob serva tio n s, o b jec ts  o f  ^ 1 0  m m  d ia m eter  are  
d ifficu lt to  eva lu ate  in  PET im ag in g , b e in g  d irec tly  re la ted  to  th e  
p rob lem  o f  PVE. It h a s b e e n  su g g e ste d  (S o ret e t  al., 2 0 0 7 )  th a t th is  
p rob lem  ty p ica lly  occurs w h e n  th e  s iz e  o f  th e  o b jec t  is le ss  th a n  
th ree  t im e s  th e  v a lu e  o f  th e  FW HM , sm a ll tu m o u rs  a p p earin g  
larger, b u t le s s  a gg ressive  th a n  th a t a ctu a lly  p r e sen tin g . S im ilarly
Comparison between volume based calculation and 
segmentation on CT images
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— — -c a lc u la tio n  
— A—  seg m en ta tio n
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Fig. 3 . Comparison betw een volum e-based calculation and segm entation using  
ProSoma.
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Fig. 4 . Volume correlation betw een CT, MRP®’’'’®'', MR1'^ “^ ‘' and PET im ages using  
ProSoma.
Table 3
Marker-based registration in terms o f centre o f gravity, accuracy o f registration (total conjugate) and accuracy o f  fusion
Data set Centre of gravity Total conjugate Actual diam eter A Fusion diam eter F Fusion accuracy =  A/
(in mm) (in  m m) FxlO O  (%) .
X y z X y z
q -RTjo-LS 0.2 0.3 0.1 1.7 0.7 1.2 37.0 37.0 100
cr'^ /^MRr 0.2 0.0 0 3 0.8 0.0 1.3 10.0 10.5 95
CjRT/pet 0.2 0.4 0 3 1.4 0.9 1.8 37.0 38.5 96
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CT im ag es  revea l u n d er e st im a tio n  o f  s iz e  for o b jects  ^  10 m m  in  
diam eter, b e in g  d u e  to  th e  p o or  s e n s it iv ity  o f  th e  CT m o d a lity  in  
d istin g u ish in g  so ft  t is s u e  (o b jec ts  filled  w ith  air).
V o lu m e e stim a tio n  b a sed  se g m e n ta t io n  h as revea led  an  
im p r o v em en t in  resu lts, e sp ec ia lly  for  o b jec t  s iz e s  greater th a n  
17 m m . H ow ever, u n cer ta in ty  in crea ses  for sm a ll o b jects  d u e  to  
th e  re la tiv e ly  th ick  s lice s  from  w h ic h  recon stru cted  im ag es  are  
ob ta in ed . V o lu m e e stim a tio n  using  Eq. (2 )  revea led  not, o n ly  th e  
m o st  su p er io r  a p p rox im ation  o f  sp h e r e  v o lu m e  in 3D , b u t  
w a s  a lso  s h o w n  to  b e  va lid  for rod s an d  c u b e-lik e  featu res  
(w ith  Vn =  AmT in  Eq. (2 )). Im proved  o b jec t  g eo m e tr y  d e fin itio n  
requires recon stru ctio n s  from  sm all s lic e  th ick n e sse s  o f  1  m m  or  
less , th e  arc o f  ea ch  sp h er ica lly  sh a p ed  se g m e n t  b e c o m in g  lin ear  
lik e  w ith  red u cin g  th ick n ess .
The accuracy o f  th e  fiducial b ased  registration  m eth od  w a s  
fou n d  to  b e  poor ( >  1  m m ); an  im proved  resu lt is to  b e  ex p ected  for  
finer-scale MRI fiducial m arkers in  p lace  o f  th e  p resen t u se  o f  
am p ou les , for exa m p le  H su e t  al. (2 0 0 7 )  h a ve  u sed  2  m m  long, 1 m m  
internal d iam eter  cylinders, ap p ly in g  th e se  to  b o th  MRI and PET.
In p r e se n t p h a n to m  s tu d ies , th e  u s e  o f  b ou n d ary  b o xes has  
b e e n  sh o w n  to  h ave n o  s ig n ifica n t e ffe c t  o n  fu s io n  accuracy. 
C onversely , in  c lin ica l s tu d ie s  it has b e e n  s h o w n  th a t in  certa in  
c a se s  th e  b ou n d ary  b o x  has a llo w ed  tr e a tm e n t ta b le  artifacts to  b e  
avoided .
In regard to  th e  lev e l o f  p rec is io n  se le c te d , in  th e  p r e se n t  
p h a n tom  s tu d ie s , th e  particu lar c h o ic e  h as b e e n  fou n d  to  have  
n e g lig ib le  e ffe c t  on  th e  tran sform ed  data.
In th e  p r e se n t p h a n tom  stu d ie s , da ta  tran sform ation  b y  m e a n s  
o f  rota tion  w a s  fou n d  u n h elp fu l; as su ch , rota tion  w a s  n o t m a d e  
u se  o f  in  th e  m a in  b o d y  o f  e x p er im e n ts . H ow ever, in  c lin ica l 
s tu d ies  tran sform ation  o f  d ata  th rou gh  ro ta tio n  w o u ld  b e  required  
in  a cco m m o d a tin g  e v e n  th e  sm a lle s t  o f  p a tie n t m o v em en t.
In su m m ary , for p h a n to m -b a sed  s tu d ie s  fo cu sin g  o n  th e  
in h eren t cap ab ilities  o f  th e  reg istra tio n  and fu s io n  softw are, it 
has b een  o b served  th a t m anu a l, a u tom a tic , m arker and  v o lu m e  
b a se  reg istra tio n  are a ll reliab le. T he m a in  p ro b lem  h as b e e n  th e  
c h o ic e  o f  fid u cia l marker, in  particular, in  regard to  th e  s iz e  o f  
th e se . T he ce n te r  o f  g rav ity  so ftw a r e -b a se d  sy s te m  h a s b e e n  fou n d  
to  b e  an e x c e lle n t  reg istra tio n  and fu s io n  too l. In c lin ica l, p a tie n t-  
b a sed  s tu d ie s  our in itia l ex p er ie n c e  h a s  b e e n  th a t a u to m a tic  
reg istra tio n  o ffers a g o o d  ch o ice , fo llo w e d  by  m an u a l a d ju stm en t  
o n e  m illim e te r  o f  tr a n sfo r m a tio n . a t a t im e  or o n e  d eg ree  o f  
rota tion  a t a t im e . T here is a c lear n e e d  for  c o m p reh en siv e  c lin ica l 
s tu d ies  in  term s o f  reg istra tio n  d e fin ition ; accu rate  reg istra tion  
provides im p rov ed  fu sio n . F id u cia l-b ased  reg istra tion  sh ou ld  b e  
e x c e lle n t in  p ro v id in g  accu rate  fu sio n , m a k in g  u se  o f  for in sta n ce  
b o n y  lan dm ark s or o th er  c o m m o n  a n a to m ica l fea tu res su ch  as th e  
v en tr ic le s  o f  th e  brain, u n a ffected  as th e  la tter  are by  b reath in g  
m o v e m e n ts .
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Abstract
There is much interest in positron emission tomography (PET) for 
measurements of regional tracer concentration in hypoxic tumour-bearing 
tissue, focusing on the need for accurate radiotherapy treatment planning. 
Generally, relevant data are taken over multiple time frames in the form of 
tissue activity curves (TACs), thus providing an indication of vasculature 
structure and geometry. This is a potential key in providing information on 
cellular perfusion and limited diffusion. A number of theoretical studies have 
attempted to describe tracer uptake in tissue cells in an effort to understand 
such complicated behaviour of cellular uptake and the mechanism of washout. 
More recently, a novel computerized reaction diffusion equation method was 
developed by Kelly and Brady (2006 A model to simulate tumour oxygenation 
and dynamic [18FJ-FMIS0 PET data Phys. Med. Biol. 51 5859-73), where 
they managed to simulate the realistic dynamic TACs of ^^F-FMISO. The 
model was developed over a multi-step process. Here we present a refinement 
to the work of Kelly and Brady, such that the model allows simulation of a 
realistic tissue activity curve (TAG) of any hypoxia selective PET tracer, in a 
single step process. In this work we show particular interest in simulating the 
TAG of perhaps the most promising hypoxia selective tracer, ^^Gu-ATSM. In 
addition, we demonstrate its potential role in tumour sub-volume delineation 
for radiotherapy treatment planning. Simulation results have demonstrated the 
significant high contrast of imaging using ATSM, with a tumour to blood ratio 
ranging from 2.24 to 4.1.
(Some figures in this article are in colour only in the electronic version)
 ^ Author to whom any correspondence should be addressed.
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1. Introduction
Head and neck squamous cell carcinomas account for approximately 5% of all malignant 
tumours worldwide (Rothschild et al 2007) and represent 93% of all oral cavity tumours 
(Goshen et al 2006). Early-stage disease can be cured with either radiation or surgery; 
however, tumour control for locally advanced head and neck squamous cell carcinoma has 
been less than satisfactory with an estimation of recurrence rate of 30% (Goshen et al 2006). 
This is in part due to tumour hypoxia (Chao et al 2001). Thus, determination of hypoxic 
extent within tumour vasculature is important in monitoring the response of therapy (Vavere 
and Lewis 2007), staging of disease that contributes directly to treatment management (Fukui 
et al 2003) and delineation of tumour sub-volumes, which represents the detected hypoxic 
cells within the gross target volume (/zGTV) for treatment planning (Lehtio et al 2001).
Improvements in imaging technology have accelerated the development of radiotherapy 
techniques, for instance intensity modulated radiotherapy (IMRT), gated radiotherapy, 
tomotherapy and image-guided radiotherapy (IGRT) (Kim and Sue 2006). Such techniques 
provide the means for radiation dose delivery to achieve the desired complex dose distributions 
of treatment (Grégoire et al 2007). Imaging is therefore the cornerstone of the entire 
radiotherapy process, from enabling planning of the desired treatment to verification of dose 
delivery. The unique feature of the positron emission tomography (PET) imaging modality 
allows measurements of regional tracer concentration in tissue and different body organs, 
quantitatively and non-invasively (Huang e ta l  1998). The objective of such procedures is, in 
general, to find a set of features which have both inter- and intra-variance in hypoxic tumour- 
bearing tissue. The temporal profile of activity provides information about the kinetics of tracer 
concentration in all of the blood and tissue. In addition, it provides information concerning the 
degree of oxygen perfusion, vascular geometry and hypoxia fraction (Kelly and Brady 2006). 
The challenge for hypoxia imaging is to demonstrate a phenomenon that occurs at a much 
smaller scale than that achieved with PET imaging (typically of spatial resolution ^5 mm). 
Therefore, in order to understand such a complicated phenomenon a number of theoretical 
studies have attempted to describe tracer uptake in tissue cells; to-date the conventional 
compartment model of Sokoloff et al (1977) has been considered the standard technique.
More recently, a novel computerized reaction diffusion method was developed by Kelly 
and Brady (2006) to simulate the realistic dynamic TAG of ^ ^F-FMISO, with representation of 
vasculature architecture and tracer kinetics. In a previous work (Dalah et al 2009 submitted) we 
refined the reaction diffusion model of Kelly and Brady (2006) that was developed to simulate 
oxygen heterogeneity in a 2D tumour-bearing vasculature. We now represent a refinement to 
the binding and free tracer formula in the Kelly and Brady model (2006). With such refinement 
the model is being developed to simulate tissue activity curves (TAGs) in a single step rather 
than the multi-step process of Kelly and Brady. Furthermore, we attempt to demonstrate the 
potential use of different PET hypoxic sensitive tracers in radiation therapy treatment planning 
as an indicator of tumour hypoxic regions. With a particular interest towards simulating the 
realistic dynamic TAGs of ^Gu-ATSM, comparison is made with ^^F-FMISO. All physical 
and biological baseline parameters related to both tracers which have been applied in this 
study were determined from the current literature, see table 1.
1.1. The physical and chemical characteristics of^Cu-ATSM and ^^F-FMISO
In recent decades, investigations into alternative, non-invasive imaging methods for measuring 
the level of oxygen tension within tumour regions have been pursued by numerous researchers. 
The use of PET in conjunction with radio-labelled molecules that undergo chemical changes
Simulation of tissue activity curves of ®'*Cu-ATSM for sub-target volume delineation in radiotherapy 683
Table 1. Baseline parameters applied in the model, together with the main physical and biochemical 
properties o f ATSM and FMISO.
Property ®^Cu-ATSM '^F-FMISO
M olecular w eigh t 
(M W )
3 22  g  m ol" ' (Basken and Green 
2 00 9)
188 .15  g  m o l“ ' calculated
Partition coefficient
( /o
2 .2 0  (Basken and Green 2009) 0 .43  (K elly and Brady 2006)
Redox potential T hiosem icarbazone group range 
from  —5 70  to —5 90  m V  (Vavere 
and L ew is 2007)
N itroim idazole group range from  
—380  to —3 9 0  m V  (Barthel et al 
2 00 4)
D iffusion coefficient  
(calculated)
5 .05  X 10“'' mm^ s“ ' (Berk et al 
1993)
6 .07  X 10“ '' mm^ s“ * (Berk et al 
1993)
Thickness o f  b lood  
vessel m em brane (x)
0 .2 -1  txm (M arieb 2004) 0 .2 -1  ixm  (M arieb 2004)
Perm eability
calculated
1 .1 2 -5 .6 1  m m  s“ ' (Cussler 1984, 
Laidler 1978)
0 .2 6 -1 .3 1  m m  s“ ' (Cussler 1984, 
Laidler 1978)
B lood  vesse l radius (r) 8 -1 0  fxm (M arieb 2004) 8 -1 0  ixm (M arieb 2004)
Surface area to volum e  
ratio (S V)
2 0 0 -2 5 0  m m “ ' calculated 2 0 0 -2 5 0  m m “ ' calculated
Surface area to volum e  
ratio (5  V)
1 7 0 -2 8 5  m m “ ' (Yuan e ta l  1995) 1 7 0 -2 8 5  m m “ ' (Yuan e ta l  1995)
Rate o f  tracer binding
( W
0.0 00 3  s“ ' (L ew is ef o f 1998, 
M cQ uade et al 2005)
0 .0001  s“ ' (K elly  and Brady 2006)
Physical h a lf-life 12.7 h  (L ew is et al  2001 ) 1.83 h  (Cutler e f u / 1 999)
D ecay m ethod /3+(19%), /3“ (40% ) and EC(41% ) 
(Cutler et al 1999)
(97% ) and EC(3% ) (Cutler et al 
1999)
M axim um 5 7 4  keV  (L ew is et al 2 00 1) N on e
M axim um 6 53  keV  (L ew is et al 2001) 6 35  k eV  (Cutler gf of 1999)
Gamma energy 1345 keV  (0.47% ) (M cCarthy et al 
1999, Obata et al 2005)
N on e
inside tumour as a result of the presence or absence of oxygen has led to a number of promising 
PET reagents. Of these the nitroimidazole group are the most widely studied in vivo PET 
reagent, in particular [^^FJfluoromisonidazole or *^F-FMISO. Although many studies have 
demonstrated that an in vivo assessment of tumour hypoxia is possible with ^^F-FMISO, 
the unfavourable imaging characteristics of this compound have limited its use in clinical 
oncology. While ^^F-FMISO has shown a direct effect with respect to tumour oxygenation, 
it suffers the limitation of low contrast ratio between hypoxic tumours and normal tissues, 
with tumour to blood ratio of just above 1.2 (Rasey et al 2000, Vavere and Lewis 2007). In 
addition, the slow cellular washout of the tracer requires a delay of approximately 2 h after 
the injection to permit clearance from normal background tissues.
Possibly the most promising hypoxic reagent is the copper(II)-diacetyl-bis(N4- 
methylthiosemicarbazone), or ^Cu-ATSM, which was developed as an alternative to '®F- 
FMISO. '^^Cu-ATSM is a neutral lipophilic molecule of low molecular weight, high membrane
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Figure 1. Retention and washout mechanism of ATSM from cellular space in tumour vasculature.
permeability and low redox potential (Aft et al 2003, Fujibayashi et al 1997). As a result, 
^''Cu-ATSM shows a rapid delineation of tumour hypoxia, less than 1 h from injection and. a 
reasonably high tumour to blood ratio )§>2 (Dence et al 2008). Table 1 illustrates in detail the 
physical and biochemical properties of ^ ‘'Cu-ATSM and '^F-FMISO.
1.2. Redox mechanism of^^Cu-ATSM
Based on literature reports on cellular Cu metabolism, the initial cellular accumulation of Cu- 
ATSM is driven by filtration across the membrane followed by the reduction of Cu(II)-ATSM 
to Cu(I)-ATSM and trapping of the latter complex in the cellular space. A schematic diagram 
demonstrating this process is illustrated in figure 1. When the unstable complex Cu(II)-ATSM 
reaches the intracellular space, it dissociates into Cu(II)-ATSM and Cu(I)-ATSM, followed 
by retention or washout based on the oxygen tension level of cellular space. In regions 
displaying oxygen deficiency the resultant Cu(I)-ATSM will become bound to intracellular 
macromolecules; in other words it will be trapped. Conversely, in regions with a sufficient level 
of oxygen, Cu(I)-ATSM will be oxidized back to Cu(II)-ATSM and be washed out through 
the blood stream. This explains the hypoxia sensitivity of ATSM (Aft et al 2003, Vavere and 
Lewis 2007, Wood et al 2008).
2. The reaction diffusion model
In principle, data taken over multiple time points in the form of tissue activity curves (TACs) 
provide an indication of the presence of hypoxia. The shape of the curve provides information 
on the degree of perfusion and vascularization (Kelly and Brady 2006). Determining the 
relationship between the TAG shape and the underlying tumour physiology is of fundamental 
importance. Standard techniques such as conventional compartment models are limited. In 
these a TAG is generated as the tracer moves through a set of states (or compartments) according 
to some kinetic rate constants. The spatial factor in such models is not considered and the 
distribution of the diffusible tracer is likely to be homogeneous across the vasculature, which 
is far from reality. Thus, compartmental models are an oversimplification of the real kinetics 
within an in vivo environment, where the structure and geometry of tumour vasculature is the 
key factor behind tracer retention and heterogeneity. In a previous work we simulated the 
heterogeneity of oxygen partial pressure in a more realistic sophisticated vascular architecture; 
the ability to solve the governing equations was made possible using numerical approaches
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that enable relationships between tissue diffusivity, tissue metabolism and anatomical structure 
of blood vessels. This allows oxygen gradients to be characterized with encouraging results, 
which have been validated against realistic values taken from the existing literature (Dalah 
et al 2009 submitted). In this work we simulate the realistic dynamic TAG of '^'Gu-ATSM, 
with representation of the complexity of vascular architecture, tracer diffusivity, tracer binding 
rate, transvascular permeability and blood vessel densities. Thus, the reaction diffusion model 
that simulates ^^Gu-ATSM heterogeneity in 2D can be described as
— = I)rrV2Tr-«:„„Tr+:^(Trpte™-Tr,te„e)«. (1)
where Tr is the concentration of tracer, ^Gu-ATSM, in tissue cells in juGi/ml, Djr is the 
diffusion coefficient of tracer in mm^ kon is the binding rate of ATSM in s“ \  Trpiasma is 
the concentration of tracer in the plasma in pC i ml“ \  is the permeability of the vessel to 
the tracer in mm s” \  S /V  is the surface area to blood vessel volume in mm“ * and R is the 
proportion of vessels covering the vasculature.
2.1. Vascular architectures
In this work the vascular architecture was defined in 2D with.vessels passing perpendicular 
through the cross-sectional plane, with the number of vessels occupying the 2D cross-sectional 
plane known as the micro-vessel density and given in terms of vessels mm“ .^ The location 
of blood vessels in the plane (i.e. the vascular map) is described by the function R(x). Blood 
vessels are randomly distributed in the imaging plane on a fixed, equally spaced Gartesian 
mesh known as the vascular mesh. The grid points on the vascular mesh will be designated 
so that where there is a vessel the value on the mesh will be ‘1’ and where there is no vessel 
the value will be zero, using a probability mass function Rij- which is defined based on the 
individual probability, p. Thus, the grid point X ij =  1 if the probability of {R ij =  1} =  /?, or 
Xi j  =  0 if the probability of [R ij =  0} =  1 — p, where p  is defined as
MVDs X Trr^
P -  M ’ '  '
where MVD is the micro-vessel density (number of vessels per unit area or volume), r is the 
capillary (blood vessel) radius and M  is the space area of the simulated vasculature, in this 
case 4 mm^. The vascular map, R(x), is then defined as
N N 
i=0 j=0
where x,- are the random locations of A blood vessels in the vasculature and 8 is the Dirac delta 
function. Hence, R(x) will be zero everywhere except at the points x, where R ij =  1. For a 
good numerical approximation of R(x), a sum of Gaussian functions is applied:
R W  =  è f : R , , . e x p ( - k ^ ) ,  (4)
i=0 j=0 ^ /
where 2a^ is the width of the Gaussian and gives the radius of the blood vessel — loP-) and 
X;j are the random locations of the capillaries (noting that they do not have to be normally 
distributed). In this work, a  is defined as
(5)
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Figure 2. A schematic diagram showing the variation in blood vessel densities at different tumour 
regions, with well-perfused areas generally at the tumour edge.
where Lx is the length of the domain, in this case 2 mm ,^ % is the number of grid points, in this 
case 25, and is a constant that is ^2, in this case 6. With such an arrangement one can vary 
this quantity, jS, (e.g. 4, 7 and 8) and come up with different scenarios, aiming to understand 
the influence of tumour vasculature geometry on oxygen and tracer heterogeneity. However, 
typical inter-vessel distances associated with normal vasculature usually range from 40 to 
100 fim  (Beckman et al 2007).
3. Methods
3.1. Simulation conditions
In this work we consider a 2D sectional tumour to appear as in figure 2, where numbers 
of micro-vessels per unit area or volume in tumour vary according to their location. All 
simulations have been coded in 2D, for a vasculature size of 4 mm^, using Matlab 2007b and 
finite difference methods. In this work two meshes were created, one to denote the random 
distribution of blood vessels while the other expresses tissue cells. The choice is made to 
account for the considerable size difference of blood vessel diameter to tissue cells. The 
scale intervals of the blood vessel mesh were made so that x  and y =  10 /zm, typical 
blood vessel radius, and mesh size of (50 x 50), whereas, the scale intervals of the cellular 
mesh were made so that x and y ~  7 fim, a typical tissue cell diameter, and mesh size of 
(300 X  300). ,
3.2. Data assessment
A comparative analysis of ^Cu-ATSM intra-tumour distribution and cellular uptake is 
discussed by demonstrating the different tumour-bearing regions that can be seen in a simulated
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system of vasculature, based on that observed in a typical case (Obata et al 2003, Tanaka et al 
2006, Oh et al 2009). The net percentage (% net) uptake of ^ ‘'Cu-ATSM is defined as
^  X  100, (6)
where /mean is the mean uptake value in the simulated space and Tr is the concentration of 
tracer in plasma.
Tissue activity curves (TACs) of '^^Cu-ATSM are generated using patient plasma input 
functions; simulation findings are validated using a key parameter, namely the typical tumour 
to blood ratio of "^^Cu-ATSM. Additionally, a comparison of TACs for ATSM and FMISO 
using arbitrary plasma input functions is demonstrated, with the aim of highlighting the high 
local contrast provided by ATSM.
4. Results
4.1. Baseline values
All physical and biological baseline parameters applied in this work were determined from the 
current literature, with some parameters calculated or estimated from these data. The diffusion 
of simple FMISO into intracellular space in tumour vascular was investigated by Cowan 
et al (1996). The group estimated the diffusion coefficient of FMISO using an in vitro model 
for the extravascular compartment of tumours. The model was built to study the flux kinetics 
of FMISO through a multi-cellular membrane (MMs) of the Chinese Hamster V79 cell line. 
The FMISO diffusion coefficient through MMs was determined to be of the order 5.5 x 
10“  ^ mm^ s“ \  which was approximately 13 times lower than in the culture medium 
(7.15 X  10“'' mm^ s“ )^. This study was subjected to FMISO concentration in mM. However, 
an earlier study by Berk e t a l ( \ 993) was carried out to study protein diffusivity as a function 
of substance molecular weight; the results were fitted by
D =  3 6 X  10-3 (M W )-°^\ (7)
where D is the diffusion coefficient in mm^ s“  ^and MW is the molecular weight. The fitting 
was obtained using protein substances of molecular weight ranging from 14 to 600 kDa. A 
simple validation method was made to check the validity of the fitting in order to justify its 
use to estimate the diffusivity of ATSM and FMISO. By comparing the calculated oxygen 
diffusivity (DoJ, using equation (7), to values that are well established in the literature, as 
in for example (Fischkoff and Vanderkool 1975, Salathe and Kolkka 1986). The calculated 
oxygen diffusivity has been found to be Dq2 =  1.4 x 10“  ^mm^ s“  ^while the literature value 
of Dq2 is given as 1.5 x 10“  ^mm^ s“ \  a difference from the calculated oxygen diffusivity 
of <7%. We have also estimated the diffusion coefficient for the transportation of ATSM 
and FMISO in the interstitial space into the tissue cells using the same fitting relationship of 
equation (7). This should allow for another simple validation method, where the calculated 
diffusion coefficient of FMISO using equation (7) can be compared to the findings of Cowan 
and his group (1996). This produces a discrepancy of <15% between the value of 7.15 x 
10“'^  mm^ s“* diffusivity for FMISO in the cellular medium and the value of 6.07 x 
10“'' mm^ s“ ' calculated using equation (11). With such analysis, we suggest the margin 
of discrepancy in estimation of the ATSM diffusion coefficient to be encouraging.
Similarly, the transvascular permeability coefficient (/*„) for ATSM and FMISO was 
calculated as (Cussler 1984, Laidler 1978)
(8)
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Figure 3. Simulation o f cellular uptake o f ®''Cu-ATSM in a 2D vasculature of size 4 mm^ 
represented in the left, with high stained cells appearing in red (on line version); typical BrdU 
immunohistochemical staining image in the right taken from Oh et al (2009), with proliferating 
cells appearing in brown (on line version). Reprinted from Oh et al (2009, p 422), with permission 
from Elsevier.
where Djr is the diffusivity of the tracer in the interstitial space in (mm^ s“ '), x is the thickness 
of blood vessel membrane measured in /xm and is the partition coefficient of the tracer. 
The binding rate of ATSM was estimated from Lewis et al (1998), who studied ATSM uptake 
at different oxygen concentration levels in the mammary cell line (EMT6). Their results were 
validated by the findings of McQuade et al (2005). The surface area to volume ratio can be 
calculated as
2n rL
(9)
V nr'^L r
where r is the blood vessel radius. Real values are also presented for comparison, see table 1 
for the complete set of baseline values.
4.2. The heterogeneous distribution o f  ^ ^Cu-ATSM
The high spatial resolution of 7 ixm provided by the system of vasculature setup in section 3.1, 
allows analysis of cellular uptake of ^ Cu-ATSM. Simulated results of ^ ''Cu-ATSM uptake in a 
2D tumour-bearing vasculature are compared herein with results reported by Oh et al (2009), 
which is in close agreement with the findings of Tanaka et al (2006). All studies have agreement 
on the correlation between the numbers of proliferating cells using immunohistochemical 
staining images and ^''Cu-ATSM uptake using autoradiography. The immunohistochemical 
staining image using the cells proliferation, BrdU, taken from Oh et al (2009), is represented in 
the right panel of figure 3, whereas, the simulation finding is represented in the left panel. With 
the cell proliferation in Oh et al (2009) appearing in brown (online version), the maximum 
cellular uptake of ^ ''Cu-ATSM appears in red (online version).
Similarly, a comparative analysis of simulated intra-tumour distributions of ^Cu-ATSM 
was preformed against typical findings of Oh et al (2009). The experimental findings show 
a greater accumulation of ^''Cu-ATSM at the tumour edges of Lewis lung carcinoma cells 
(LLCl), where tumour hypoxia typically occurs in the regions with the most populated viable 
tumour cells. The tracer biodistribution was imaged using autoradiography; representation of 
typical intra-tumour biodistributions is in the left panel of figure 4. Simulation finding shows
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Figure 4. Demonstration o f the % net uptake with respect to different tumour regions. Simulation 
results are represented in the diagram on the right, illustrating high uptake at the tumour surface, 
becoming greatly reduced near the tumour core. Simulation results show good agreement with the 
real biodistribution o f ATSM tracer determined using autoradiography; image taken from Oh et al 
(2009). Reprinted from Oh et al (2009, p 422), with permission from Elsevier.
good agreement with typical intra-tumour ATSM distribution, where the highest net uptake 
of ^''Cu-ATSM was seen at the tumour surface, with a net percentage uptake of 58%. This 
reduces to 14% near the tumour core. A diagram representing simulation findings is shown in 
the right panel of figure 4.
4.3. Simulated ^^Cu-ATSM and ^^F-FMISO tissue activity curves
Simulated tissue activity curves (TACs) of ^Cu-ATSM are generated using de-identified 
patient plasma input data (Mintun et al 2000). Representation of simulated results using two 
patient data sets are shown in figure 5; the plasma input function (de-identified data) was 
provided by Drs Farrokh Dehdashti and Jason Lewis, Washington University, St Louis, MO, 
USA. Both curves were validated using a key potential characteristic known as the tumour to 
blood ratio (T/B). Clinically this quantity is a key factor in addressing issues of imaging local 
contrast. With a high T/B  ratio (T/B >  3) the targeting of positive lesions on clinical imaging 
can be generated with high sensitivity and speeificity. In figure 5, the simulated results show 
a very similar T/B  ratio, with 2.6 and 2.24 for curve 1 and 2 respectively.
Figure 6 illustrates the simulated tissue activity curves for ^''Cu-ATSM and '^F-FMISO, 
both being generated using one arbitrary plasma input function. Simulated results show a 
significantly higher T/B  ratio figure using ATSM if compared to FMISO. In the literature, 
a number of in vivo and ex vivo studies have shown that ATSM provides reasonably high 
imaging contrast, leading to better inter-intra variance in the image. A distinguishable tumour 
to blood ratio in the range of )g>2 was demonstrated in Dence et a l (2008), whereas in Yuan 
et al (2006) the tumour to blood ratio was up to 5. Simulation findings for ATSM show good 
agreement if compared with finding of those in vivo and ex vivo studies, where simulation 
results of ATSM tissue activity curves reveals a T/B ratio ranging from 2.24 to 4.1, based 
on transvascular permeability conditions. Using FMISO the simulated T/B >  1.4, whereas 
the typical T/B  > 1 .2  for FMISO (Rasey et al 2000). The differenee is in part related to the 
differences assoeiated with the biochemical and biophysical properties of each tracer. Among
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TACs generated using two different plasma input functions of two patients
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Figure 5. Simulated TACs generated using two plasma input functions, taken from two different 
patients (data de-indentified), where transvascular permeability was chosen to be 1 . 2 2  mm s~', 
and MVDs ~121 vessel mm~^.
Comparison between TAG of ATSM and FMISO
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Figure 6. Tissue activity curve for ATSM and FMISO showing high image contrast using ATSM 
with T/B > 3.0 and lower image contrast using FMISO with T/B >  1.4.
these characteristics the partition coefficient, which plays a significant role in tracer cellular 
perfusion, leads to a significant influence on the transvascular permeability, see table 1. The 
quantitative analysis presented in Lewis et al (1998) for real blood to tumour active curves 
highlights the potential effect of cellular metabolism. It was clearly demonstrated that local 
contrast on the image improves dramatically 5 min after tracer injection. Thus, real T/B  ratios 
show inconsistent values along the time frame intervals, with low T/B  ~  1 immediately after 
injection, to high T/B  > 3 after 20 min from injection. However, in general, simulation results 
reveal a consistent value of the T/B  ratio. This in part is related to the tracer washout rate and 
the metabolic activity factor, which have been neglected in the main model in equation (1).
4.4. Tumour structure and ^Cu-ATSM uptake
Of note is that solid tumours are associated with a number of vascular architecture disorders, 
especially in geometry and structure of blood vessel. They are disorganized, highly permeable 
and become leaky, twisted, unevenly distributed with irregular diameter and unusual branching
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Figure 7. Simulated TACs using a single plasma input function, with the argument of 
heterogeneous structure of transvascular permeability ranging from 1.2 to 2 mm s " \  MVDs 
~ 1 2 1  vessel mm~^.
Local co n tra st and b lood  v e s s e l  condition
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Figure 8 . The effect o f tumour vascular conditions on local image contrast, with transvascular 
permeability varying from 1.2 to 2 mm s“ ^ The local contrast in terms of the T /B  ratio increases 
significantly from 2.24 to 3.27; MVDs ~121 vessel mm“ .^
patterns (Padhani et al 2007). This leads to high perfusion and limited diffusion areas, 
see figure 7. This supports the argument concerning the heterogeneous condition of blood 
vessel structure among tumour regions. The assumption to build on different transvascular 
permeability levels at different regions of the same tumour is realistic, leading to a significant 
impact on image local contrast as shown in figure 8.
5. Conclusions
The aim of radiotherapy is to achieve maximum therapeutic benefit in terms of adequate 
local control of the disease while maintaining dose to the surrounding normal tissue to a 
minimum. Techniques such as intensity-modulated radiotherapy (IMRT) provide the means 
for radiation dose delivery to achieve the desired dose distributions. However, tumour control 
for locally advanced head and neck squamous cell carcinoma has been less than satisfactory
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with an estimation of recurrence rate of 30%. This in part is due to tumour hypoxia. A 
hypoxic tumour sub-volume guided IMRT technique could be used as a novel approach 
to escalate radiation dose in only selective hypoxic regions within the gross target volume 
(GTV) without compromising the advantage of normal tissue sparing of IMRT (Chao et al 
2001, Thorwarth et al 2007). However, in order to benefit from such treatment, knowledge 
on the severity of hypoxia as well as its spatial extent is required. As a result the choice of 
the radiopharmaceutical that allows examination of certain pathophysiology pathways within 
the tumour is of great importance. Nevertheless, confirming the appropriate thresholding 
method to delineate the considered tumour sub-volume is of greater significance. The poor 
spatial resolution of typical PET images (i.e. >5 mm) and the low image contrast using 
hypoxia sensitive reagents, such as FMISO, are a limitation on improving local control 
based on boosting hypoxic regions. Clinical evidence has shown that with a high T/B  ratio 
(T/B >  3) targeting of positive lesions on PET imaging can be generated with high sensitivity 
and specificity. With such high contrast oncologists and nuclear medicine radiologists would 
be able to image ATSM with satisfactory tumour/muscle contrast to identify the hypoxic 
tumour sub-volume as early as 1 h after the ATSM injection (Dence et al 2008). From 
which the acquired imaging would therefore represent the accumulative changes in tumour 
oxygenation dynamics during this period of time, where ATSM is only present in cells with 
intact mitochondria (i.e. viable tumour cells) and which suffer a lack of electron carriers. 
Herein the simulated tissue activity curves generated demonstrate the potential high contrast 
of imaging using ATSM if compared to FMISO, with an average tumour to blood ratio of >3 
and > 1.4, respectively. Thus, ATSM should allow for more accurate and reliable delineation of 
hypoxic tumour sub-volume due to its high local imaging contrast. This is in close agreement 
with expected properties of such tracers and so ATSM may provide sufficient knowledge on 
the severity of hypoxia. Hypoxia and likewise tissue activity curves (TACs) are heterogeneous 
problems. Therefore, tumours that appear identical in clinical and radiographic examination 
may have significantly different tumour sub-volume delineation. Simulation findings illustrate 
clearly the influence of transvascular heterogeneity even on the same tumour as shown in 
figures 7 and 8.
Acknowledgments
The authors would like to thank Dr Farrokh Dehdashti of the Washington University School 
of Medicine, USA and Dr Jason Lewis of the Memorial Sloan-Kettering Cancer Center, USA 
for provision of the de-identified ATSM plasma input functions (generated under NIH grants 
CAS1525 and DOE grant DE-FG02-87ER60512) and for Dr Lewis for his critical comments. 
We also wish to thank Dr David Lloyd and Dr Anne Skeldon of the Department of Mathematics, 
University of Surrey, for support in the development of the computational code. Finally, the 
first author acknowledges the support of the Libyan government in providing a studentship 
which allowed this work to be undertaken.
References
Aft R, Lewis J, Zhang F, Kim J and Welch M 2003 Enhancing targeted radiotherapy by copper(II)diacetyIbis(7/4- 
methylthiosemicarbazone) using 2-Deoxy-D-GIucose Cancer Res. 63 5496-504  
Barthel H, Wilson H, Collingridge D, Brown G, Osman S, Luthra S, Brady F, Workman P and Price O 2004 
In vivo evaluation of [**F]fluoroetanidazole as a new marker for imaging tumour hypoxia with positron emission 
tomography Br. J. Cancer 90 2232-42  
Basken N  E and Green M A 2009 Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: 
further definition of species dependence and associated substituent effects Nucl. Med. Biol. 36 495-504
Simulation of tissue activity curves of ^ '^Cu-ATSM for sub-target volume delineation in radiotherapy 693
Beckman R, Weiner L and Davis H 2007 Antibody constructs in cancer therapy Cancer 109 170-9 
Berk D, Yuan M and Jain R 1993 Fluorescence photobleaching with spatial fourier analysis; measurement of diffusion 
in light-scattering media Biophys. J. 65 2428-38 
Chao K S C, Bosch W R, Mutic S, Lewis J S, Dehdashti F, Mintun M A, Dempsey J F, Perez C A, Purdy J A 
and Welch M J 2001 A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity- 
modulated radiation therapy Int. J. Radiat. Oncol. Biol. Phys. 49 1171-82 
Cowan D, Hick K and Wilson W 1996 Multicellular membranes as an in vitro model for extravascular diffusion in 
tumours Br. J. Cancer 27 28-31 
Cussler B 1984 Diffusion: Mass Transfer in Fluid Systems (Cambridge: Cambridge University Press)
Cutler C S, Lewis J S and Anderson C J 1999 Utilization of metabolic, transport and receptor-mediated processes to 
deliver agents for cancer diagnosis Adv. Drug Delivery Rev. 37 189-211 
Dalah E, Lloyd D, Skeldon A, Bradley D and Nisbet A 2009 Simulating the heterogeneous distribution of 0% partial 
pressure in 2D vasculature using the reaction diffusion model Phys. Med. Biol, submitted 
Dence C, Ponde D, Welch M and Lewis J 2008 Autoradiographic and small-animal PET comparisons between 18F- 
FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer Nucl. Med. 
Bio/. 35 713-20
Fischkoff S and Vanderkool J 1975 Oxygen diffusion in biological and artificial membranes determined by the 
fluorochrome pyrene J. Gen. Physiol. 65 663-76 
Fukui B, Blodgett M and Meltzer C 2003 PET/CT imaging in recurrent head and neck cancer Semin. Ultrasound CT 
M R/24 157-63
Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J and Yokoyama A 1997 Copper-62-ATSM: a new hypoxia 
imaging agent with high membrane permeability and low redox potential J. Nucl. Med. 38 1155-60 
Goshen E, Davidson T, Yahalom R, Talmi Y and Zwas S 2006 PET/CT in the evaluation of patients with squamous 
cells cancer of the head and neck Int. J. Oral Maxillofac. Surg. 35 332-6 
Grégoire V, Haustermans K, Geets X, Roels S and Lonneux M 2007 PET-based treatment planning in radiotherapy: 
a new standard? J. Nucl. Med. 48 68S-77S 
Huang C, Yu X, Bading J and Conti P 1998 Feature extraction by subspace fitting of time activity curve in PET 
dynamic studies IEEE 2 1721-5 
Kelly C and Brady M 2006 A model to simulate tumour oxygenation and dynamic [18FJ-FMIS0 PET data Phys.
Med: Bzo/. 515859-73  
Kim S and Sue T 2006 Imaging in radiation therapy Nucl. Eng. Technol. 38 327-38 
Laidler K 1978 Physical Chemistry with Biological Applications (New York: Benjamin/Cummings)
Lehtio K, Oikonen V, Grbnroos T, Eskola 0 , Kalliokoski K, Bergman J, Solin O, Grènman R, Nuutila P and 
Minn H 2001 Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with ['^0]H20 
and [*^F]fluoroerythronitoimidazole PET J. Nucl. Med. 42 1643-52 
Lewis J, McCarthy D, McCarthy T, Fujibayashi Y and Welch M 1998 Evaluation of ®‘*Cu-ATSM in vitro and in vivo 
in hypoxia tumour model J. Nucl. Med. 40 177-83 
Lewis J, Sharp T, Laforest R, Fujibayashi Y, Buettner T, Kwei Song S and Connett J 2001 Copper-64-diacetyl-bis 
(W-mehylthiosemicarbazone): an agent for radiotherapy J. Nucl. Med. 98 1206-11 
Marieb E 2004 Human Anatomy and Physiology 6th edn (New York: Benjamin Cummings)
McCarthy D, Bass L, Cutler D, Shefer R, Klinkowstein R, Herrero P, Lewis J, Cutler C, Anderson C and 
Welch M 1999 High purity production and potential applications of copper-60 and copper-61 Nucl. Med. 
B/o/. 26 351-8
McQuade P, Martin K E, Castle T C, Went M J, Blower P J, Welch M J and Lewis J S 2005 Investigation into ®"*Cu- 
labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents Nucl. 
Med. B io/ 32 147-56
Mintun M A, Berger K, Dehdashti F, Lewis J, Chao C and Welch M 2000 Kinetic analysis of the novel hypoxia 
imaging agent [^^CujATSM in human neoplasms J. Nucl. Med. 4158 Ref Type: Abstract 
Obata A et al 2005 Basic characterization of ^ ''Cu-ATSM as a radiotherapy agent Nucl. Med. Biol. 32 21-8  
Obata A et al 2003 Intra-tumoral distribution of 64Cu-ATSM: a comparison study with FDG Nucl. Med. Biol. 
30 529-34
Oh M, Tanaka T, Kobayashi M, Furukawa T, Mori T, Kudo T, Fujieda S and Fujibayashi Y 2009 Radio-copper-labeled 
Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model 
Nucl. Med. Biol. 36 419-26
Padhani A, Krohn K, Lewis J and Alber M 2007 Imaging oxygenation of human tumours Eur. J. Radiol. 
17 861-72
Rasey J, Casciari J, Hofstrand P, Muzi M, Graham M and Chin L 2000 Determining hypoxic fraction in a rat glioma 
by uptake of radiolabeled fluoromisonidazole Radiat. Res. 53 84-92
694 E Dalah et al
Rothschild S, Studer G, Seifert B, Huguenin P, Glanzmann G, Davis B, Lütlof U, Hany T and Ceiemik F 2007 
PET/ CT staging followed by intensity modulated radiotherapy (IMRT) improves treatment outcome of locally 
advanced pharyngeal carcinoma a matched-pair comparison Radiat. Oncol. 2 1 -10
Salathè E and Kolkka R 1986 Reduction of anoxia through myoglobin-facilitated diffusion of oxygen J. Biophys. 
Boc. 50 885-94
Sokoloff L, Reivich M, Kennedy C, Des Rosiers M H, Patlak C S, Pettigrew K D, Sakurada O and Shinohara M 1977 
J. Neurochem. 28 897-916
Tanaka T, Furukawa T, Fujieda S, Kasamatsu S, Yonekura Y and Fujibayashi Y 2006 Double-tracer autoradiography 
with Cu-ATSM/ FDG and immunohistochemical interpretation in four different mouse implanted tumour models 
Nucl. Med. Biol. 33 743-50
Thorwarth D, Eschmann S M, Paulsen F and Alber M 2007 Hypoxia dose painting by numbers: a planning study Int. 
J. Radiat. Oncol. Biol. Phys. 68 291-300
Vavere A and Lewis J 2007 Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia J. R. Soc. Chem. 43 
4893-902
Wood K, Wang W and Saunders M 2008 [64Cu]diacetyl-bis(N4-methyl-thiosemicarbazone)— a radiotracer for tumour 
hypoxia Nucl. Med. Biol. 35 393-400
Yuan F, Dellian M, Fukumura D, Leunig M, Berk D, Torchilin V and Jain R 1995 Vascular permeability in human 
tumour xenograft: molecular size dependence and cutoff size Cancer Res. 55 3752-6
Yuan H, Schroeder T, Bowsher J, Hedlund L, Wong T and Dewhirst W 2006 Intertumoral differences in hypoxia 
selectivity o f the PET imaging agent ®‘^ Cu(II)-diacetyl-bis(NLmethylthiosemicabazone) J. Nucl. Med. 47 989-98
N uclear Instrum ents and M ethods in  Physics Research A I (n i l)  III III
M s
ELSEVIER
C o n t e n t s  l i s t s  a v a i la b le  a t  S c ie n c e D ir e c t
Nuelear Instruments and Methods in 
Physics Research A
, j o u r n a l  h o m e p a g e :  w w w . e l s e v i e r . c o m / l o c a t e / n i m a
INrfnUMEWT* 
A METHODS
A mathematical approach towards simulating a realistic tissue activity curve 
of "^^ Cu-ATSM for the purpose of sub-target volume delineation in 
radiotherapy
E D a l a h D  Bradley^, A Nisbet
^ Departm ent o f Physics, University o f  Surrey, Guildford GU2 7XH, UK 
^D epartm ent o f Medical Physics, Royal Surrey County Hospital, Guildford, UK
A R T I C L E  I N F O
Keywords:
Tissue activity curve 
G"Cu-ATSM 
Tissue to blood ratio 
Reaction diffusion m odel
A B S T R A C T
One unique feature of positron em ission tom ography (PET) is that it allows m easurem ents of regional 
tracer concentration in hypoxic tumour-bearing tissue, supporting the need for accurate radiotherapy 
treatm ent planning. Generally the data are taken over m ultiple tim e frames, in the form o f tissue  
activity curves (TACs), providing an indication o f the presence of hypoxia, the degree o f oxygen  
perfusion, vascular geom etry and hypoxia fraction. In order to understand such a com plicated  
phenom enon a number o f theoretical studies have attem pted to describe tracer uptake in tissue cells. 
More recently, a novel com puterized reaction diffusion equation method developed by Kelly and Brady 
has allow ed simulation of the realistic TACs of ’®F-FMISO, w ith  representation of physiological oxygen  
heterogeneity and tracer kinetics. W e present a refinem ent to the work of Kelly and Brady, w ith  a 
particular interest in sim ulating TACs o f the m ost promising hypoxia selective tracer, '^‘Cu-ATSM, 
demonstrating its potential role in tumour sub-volum e delineation for radiotherapy treatm ent 
planning. Simulation results have demonstrated the high contrast of imaging using ATSM, w ith  a 
tumour to blood ratio ranging 2 .24-4 .1 . Similarly, results o f tumour sub-volum es generated using three 
different thresholding m ethods w ere all w ell correlated.
© 2009 Elsevier B.V. All rights reserved.
1. Introduction
T oday it  is w e l l  a p p recia ted  th a t h y p ox ia  p lay s a s ig n ifican t 
role in  tu m o u r re sista n c e  to  rad io th era p y  trea tm en t, ch e m o th e r ­
apy, trea tm en t [ 1 ] and  a lso  o f  su rgery  [2 ], th is  b e in g  a ttr ib uted  to  
th e  e ffec t o f  o x y g en . Ideally , th e  p r esen ce  o f  o x y g e n  is required  to  
repair th e  in d u ced  d a m a ge  to  DNA b y  rad iation . It appears a lso  
th a t o x y g e n  p lays a m ajor role in  in crea sin g  th e  d a m a ge produced  
b y  rad ia tion  [2]. A n a d eq u ate  lev e l o f  o x y g en a tio n , ap p rox im ate ly  
2 5 - 3 0  m m H g, w o u ld  s ig n ifican tly  in crea se  th e  e ffe c tiv e  h a lf-life  
o f  th e  to x ic  free rad icals, th u s c a u sin g  fu rth er d a m a g e  to  th e  cell 
c o m p o n en ts . T his in  turn, e x p la in s  th e  p o or  loca l con tro l and  
q u a lity  o f  life  s o m e tim e s  e x p er ien ced  b y  su rv ivors o f  sq u am ou s  
cell carcinom a o f  h ea d  and n eck  and  cerv ix  cancer, w h er e  
p 0 2 < 1 0 m m H g [3].
One unique feature o f positron em ission  tom ography (PET) 
im aging is that it a llow s m easurem ents o f  regional tracer concentra­
tion  in tissue and different body  organs, quantitatively and non- 
invasively. The objective o f  such procedure is, in general, to  find a set
* Corresponding author. Tel.: + 4 41483  689416; fax: + 441483  686781. 
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o f  features w h ich  have both  inter- and intra-variance in hypoxic  
tum our-bearing tissue. To-date possib ly th e m o st w ell-in d ica ted  
alternative to  ’®F-FM1S0 as a hypoxic reagent is ^Cu-ATSM [4].
D e term in in g  th e  r e la tio n sh ip  b e tw e e n  th e  reg ion a l tracer  
c o n cen tra tio n  in  t is su e , in  th e  form  o f  t is su e  a ctiv ity  cu rves  
(TACs), sh a p e  a n d  th e  u n d er ly in g  tu m o u r p h y sio lo g y  is  o f  
fu n d a m en ta l im p o rta n ce , as k n o w le d g e  o f  th e  tu m o u r  e n v ir o n ­
m e n t  m a y  h e lp  d e te r m in e  th e  m o s t  lik ely  co u rse  o f  a re sp o n se . 
Standard  te c h n iq u e s  su c h  as c o n v en tio n a l c o m p a r tm e n t m o d e ls  
are lim ite d  as th e y  a ssu m e  th a t each  c o m p a r tm e n t is  a 
m a th em a tica l ab straction , in d e p e n d e n t o f  its  lo ca tio n . T hus, th e  
d iffu sib le  tracer is lik e ly  to  b e  h o m o g e n e o u s  across th e  v a sc u ­
lature, w h ic h  is far from  rea lity , as argued b y  Ref. [5 ]. K elly  and  
Brady h a ve  d e v e lo p e d  a n o v e l com p u ter ized  reaction  d iffu sio n  
m e th o d  [5] to  s im u la te  rea lis tic  TACs o f  ’ ®F-FM1S0, w ith  
r e p resen ta tio n  o f  v a scu la tu re  arch itectu re and tracer k in e tic s . 
H ere, w e  p r e se n t a r e fin e m e n t to  th a t w ork, sh o w in g  a particu lar  
in ter e s t  tow a rd s  s im u la t in g  th e  TACs o f  ^''Cu-ATSM. F u rth erm ore, 
w e  a tte m p t to  d e m o n s tra te  th e  p o ten tia l u se  o f  '^’Cu-ATSM in  
rad ia tion  th era p y  tr e a tm e n t p lan n in g  as an in d ica tor  o f  tu m o u r  
h y p o x ic  reg ion s. In th is  w o rk  all s im u la tio n s  h a v e  b e e n  c o d ed  in  
2 0 ,  for a v a scu la tu re  s iz e  o f  4 m m ^ , u s in g  M atlab  2 0 0 7 b  and  f in ite  
d ifferen ce  m e th o d s .
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2. The reaction diffusion model
In th is w o rk  w e  s im u la te  rea listic  TACs o f  ®'*Cu-ATSM, w ith  
rep resen ta tio n  o f  th e  c o m p le x ity  o f  v ascu lar arch itectu re, tracer  
d iffu siv ity , tracer  b in d in g  rate, tran svascu lar p erm ea b ility  an d  
blood  v e s se l  d e n s it ie s . T hus, th e  reaction  d iffu sio n  m o d e l  
s im u la tin g  ®"*Cu-ATSM h e te r o g e n e ity  in  2D  can  b e  d escr ib ed  as:
C o m p a r iso n  b e tw e e n  TAG o f  ATSM  a n d  FMISO
dTr(x,y,t)
dt =  D jrV  Tr — kc iTr + - (^TVpiasma ~ Tr^ sue)^ ) (1)
w h er e  Tr is  th e  con cen tra tio n  o f  th e  tracer (®'’Cu-ATSM) in t is su e  
ce lls , in pC i/m l, Dpr is  th e  d iffu sion  co e ffic ie n t o f  tracer  in  
m m ^ s " \  kon is th e  b in d in g  rate o f  ATSM in  s ' \  Trpiasma is  th e  
con cen tra tio n  o f  tracer in  th e  p lasm a  in pC i/m l, P„ is 
th e p erm ea b ility  o f  th e  v e s se l  to  th e  tracer in  m m s “ ’ , SjV is th e  
surface area  to  b lood  v e s se l  v o lu m e  in m m " ’ and R is  th e  
proportion o f  v e s se ls  co v er in g  th e  vascu la tu re.
The lo c a tio n  o f  b lood  v e s se ls  in th e  p lan e  (i.e . th e  vascu lar  
n a p )  is d escr ib ed  b y  th e  fu n ction  R(x). B lood v e s se ls  are ran d om ly  
Jistributed  in  th e  im ag in g  p lan e  on  a fixed  e q u a lly  sp aced  
Cartesian m e sh  k n o w n  as th e  v a scu la r  m esh . T he grid  p o in ts  on  
h e  v a scu la r  m e sh  w ill b e  d es ig n a te d  so  th a t w h e r e  th ere  is a 
vessel th e  v a lu e  o n  th e  m e sh  w ill  b e  ‘o n e ’ and  w h e r e  th ere  is no  
vessel th e  v a lu e  w ill  b e  zero , u s in g  a prob ab ility  m a ss  fu n ction  Rfj 
lefin ed  o n  th e  b a sis  o f  in d iv id u a l probab ility , p . T hus, th e  grid  
)oints are:
1  i f  Rij =  1 = p  
0  i f  Rjj =  0  =  1  — p  ’
able 1
aseline parameters applied in the model for the reagent ®''Cu-ATSM.
(2)
Property Parameter values (and reference)
Diffusion coefficient (calculated) 5 .05x lQ -'*m m ^ S - ’ [6]
Thickness o f  blood vessel membrane 0 .2 -1  pm  [7]
(X)
Permeability calculated 1.12-5.61 m m s" ' [8.9]
Blood vessel radius (r) 8 - 1 0 pm  [7]
Surface area to volum e ratio (S/V) 170 -2 8 5  m m -'
Micro-vessel density (MVDs=W) 240 vessel m m -^ (at tum our surface)
[11]
M icro-vessel density (MVDs=N) 60 vessel m m '^  (near tumour surface)
[11
Rate o f tracer binding (kon) 0.0003 s - '  [2,13]
TA Cs g e n e ra te d  u sin g  tw o  d iffe ren t p la sm a  inpu t fu n c tio n s  o f  tw o  p a tie n ts
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. 1. Sim ulated TACs generated using tw o plasma input functions, taken from 
) different patients (data deindentified). w here transvascular permeability was 
sen to be 1 .2 2 m m s “ \  and MVDs approximately 121 vessel/mm^.
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Fig. 2. Simulated TACs using the plasma input function for patient 1, w ith the 
transvascular permeability ranging 1 .2 -2 m m s ” ’ and MVDs approximately 121 
vessel mm"^.
Table 2
The influence o f transvascular permeability status on tum our local contrast; 
m easurements are presented in term o f mean ±  SO, n=15.
Permeability level (m m /s) T/B ratio
1.22 2.6 ± 0 .0 0
1.5 3 .1 + 0 .0 0
1.8 3.6 ± 0 .0 5
2.0 4.1 ± 0 .0 1
w h e r e  p  is  d e fin ed  as: 
MVDs X nr^
P = M (3)
w ith  MVDs th e  m ic r o -v e sse l d e n s ity  (i.e . th e  n u m b er  o f  v e s se ls  
per u n it  area or v o lu m e ), r th e  rad iu s o f  b loo d  v e s se l  and M  th e  
spatia l e x te n t  o f  th e  s im u la ted  v a scu la tu re, in  th is  c a se  4 m m ^ .  
T he vascu la r  m ap, R(x), is  th en  d e fin ed  as:
i = Oj = 0
(4)
w h e r e  x,- are th e  ran d om  lo ca tio n s  o f  N  b lo o d  v e s se ls  in  th e  
v ascu la tu re  and 6 is  th e  D irac d e lta  fu n ction . H en ce , R(x) w ill  b e  
zero  ev e r y w h e r e  o th er  th a n  a t p o in ts  x, w h e r e  =  1. F o r a  g o o d  
n u m erica l a p p rox im ation  o f  R(x), a su m  o f  G au ssian  fu n ctio n s  is 
ap p lied , as fo llo w s:
(5)
w ith  2a^ th e  w id th  o f  th e  G aussian , g iv in g  th e  rad iu s o f  th e  b lood  
v e sse l (r^= 2 a^) and x ,j  th e  ran d om  lo c a tio n s  o f  th e  cap illaries  
(n o tin g  th a t th e y  d o  n o t  h a v e  to  b e  n o rm ally  d is tr ib u ted ).
3. Results
3.1. Baseline values
All p h y sica l and b io log ica l b a se lin e  p a ram eters  a p p lied  in  th is  
w o rk  w e r e  d e te r m in e d  from  an e x h a u s t iv e  litera tu re  search ; s ee  
T able 1 for th e  c o m p le te  s e t  o f  th e se  b a se lin e  v a lu e s .
3.2. Simulated ^^Cu-ATSM tissue activity curves
S im u la ted  t is s u e  a ctiv ity  cu rves (TACs) o f  ®'’Cu-ATSM are  
g en era ted  u s in g  d e id e n tif ied  p a tie n t p la sm a  in p u t d ata  [6 ]. 
R ep resen tation  o f  s im u la ted  resu lts  u s in g  tw o  p a t ie n t  d ata  se ts
lease cite this article as: E Dalah, et al., Nucl. Instr. and Meth. A (2009), doi:10.1016/j.nima.2009.10.160
E Dalah e t  al. /  Nuclear Instruments and M ethods in Physics Research A I ( im )  i i l - l i l
tumour sub-volum e defined at 40%  suv tumour sub-volum e defined at 15% of m ean  intensity tumour sub-volum e defined at T/B > 2
Q  surface □  middle Q  core E3 surface g  m iddle O  core 0  su rface  g  middle CD core
liiii
'p i i i i i l  
p i i i i i i '
49%
26%
14%
lilt
. . .ir 31%60%
13%
|iiiIIP 56%
Fig. 3 . Results o f com parative analysis for tumour sub-volum e regions wittiin 2D tumour-bearing vasculature. The threshold levels w ere defined using three different 
m ethods (see text for details). Real plasma input function data w ere used and a transvascular permeability o f 1 .2 m m s“ ’ w as assum ed. Analysis w as made using the 
highest ATSM uptake value.
a re sh o w n  in Fig. 1; p lasm a  in p u t fu n c tio n  (d e in d en tified  data) 
w a s  provided  b y  Dr. Farrokh D eh d ash ti and Dr. Jason  Lewis, 
W a sh in gto n  U n iversity , St. Louis, M issouri, USA. B oth  curves w e r e  
v alid a ted  u s in g  a k ey  p o ten tia l ch a ra cter istic  k n o w n  as th e  
tu m o u r  to  b lo o d  ratio  (T/B). C lin ically  th is  q u a n tity  is a key  
factor  in a d d ress in g  is su e s  o f  im ag in g  lo ca l con trast. W ith  a h igh  
T/B ratio  (T/B >  3 )  th e  ta r g e tin g  o f  p o s it iv e  le s io n s  o n  c lin ica l 
im ag in g  can  b e  g en er a te d  w ith  h igh  sen sit iv ity  an d  sp ecific ity . In 
Fig. 1, th e  s im u la ted  resu lts  s h o w  a v ery  s im ilar  T/B ratio, w ith  2 .6  
and  2 .2 4  for cu rves 1 an d  2  r e sp ec tiv e ly .
3 .3. Tumour structure and ^Cu-ATSM uptake
T he s im u la ted  t is s u e  a ctiv ity  cu rves o f  Fig. 2  ad d ress th e  
h e te r o g e n e ity  o f  b loo d  v e s se l  s tru ctu re  a m on g  tu m o u r  regions. 
H ere, d ifferen t p erm ea b ility  lev e ls  h a v e  b een  a d o p ted  for th e  
sa m e  tum our, th e  resu lts  in d ica tin g  s ig n ifican t im p a ct on  im ag e  
loca l con tra st ( s e e  T able 2  for d eta iled  in form ation ).
3 .4 . Evaluation of tumour sub-volume target
S h o w n  in Fig. 3 are o u r  s im u la tio n  r esu lts  o b ta in ed  u s in g  th ree  
d ifferen t th resh o ld in g  m e th o d s . T he first o f  th e se  th resh o ld in g  
m e th o d s , rep resen ted  b y  Ref. [7] and  u s in g  th e  stand ard  uptake  
v a lu e  (SUV) revea ls  49% o f  th e  v o lu m e  o f  in ter e s t  (VOl) [8 ] to  
o ccu r  w ith in  th e  tu m o u r  su rface, w ith  o n ly  20% o f  th e  VOl 
o ccu rin g  near th e  core. U s in g  th e  sec o n d  th r e sh o ld in g  m eth o d , 
r ep resen ted  b y  Ref. [9] and u s in g  th e  s ig n a l-to -b a ck gro u n d  ratio, 
s h o w s  60% o f  th e  VOl to  occu r  w ith in  th e  tu m o u r  surface, 
red u cin g  in v a lu e  to  14% near th e  tu m o u r  core. S im ilarly, th e  third  
m e th o d  o f  th resh o ld in g , rep resen ted  b y  Ref. [10 ] and u sin g  
tu m o u r  to  m u sc le  ratios, in d ica tes  56% o f  th e  VOl to  b e  s itu a ted  
w ith in  th e  tu m o u r  surfa ce  and o n ly  13% n ear th e  core. Our 
s im u la tio n  resu lts  s h o w  reason a b le  a g r e e m e n t w ith  th e  fin d ings  
o f  Ref. [10], th e  h y p ox ia  fraction  for th e  la tter  b e in g  in  th e  range
0 .1 6 6  +  0 .0 6 7 -0 .4 4 2  +  0 .0 9 4  for th e  d ifferen t tu m o u r  ce ll lin es  
w h ile  p resen t s im u la tio n  resu lts  s h o w  th e  h y p o x ic  lev e l to  b e  in  
th e  ran ge 0 .341  ± 0 .0 1 0 - 0 .0 2 2  +  0 .0 05 .
4. Conclusions
T he a im  o f  rad io th erap y  is  to  a ch ie v e  m a x im u m  th erap eu tic  
b e n e fit  in term s o f  a d e q u a te  loca l con tro l o f  th e  d ise a se  w h ile
m a in ta in in g  a m in im u m  d o se  to  th e  su rro u n d in g  n orm al t issu e . 
T ech n iq u es  su ch  as in ten sity  m o d u la ted  rad io th era p y  (IMRT) 
p rovid e th e  m ea n s  for rad iation  d o se  d e liv ery  to  a ch ie v e  th e  
d esired  d o se  d istr ib u tio n s. H o w ever, tu m o u r  con tro l for loca lly  
a d va n ced  h ea d  and n eck  sq u a m o u s ce ll  carcin om a h a s b e e n  less  
th a n  sa tisfacto ry . This is in  part d u e  to  tu m o u r  h y p ox ia . T he 
s im u la ted  t is su e  a c tiv ity  cu rves th a t  h a v e  b e e n  g en era ted  
d e m o n stra te  th e  p o ten tia l h igh  c o n tra st o f  im a g in g  u s in g  ATSM, 
w ith  a tu m o u r  to  b loo d  ratio  ran gin g  2 .2 4 - 4 .1 .  T his is in  c lo se  
a g r e e m e n t w ith  th e  e x p ec te d  p ro p erties  o f  su ch  tracers. H yp oxia  
and l ik e w is e  t is su e  a ctiv ity  cu rves (TACs) are h e te r o g e n e o u s  
p ro b lem s. T herefore, tu m o u rs  th a t ap p ear id e n tic a l in  c lin ica l and  
rad iograp h ic  e x a m in a tio n  m ay  h a v e  s ig n ifica n tly  d ifferen t tu ­
m o u r s u b -v o lu m e  d e lin ea tion . S im u la tio n  fin d in g s  illu stra te  
c learly  th e  in flu en ce  o f  tran svascu lar  h e te r o g e n e ity  e v e n  o n  th e  
sa m e  tu m o u r, as in  Fig. 2  and T able 2 . S im u la tio n  resu lts  for  
tu m o u r  s u b -v o lu m e s  g en era ted  u s in g  th e  th r e e  d ifferen t th r e sh ­
o ld in g  m e th o d s  w e r e  all w e ll  correlated . U p take w ith in  th e  en tire  
v o lu m e  o f  in ter e s t  w a s  fou n d  to  b e  m o s t  e v id e n t  a t th e  tu m o u r  
su rface. In co n tra st s ig n ifican tly  sm a ller  u p ta k e  w a s  o b served  
near th e  core , as e x p ec ted .
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A B S T R A C T
In radiotherapy the efficacy o f medical imaging is central to the selection and delineation of target 
volume. Of note is that target volum e is intended to be larger than tum our volum e, including a 
geometric margin that accounts for the possible uncertainties in patient set-up. However this reduces 
potential tissue sparing, irradiating not only the target but also normal tissue. Additionally, features of 
the object that appear in the 2D image display may be influenced by the appropriate w indow  level 
selection. This is especially critical for target volum e delineation in radiotherapy. The present work 
seeks to assess the effect o f w indow  level selection on feature size in CT, MR and PET images, use being 
made o f a NEMA body phantom and ProSoma™ 3D sim ulation software. In general, the w indow  level 
produced discrepancies of up to  ± 2  mm  in all imaging modalities.
, © 2009  Elsevier Ltd. All rights reserved.
1. Introduction
E xternal b ea m  rad io th erap y  can  be d efin ed  as th e  u s e  o f  
p rec ise ly  targ eted  h ig h -e n e r g y  rad iation  b ea m s, in c lu d in g  X-rays, 
g am m a  rays, e lec tro n s, had ron s and n eutron s, in particu lar  to  kill 
ca n cer  c e lls  and red u ce  tu m o u r  s iz e  (Kim and Sue, 2 0 0 6 ) . T his is 
fea s ib le  o n ly  if  th e  reg ion  o f  in ter e s t  (i.e. th e  target) can  b e  clearly  
d e lin e a te d  from  th e  su rrou n d in g  h ea lth y  t is su e  (R ajasekar e t  al., 
2 0 0 3 ) . Im p ro v em en t in  p h ysica l d o se  d istr ib u tio n  o b ta in ed  
th rou gh  u se  o f  in te n s ity  m o d u la ted  rad iation  th erap y  tech n iq u es  
(IMRT) p rovok es th e  issu e  o f  th e  accuracy  o f  targ et v o lu m e  
se le c t io n  and  d e lin e a tio n  o n  a 3D  b asis (D a isn e  e t  al., 2 0 0 3 ) . T hus 
said , it is  a lso  w e ll  a p p recia ted  th a t th e  m erg in g  o f  a n ato m ica l 
an d  fu n ction a l in form a tio n  h as s ig n ifican t im p a ct o n  im p rov in g  
s e le c t iv ity  and d e lin e a tio n  o f  ta rg e t v o lu m e  for certa in  ty p e s  o f  
ca n cer  su ch  as h ea d  an d  neck , n o n -sm a ll ce ll lu n g  cancer, cervical 
carcin om a and eso p h a g e a l carcinom a (G ergorie e t  al., 2 0 0 7 ) . M ore 
recen tly  so ftw a re  fu s io n  packages h ave b e e n  d ev e lo p ed , th e  in ten t  
o f  w h ic h  h a s b e e n  th e  reg ister in g  and fu s in g  o f  d ifferen t im ag in g  
m o d a lity  s e ts  o f  data, for a g iv en  tu m o u r site , for a g iv en  su bject. 
H ow ever, th e  lim ita tio n  o f  con ven tio n a l 2 -d im en sio n a l im a g in g  
has b e e n  th e  n e e d  to  a d ju st grey  sca le  w in d o w  and lev e l du rin g  
im a g e  cap tu rin g  o f  sp ec ific  structural featu res (K urim s e t  a l ,  
2 0 0 3 ) . T he d ia g n o stic  accu racy  o f  2D  section a l im a g in g  te c h n iq u es  
su ch  as c o m p u te r  tom og rap h y  (CT), m a gn etic  reason s  im a g in g  
(M Rl) as w e l l  as p o sitron  e m iss io n  tom ograp h y  (PET) m a y  b e  
in flu en ced  by th e  su ita b ility  o f  w in d o w  grey  sca le  s e le c tio n . This
* Corresponding author. Tel.: +441483689416; fax: + 441483 686781. 
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in  part red u ces th e  p o ten tia l d ia g n o stic  v a lu e  o f  th e  te c h n iq u e  as 
it  a lso  red u ces th e  accuracy  o f  ta rg e t d e lin e a tio n . C onsiderin g  
th e se  factors, th ere  is co n sid era b le  d em a n d  to  e v a lu a te  th e  e ffect  
o f  w in d o w  w id th  and w in d o w  lev e l s e le c t io n  on  th e  s iz e  o f  
fea tu res in th e  m ed ica l im age, th is  b e in g  th e  m o tiv a tio n  b eh in d  
th e  p r e se n t stu dy.
2. Materials and methods
2.7. Imaging facilities
2.1.1. GE Discovery IS PET/CT system
T he in teg ra ted  GE D iscovery  PET/CT sy s te m  in vo lv ed  in  th is  
s tu d y  m a k es u se  o f  a con ven tio n a l b ism u th  g erm a n a te  (BGO) 
d e te c to r  b lock  sy s tem , o fferin g  a variab le  in tr in s ic  fu ll w id th  ha lf­
m a x im u m  (FW HM ) reso lu tio n  o f  4 .8  and  5 .6  m m  for 2 -D  an d  3 -D  
im ag es, resp ective ly . T he s y s te m  c o m p le te ly  re lies  o n  th e  
corrected  CT data to  correct for th e  a tte n u a te d  511 keV  p h o ton s . 
In our ca se  a 2 -D  im a g e  m o d e  w a s  acq u ired  for  1 0 m in /2 fr a m e s  
( 2  b ed  p o sitio n s), th e  im age b e in g  reco n stru cted  to  an average  
th ick n ess  o f  4 .2 5  m m .
2.1.2. GE Lightspeed RT/16 CT scanner
CT sca n s w e r e  perform ed  w ith  an  a b d o m in a l p ro to co l u s in g  
th e  GE L igh tspeed  RT/16 CT scann er; im a g e s  w e r e  recon stru cted  
to  a th ick n e ss  o f  5 m m  w ith  a final r e so lu tio n  a t FW HM o f  
0.8 X 0.8 mm^ .
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U.3. CE SIGNA MR/11ST MRI scanner 
MRl sca n s w e r e  p erform ed  w ith  a p e lv ic  p ro toco l MRl acq ui- 
ition  u s in g  th e  GE SIGNA MRl for recon stru cted  s lice  th ick n esses  
)f 5 m m .
Î.2. Phantoms and registration software
1.2.1. Phantom details
The e x p er im en t w a s  carried  o u t u s in g  th e  com m ercia lly  
iva ilab le  NEMA (N ation al E lectrical M anufacturers A ssocia tion )  
standard b o d y  p h a n to m  (NEMA, 2 0 0 1 )  r eco m m en d ed  by  th e  
n tern ation al E lectro -tech n ica l C o m m ission  (NEMA, 2 0 0 1 ). The  
•^EMA lEC b o d y  p h a n to m  c o n sis ts  o f  s ix  filla b le  sp h eres o f  
/arious d iam eters , th e  a rra n gem en t a llo w in g  u se  in  eva lu ation  
] f  CT, MR and PET im a g es; fu ll in form a tio n  is provided  in th e  
^EMA lEC b o d y  p h a n to m  m a n u a l (NEMA, 200 1  ). Fig. 1 sh o w s  th e  
:om m ercia l NEMA b o d y  p h a n tom .
2.2.2. ProSoma™ 3D registration and fusion package
T he com m ercia l ProSoma™  s im u la tio n  so ftw a re  offers five  
different im age reg istra tio n  m e th o d s  th a t a llo w  fu s io n  o f  any tw o  
;e ts  o f  data: m anual, m arker-b ased , iso cen tre  a lign m en t, a u to ­
m atic and v o lu m e  b a sed  o n  co n to u r  data. In ad d ition , ProSoma™  
allow s for im ag e  m a n ip u la tio n  th a t a lters w in d o w  w id th  and  
w in d o w  lev e l sca le  to  o p t im iz e  th e  v ie w in g  o f  th e  fu ll d y n am ic  
range o f  in form ation  in  th e  im ag e . This h e lp s  to  h ig h lig h t lo w  and  
high con trast areas s ep a ra te ly  w h e n  b o th  featu res in  th e  im ag e  
have s im ilar  in ten sity .
2.2.3. Phantom preparations
For CT scan s th e  NEMA p h a n to m  w a s  filled  to  th e  top  (i.e. to  a 
v o lu m e o f  a p p rox im ate ly  9 .7  L) u s in g  w ater, th e  sp h eres  b e in g  
le ft  em p ty . Sim ilarly, for MRl sca n s  th e  p h a n tom  sp h eres  w ere  
again  le ft em p ty , th e  p h a n to m  b e in g  filled  w ith  w ater. Based  
o n  an earlier  s tu d y  b y  th e  a u th ors (D alah  e t  al., 2 0 0 8 )  w a te r  can b e  
an effic ien t MRl co n tra st reagen t. Finally, for PET scan s th e  
p h a n tom  w a s  filled  w ith  [^^F-FDG] (h a lf-life  109 .8  m in ), as w e r e  
th e  sp h eres (u n filled  sp h e r es  b e in g  u n d e te c ta b le  in  scan s). In 
th e  p resen t stu dy, to  e n su r e  sp h e r e  v isu a liza tio n , th e  ch o sen  
a ctiv ity  o f  sp h eres (4 0 M B q /4 8 m L ) w a s  so m e  1 50  t im e s  h igher  
th a n  th e  background a ctiv ity  in  th e  [^^F-FDG] filled  p h a n tom  
(51 .36  M Bq/9.7L).
-  " r+wST
3 . R e su lts
3.1. Assessing target diameter
C h an ges in  w in d o w  lev e l w e r e  fou n d  to  s ig n ifican tly  a ffect a ll 
o f  th e  CT, MR an d  PET im ag es. Fig. 2 sh o w s  th a t sp h eres  app eared  
sm a ller  b y  u p  to  2  m m  on  CT im ag es, th e  d iscrep an cy  b e in g  
g rea ter  for sp h eres  th a t range from  1 0 -1 7  m m  in d iam eter , w h ile  
Fig. 3  illu stra tes  th e  e ffec t o f  w in d o w  lev e l on  MR im ag es, a
Effect of Window level (WL) on CT Images
E%
Îx:
40 — Actual 
— W (-191) 
^ W ( - 5 4 2 )
35
30
25
20
15
10
5
1 2 3 4 6 70 5
Spheres features of increasing diameter
Fig. 2 . CT im ages and illustration o f the effect o f w indow  scale on sphere diam eter  
using ProSoma™.
Fig. 3 . Illustration o f the effect o f tw o different w indow  scales in MR images. The 
image on the right show s the largest sphere diameter to be 37 m m  and a central 
w indow  scale 29; the image on the left show s sphere diameter o f  39  m m  and a 
central w indow  scale 78. The manufacturers' given diameter is 37 mm.
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Fig. 1. Photograph o f the commercial NEMA body phantom.
Sphere features of increasing diameter
Fig. 4 . PET im ages and effect of w indow  level on spheres diam eter using  
ProSoma™.
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Table 1
Typical w indow  level used and minimum, m axim um  and central value for each o f the modalities CT, MR and PET.
M anufacturers’ given  
diam eter (mm )
CT W indow  level; min= — 577 HU, 
m ax=194H U, centre=191 HU. 
m ean ± S D , n=3
MRI (w ater) W indow  level: 
m in=8, m ax=49, centre=29. 
m ean ± S D , n=3
PET W indow level: m in=10, 
m ax=68, centre=39.m ean±SD , 
n=3
10 9.0 ± 0 .0 10.0 ± 0 .0 11.0 ± 0 .0
13 12.5 +  0.6 13.3 ± 0 .6 14.7 ± 1 .2
17 17.0 ± 0 .0 17.0 ± 0 .0 19.0 ± 0 .0
22 22.0 ± 0 .0 22.0 ± 0 .0 24.3 ± 1 .5
28 28.0 ± 0 .0 28.0 ± 0 .0 31.3 ± 2 .3
37 37.0 ± 0 .0 37.3 ± 0 .6 41.3 ± 0 .6
The uncertainties are the standard deviation o f the dispersion in the data.
d iscrep an cy  o f  u p  to  2 m m  b e in g  fou n d  for th e  largest sp h eres o f  
n o m in a l d ia m eter  3 7  m m  d u e  to  s tr e tc h in g  o f  th e  lu m in an ce  
lev e l fu n ction . For PET im ag es, th e  c h o ic e  o f  w in d o w  lev e l 
p rod u ced  a d iscrep an cy  o f  up  to  2  m m  (s e e  Fig. 4 ). Each im ag e  
m o d a lity  produ ced  a d ifferen t r e sp o n se  in  term s o f  o b served  
d ia m eter  v a lu e s  as n o ted  in  Table 1, w ith  CT im ag es  o b ta in ed  at 
typ ica l w in d o w  lev e ls  p rovid in g  a p e r fec t m a tch  for sp h ere  
d ia m eters  in th e  range 1 7 -3 7  m m . MR im a g es  provid ed  c lo se ly  
s im ilar  d ia m ete r  m e a su rem en ts  com p ared  to  th e  m an u factu rers’ 
g iv en  v a lu es  ( to  ~ l m m  or b etter). C on versely  for PET im ages, 
th e se  sh o w e d  a c o n sis te n t o v e r -e st im a te  in  sp h ere  d iam eter, 
p articu larly  for th e  larger sp h eres  ( 2 8 - 3 7  m m ), w h er e  a d ifferen ce  
o f  up  to  4 .3  ±  0 .0 5  m m  w a s  o b served . It is  o f  n o te  th a t typ ica lly  th e  
PET im a g es  w e r e  h igh ly  b lurred a t th e  ed g es , current ob serva tio n  
s h o w in g  blurring to  con tr ib u te  as m u ch  as 2 - 3  m m  to  th e  
d ia m eter  o f  a ll sp h eres larger th a n  13 m m  as a resu lt o f  th e  
partial v o lu m e  effect p h en o m en o n .
4. Discussion
In m ak in g  a n y  m e a su rem en ts  u s in g  an y  im ag in g  m a n ip u la tio n  
so ftw a re  for in sta n ce  ProSoma™, i t  is  im p o rta n t for c o n sis te n c y  
th a t th e se  b e  referred to  a particu lar w in d o w  lev e l, sp ec ified  in  
te r m s  o f  m in im u m , m a x im u m  and  cen tra l v a lu es. G iven th a t 
w in d o w  lev e l h as a p o w erfu l e ffe c t  u p o n  v isu a liza tio n  o f  an  ob ject 
an d  its  ed g es , th is  sh ou ld  b e  d ea lt w ith  carefu lly  w h e n  ex a m in in g  
o b jec ts  in  any  im ag in g  m od a lity . As a resu lt th is  can  cau se  
co n sid era b le  p ro b lem s w h e n  m a n ip u la tio n  too l fac ilit ie s  are u sed  
to  a ss is t  in  d e lin e a tin g  a target for tr e a tm e n t p lan n ing.
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